Clinical guideline use and compliance: examining variation from the clinical pathway by Cooper Maidlow, Serin
i 
 
Clinical guideline use and compliance: 









Thesis submitted for the degree of 
Masters of Medical Science at the 












Clinical guidelines are developed with the aim of optimising patient care and have been 
shown to improve both clinical outcomes and the care process. ‘Hospital HealthPathways’ are 
guidelines published for use within Canterbury District Health Board (CDHB) hospitals.  
Previous research into guideline use and compliance in CDHB coined the term ‘appropriate 
non-compliance’, describing clinically appropriate variation from guideline recommendations. 
This study used a prospective methodology to observe access of and compliance with the 
Hospital HealthPathways Community Acquired Pneumonia (CAP) guideline and explore 
reasons for not accessing or not complying with the guideline. Cases of ‘appropriate non-
compliance’ were identified, and a target rate of compliance quantified, taking this into 
account. 
Based on findings from the previous research, ‘Practice Points’ – bullet points for emphasis 
and clarity – were added to acute pancreatitis and CAP guidelines. This study also evaluated 
the effect of these Practice Points.  
Findings from the study suggested that the purpose behind a guideline recommendation might 
influence compliance. A survey was performed to investigate this possibility. 
 
Method 
Demographic data, and data regarding compliance with five key CAP guideline 
recommendations was collected. Doctors were interviewed regarding their access of and 
compliance with the guideline. Logistic regression was used to perform subgroup analysis. 
Demographic data, and data regarding compliance with a ‘Practice Point’ added to the acute 
pancreatitis guideline was obtained for comparison with data from the previous CDHB 
research. 
A survey was designed using a modified three-round Delphi technique to investigate how 
often doctors thought they should comply with recommendations made for a variety of 
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different reasons, and the comparative importance they placed on the reasons behind the 
recommendations. 
Results 
Usage of the CAP guideline was 38%. Doctors stated they did not access the guideline 
because they had already made management plans or because they disagreed with the 
guideline. Both patient and doctor related factors were shown to affect whether guidelines 
were accessed. Doctor related factors were also shown to affect the reasons for not accessing 
the guideline. 
Compliance with four of the guideline recommendations ranged between 67.5-73.5%, 
however compliance with the recommendation regarding antibiotic choice was lower at 
47.5%, leading to poor overall guideline compliance (21.2%). Most doctors did not follow the 
antibiotic recommendation for objective reasons. Patient and doctor related factors were 
shown to affect overall guideline compliance. Doctor related factors were also shown to affect 
the reasons for non-compliance. The target rate of compliance with the antibiotic 
recommendation, taking into account appropriate non-compliance, was quantified as 62-72%.  
A significant increase in compliance of 13% was observed with both acute pancreatitis and 
CAP guideline recommendations following the addition of the Practice Points.  
In the final round of the survey, a recommendation made for the purpose of preventing short 
term adverse effects on patients was rated most important.  
Conclusion 
The results of this study illustrate the complexity of influences on guideline compliance. The 
many and varied examples of appropriate non-compliance reflect the case-by-case 
reprioritisation of the facets of patient care by clinicians, despite the continued proliferation of 
clinical guidance. Studies such as this can enhance understanding of how doctors use clinical 
judgement to respond to scenarios they feel outlie the guidelines. Improving guidelines to 
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1 Chapter 1 – Introduction 
 Chapter Overview 
Clinical guidelines are evidence-based recommendations intended to help optimise patient 
care. Guidelines have been shown to improve both clinical outcomes and the care process.(1) 
Guideline use and compliance are influenced by a range of factors, but have often been shown 
to be sub-optimal. (2, 3) This study examines access of and compliance with local clinical 
guidance on the assessment and management of Community Acquired Pneumonia (CAP) by 
clinicians working for Canterbury District Health Board (CDHB) in Canterbury, New 
Zealand.  
This chapter introduces the study setting and explains the history of the Hospital 
HealthPathways clinical guidelines within the Canterbury District Health Board (CDHB). The 
CURB-65 severity score is central to the Hospital HealthPathways Community Acquired 
Pneumonia (CAP) guidelines and so its development is described alongside strengths and 
limitations as a risk stratification tool. Another key concept behind the guidelines, 
antimicrobial resistance, is introduced, and the risks posed by multi-drug resistant organisms 
(MDROs) to patients and the wider community is explained. 
This study was predated by a research project which compared access of and compliance 
with CDHB guidelines before and after they were reformatted to become the Hospital 
HealthPathways clinical guidelines. The concepts and findings of this research are outlined, 
including ‘appropriate non-compliance’, a term coined during the project to describe 
scenarios where clinicians deviate from clinical guideline recommendations for appropriate 
clinical reasons.(3) 
The chapter concludes by laying out the aims of the study and the outline of the thesis. 
 Background 
Canterbury, in the South Island of New Zealand, has a population slightly over half a million 
people, 11.5% of the New Zealand population. These residents are largely European in 
ethnicity (86.9%), with Maori being the largest ethnic minority group. At 8.1%, this is a 
smaller proportion than the national average. The average age in Canterbury is 39.9, two years 
older than the New Zealand average.(4) It is estimated that 15.8% of Canterbury’s population 





The area’s largest hospital, with 650+ beds, is Christchurch Public Hospital, located in 
Christchurch city, providing secondary care for Canterbury and tertiary care for the South 
Island. The hospital’s Emergency Department sees approximately 91,000 presentations per 
annum.(5) 
1.2.1 Hospital HealthPathways 
CDHB employs a ‘HealthPathways’ team, who publish and update the local community and 
hospital clinical guideline website.  
The roots of clinical guidelines within CDHB date back to audits performed in 1979, 
showing that even patients with common medical conditions were receiving sub-standard and 
inconsistent care.(6) The first set of guidelines ‘Management Guidelines of Common Medical 
Conditions’, was published in 1983, and became known as ‘The Blue Book’. These guidelines 
were developed by clinical director of each relevant specialty together with a voluntary 
editorial committee. In 2001, an online searchable PDF version was published on the hospital 
intranet. 
In 2008, following discussions between primary and secondary care physicians, a clinical 
pathway detailing the assessment, management and referral criteria for patients with chronic 
obstructive pulmonary disease (COPD) within CDHB was developed and published online.(7) 
The pathway provided clear, mutually agreed upon referral criteria, and detailed the services 
available in the community with the intention of streamlining the patient journey. This first 
pathway proved successful and the HealthPathways website was launched.(8) The audience 
for this website was primarily general practitioners. 
In 2015, a project with its basis in the same principles of transparency and equity of care 
which had been central to the initial ‘Community’ HealthPathways website, took the place of 
the Blue Book as CDHB’s local clinical guideline resource.(9) These ‘Hospital 
HealthPathways’ are targeted at hospital medical officers working in CDHB. Each pathway 
consists of a series of recommendations on the management of common medical conditions 
with every page based around a single common symptom, disease, or procedure. The 
guidance is based on available evidence and written by a dedicated HealthPathways team in 
consultation with local specialty clinical directors. The interactive nature of the intranet pages 
enables the guidelines to be easily updated in line with the newest clinical research and 





The Hospital HealthPathways CAP guideline centres around a risk stratification system 
known as the ‘CURB-65’ score. This has its roots in the 1993 British Thoracic Society 
guidelines for assessment and treatment of adults hospitalised with pneumonia.(11) The risk 
stratification tool included in these guidelines was based on evidence from a study into 
aetiology, mortality and prognostic factors carried out in 1987. In 1996, the modified BTS 
pneumonia assessment tool was developed in Christchurch.(12)   A complex assessment tool 
was simplified into four key components which identified those most at risk of deterioration 
or death: confusion, urea, respiratory rate and blood pressure.  
The CURB-65 score itself was developed in 2002, using data on 30-day mortality rates in 
patients with pneumonia caused by multiple organisms from New Zealand (Christchurch and 
Waikato), UK and the Netherlands.(13) A simple tool, it allows stratification of both low and 
high risk patients on admission to hospital, identifying those suitable for treatment at home as 
well as those who may need Intensive Care Unit (ICU) input during their admission. 
Prognostic features not usually available at the time of assessment (eg. albumin) were 
purposefully excluded in order to allow acute use of the scoring system in both primary and 
secondary care.  
Table 1-1- CURB-65 score criteria 
CURB-65 score (1 point per criteria) 
Confusion Confused mental state 
Urea >7 mmol/L 
Respiratory Rate >30 breaths per minute 
Blood Pressure <90 systolic or <60 diastolic 
65 Aged >65 years 
 
Table 1-2 - CURB-65 score risk stratification 
Number of points Risk stratification Recommendation 
0 – 1 points Mild pneumonia Likely suitable for home treatment 
2 points Moderate pneumonia Consider hospital supervised treatment 
3 – 4 points Severe pneumonia Manage in hospital 





More recent studies comparing the CURB-65 score with generic sepsis severity scores and 
other pneumonia specific risk stratification techniques reflect the pros and cons of each 
approach – for example, two studies have shown that the APACHEII sepsis score performs 
better than CURB65 score at predicating mortality of patients with methicillin resistant 
staphylococcus aureus (MRSA) and pneumococcal pneumonias, while another two have 
shown that the Systemic Inflammatory Response Syndrome (SIRS) sepsis score performs 
worse than CURB65 score at predicating mortality of patients.(14) The stand out benefit of 
CURB-65, and the reason it continues to feature in Hospital HealthPathways guidelines today, 
however, is its easy-to-use practicality. 
1.2.3 Antibiotic resistance 
As well as informing admission and referral criteria, the CURB-65 score is used in Hospital 
HealthPathways and many other CAP protocols to guide empiric antibiotic selection. Hospital 
HealthPathways recommends the use of narrow spectrum antibiotics for mild to moderate 
pneumonias and broader spectrum antibiotics for severe and very severe pneumonias.(15) 
Narrow spectrum antibiotics treat the most common causes of CAP, whereas broad spectrum 
antibiotics treat these as well as a wider range of bacteria which can cause CAP.  
Hospital HealthPathways does not advise broad spectrum antibiotics empirically for every 
patient with CAP due to concern over the increasing development of antibiotic resistance. 
Bacterial resistance to antibiotics develops naturally in a ‘survival of the fittest’ style model. 
As bacteria are exposed to antibiotics, those which are naturally resistant to the antibiotic used 
are not eradicated, surviving to be transmitted or cause further infection.(16) However, 
widespread use of broad spectrum antibiotics speeds up this process, whittling the strains of 
bacteria down to those which have survived exposure to broad as well as narrow spectrum 
antibiotics. As these MDROs become more widespread, infections are likely to become 
untreatable and procedures that rely on prophylactic antibiotics to protect the body when it is 
vulnerable, such as surgery and chemotherapy, will become less safe. (17)  
Treating a patient with broad spectrum antibiotics in place of narrow spectrum antibiotics has 
been shown to increase that patient’s risk of developing risk of MRSA, Clostridium Difficile 
(C. difficile, which can cause a serious inflammation of the gastrointestinal tract) and 
antibiotic resistant urinary tract infections.(18) New Zealand has comparatively low 
antimicrobial resistance, however recently this has increased, with MRSA, ESBL, 




rise.(19) Alongside this, between 2006 and 2014 New Zealand’s antibiotic consumption 
increased by 49%.(20) 
 Previous Research 
A research project carried out in 2017 compared the access of and compliance with guideline 
recommendations before and after CDHB’s change to Hospital HealthPathways in 2015.(3)  
The effect of the development process and design of a clinical guideline on guideline access 
and compliance was examined, and variation in compliance between different clinicians, 
different patients, and different environments was explored. Three conditions were studied: 
CAP, acute pancreatitis and intracranial haemorrhage on warfarin. The use of the clinical 
guideline website was assessed by analysing unique page views of the guidance pages using 
Google Analytics. Compliance with guideline recommendations was assessed by a 
retrospective audit of the clinical notes.  
This study found that a change in the guideline development process and design not only 
improved guideline access and compliance, but also reduced the variation in practice between 
doctors. Clinician gender, specialty and seniority had a significant effect on guideline 
compliance with the Blue Book guidelines, but not the Hospital Heathpathways guidelines. 
Presence of co-morbidity and severity of illness were significant factors contributing towards 
non-compliance in both groups. 
The most common condition analysed in this study was CAP.(21) Results highlighted that in 
2016 only 10% of patients with CAP received care that was compliant with all five key 
Hospital HealthPathways recommendations studied: recording CURB-65 score, admission, 
antibiotic route, antibiotic choice, follow up x ray. (3) In 12.2 - 27.1% of cases of non-
compliance, an appropriate reason for deviating from HealthPathways was documented.(3)  
A survey then examined barriers to guideline compliance reported by clinicians to understand 
perceived obstacles to following guideline recommendations. Many respondents agreed that 
clinical guideline recommendations do not apply to all patients. 
1.3.1 Appropriate Non-Compliance 
This idea that clinical guideline recommendations do not apply to all clinical scenarios led to 
the development of the concept of ‘appropriate non-compliance’. This was explored further 




clinicians to deviate from the clinical guideline recommendations, although this was limited 
by the study’s retrospective methodology.(3)  
These findings support assertions within current medical literature that not every 
recommendation in a clinical guideline is right for every patient.(22) Clinical guidelines have 
been proven by this and many other studies to promote streamlined, co-ordinated and 
consistent care by reducing variation in practice between clinicians, often leading to improved 
outcomes.(23) Nevertheless, use of clinical guidelines does not contradict ‘personalised’ 
medicine; management can be tailored to a patient’s individual needs and based around 
evidence-based care standards.(1) This means a certain percentage of clinical practice 
deviates from clinical guidelines out of the necessity to adapt our approach to suit each 
patient’s unique requirements. Despite this, compliance rates are used as measures of quality 
and even funding allocation tools in certain areas of healthcare.(24) 
 Aims of Study 
The aim of this study was to better understand the clinician’s approach to using and 
complying with clinical guidelines. The objectives of the study were to: 
• Review reasons for non-compliance with clinical guidelines identified in recent 
literature  
• Describe the rates of access of and compliance with Hospital HealthPathways CAP 
guidelines 
• Determine how patient, doctor and environmental variables affect access of and 
compliance with Hospital Health Pathways CAP guidelines 
• Describe and quantify reasons why some doctors do not access Hospital 
HealthPathways CAP guidelines 
• Determine how patient, doctor and environmental variables affect the reasons given 
for not accessing Hospital Health Pathways CAP guidelines 
• Describe and quantify reasons why some doctors don’t comply with Hospital 
HealthPathways CAP guideline antibiotic recommendations  
• Determine how patient, doctor and environmental variables affect the reasons given 
for non-compliance with Hospital HealthPathways CAP guideline antibiotic 
recommendations  




• Examine the effect of the addition to HealthPathways guidelines of ‘Practice Points’ 
on compliance 
• Examine the degree to which compliance is influenced by the importance attributed by 
doctors to the purpose behind guideline recommendations 
It is intended that achieving these objectives will contribute to the improvement of guidelines 
to better reflect how they are used by clinicians. 
 Outline of Thesis 
This thesis consists of seven chapters. This introductory chapter contextualises this study 
with information regarding the setting and introduces a number of key concepts. The aim and 
objectives of the thesis are presented. Chapter Two is a systematic review of recent literature 
regarding doctor related and external barriers to compliance with clinical guidelines. The 
findings of this review shaped the prospective, mixed methods study design and emphasised 
retention of focus on a relatively narrow aspect of guideline compliance. The rates of access 
of the Hospital HealthPathways CAP guideline and the reasons given for not accessing it are 
reported, analysed and discussed in Chapter Three. Compliance with the Hospital 
HealthPathways CAP guideline is then reported, analysed and discussed in Chapter Four. The 
relationship between guideline access and compliance is explored, reasons for non-
compliance with the antibiotic recommendation are examined and a target compliance rate is 
quantified. Chapter Five presents the use of Practice Points to clarify and emphasis guideline 
recommendations, and reports compliance rates before and after their addition to the 
guideline. In Chapter Six, a survey is designed and disseminated to investigate whether the 
purpose behind guideline recommendations influences the likelihood of compliance. Lastly, 
Chapter Seven discusses clinical guidelines from a legal and economic perspective and 
cautiously compares the findings of this study to previous research undertaken within CDHB. 
Key findings are then summarised, strengths, limitations and implications of the study and its 





2 Chapter 2 – Why are guidelines not always followed? A literature 
review 
 Chapter Overview 
Beginning with a brief history of the need for clinical guidelines, this chapter then moves on 
to explain the literature review rationale. The questions the review is intended to answer, the 
outcome of interest and basic information about the type of studies included are outlined. The 
PRISMA protocol, which was used to identify relevant papers, and the SPIDER search 
strategy, used to define characteristics of eligible studies, are explained. Information sources, 
search terms, the types of data collected from the studies and the tools used to assess their 
quality are described. 
The results section shows the process of selection of the 49 studies included in the review and 
examines their quality and characteristics. The results of the individual studies are reported in 
terms of doctor related barriers to compliance – attitude, knowledge and other; and external 
barriers – patient, guideline and setting.  
The discussion section expands on wider concepts suggested by the results and reflects on the 
strengths and limitations of the review. Finally, the conclusion summarises the findings of the 
review and how they informed this study. 
 Introduction 
In the nineteenth and early twentieth centuries, there were limited medical treatment 
modalities, with much of the medical science we now use every day still to be discovered.(25) 
Healthcare professionals individualised their care to each patient as best they could.(26) Over 
the past hundred years, fuelled by improvements in technology and research, our medical 
knowledge has massively proliferated. Subspecialisation became necessary for doctors, and 
the sheer amount of new information meant evidence based practice became increasingly 
complex.(27) 
Towards the late twentieth century, new medical technology, such as radiotherapy, required 
guidelines for safe use. The success of the standardised practice introduced by large scale 
public health interventions led to the popularisation of clinical practice guidelines, offering 
expert-approved syntheses of clinical evidence.(27) As randomised controlled trials continued 
to be published, the ‘gold standard’ of care advanced, and healthcare systems grew ever more 




matched the pace of this progression, helping clinicians navigate the constantly changing 
landscape of modern medicine. This systematic review was undertaken to explore reasons 
why studies continue to show varying levels of compliance with these guidelines.(24) (28)  
 Rationale 
This systematic review was undertaken to explore reasons for non-compliance with clinical 
guidelines which have been identified in recent literature. Areas found which required further 
research directed the scope of the subsequent study.  
 Objectives 
This review aimed to answer the question: why are clinical guidelines not always followed by 
doctors?  
The outcome of interest was compliance with clinical guidelines by doctors. Therefore, the 
study populations of interest in this review were doctors, or patients managed by doctors. This 
review included studies that focussed on doctors, and studies that assessed guideline 
compliance of multi-disciplinary teams were included if the team included doctors. Studies 
assessing guideline compliance by both primary and secondary care doctors were included.  
The independent variables associated with clinical guidance compliance were grouped in to 
the following categories:  








These categories were adapted from classifications developed in previous systematic 
reviews.(29-31)  
This review included articles published in and after 1999. Included studies focussed on 
clinical guidelines in both online and paper format and studies from all sources and levels of 




guidelines were included, as well as all different formats of clinical guidelines, for example 
‘care bundles’ and more structured plans of care such as pathways.  
Compliance was defined as the patient receiving care that conformed to a recommendation in 
a clinical guideline. Compliance has also been described throughout the literature as 
“guideline implementation” and “guideline adherence”.(32, 33) Within this literature review, 
where the doctor the term compliance is used for consistency, with the exception of the term 
“intentional non-adherence”, a specific phrase coined by one of the included systematic 
reviews.(32) 
Studies which quantified the numbers, proportions or odds of doctors who reported or were 
observed to encounter barriers to guideline compliance were included. Studies which 
speculated or assumed reasons for non-compliance were not included. 
Included studies focus on management of both acute and chronic conditions. However, 
studies focussing on hand hygiene and other infection control topics were excluded as these 
were not classed as clinical conditions. 
Systematic reviews, cohort studies, surveys, interviews were included but not editorials or 
opinion pieces. Many studies were performed in two parts – a retrospective review of notes to 
evaluate levels of compliance, and a cross-sectional survey to analyse barriers to compliance. 
In these cases the part of the study answering the research question, ie. the survey, was used, 







The PRISMA protocol, shown in figure 2-1, was used to identify relevant papers. (34) 
 
Figure 2-1 - The PRISMA Protocol 
2.5.2 Eligibility 
Characteristics of eligible studies were defined using the SPIDER standardised search 
strategy tool. The SPIDER tool was developed as an alternative to the PICOS tool, and is 
more appropriate when searching for mixed methods or qualitative research.(35) The SPIDER 
acronym stands for sample, phenomenon of interest, design, evaluation and research type. In 
contrast, the PICO acronym stands for population, intervention, comparison, outcome and 
study. ‘Comparison’ is often not part of a qualitative research question, and ‘Intervention’ and 
‘Outcome’ are more relevant to quantitative studies. Using ‘Phenomenon of interest’ and 
Evaluation as alternative domains means the search tool is better equipped to identify 




Table 2-1 - The SPIDER standardised search strategy tool 
Domain Inclusion Criteria 
Sample Doctors (or patients being treated by doctors) 
Phenomenon of 
Interest 
Compliance with clinical guidelines 
Design Systematic reviews 
Cohort studies  
Surveys  
Interviews 
Evaluation Barriers to guideline compliance 




2.5.3 Information Sources 
A search of the literature was undertaken in the following databases: Pubmed (and thus 
MEDLINE), Ovid and Google Scholar during January 2018. The other source of data used 
was the thesis of the 2017 research project outlined in Chapter One.(3)  
2.5.4 Search 
The search process was developed with guidance from the National Institute of Health US 
National Library of Medicine PubMed Tutorial and the Cochrane Handbook for Systematic 
Reviews.(36, 37) The search strategy (shown below) was developed on PubMed and then 





#1 Search Compliance [All Fields] 
#2 Search Compliance [MeSH terms] 
#3 Search Guidelines [All Fields] 
#4 Search Guidelines as topic [MeSH terms] 
#5 Search Barriers [All Fields] 
#6 Search #1 OR #2 
#7 Search #3 OR #4 
#8 Search #5 AND #6 AND #7 
Surveys regarding perceived barriers to compliance often formed a secondary outcome for 
retrospective studies into compliance, and many of these studies identified themselves as 
patients being the population sample for their primary outcome, despite surveying doctors on 
barriers to compliance as a secondary outcome. Searches including the ‘sample’ and ‘design’ 
domain of the SPIDER search tool failed to find these, and these domains were omitted from 
the eventual initial search. 
2.5.5 Data Collection 
The following characteristics were collected from each included study:  
• Year of publication 
• Country of publication 
• Study design 
• Size of study 
The following data from the SPIDER tool were collected from each study:  
• Sample 
• Phenomenon of interest 
• Evaluation 
Key results of the individual studies were also recorded and entered alongside the above 




2.5.6 Quality Assessment 
The assessment of the quality of articles was completed using a combination of quality assessment 
tools published by the Critical Appraisal Skills Programme.(38-40)  Quality assessment forms were 
adapted for different study designs and used to classify the quality of included studies as “High”, 
“Moderate” or “Low” (Details shown in Appendix A, Table 2). An algorithm for classifying study 




2.6.1 Study Selection 
There were 50 studies selected for inclusion. The process of the study selection is illustrated 





Figure 2-2 - Study Selection Criteria 
2.6.2 Study Characteristics 
The characteristics of the included studies are summarised in Appendix A, Table 1. The 
oldest study was published in 1999 and the most recent in 2017.(3, 29, 42, 43) Fourteen of the 
studies were published in the United States of America; 6 in Australia; 4 each in the 
Netherlands, Canada, and the UK; and 2 in China and Saudi Arabia. Single studies were 
included from Germany, Estonia, Pakistan, Palestine, France, Taiwan, Spain, Denmark, 
Europe, Sweden and New Zealand. 28 of the included studies were surveys, 11 were 
interviews, 8 were systematic reviews, 2 were cohort studies and a single controlled before 
and after study was included. The smallest study population was 7, and the largest was 
2711.(44, 45)  
2.6.3 Quality Assessment 
The quality assessment of individual studies is presented in Appendix A, Table 2. A mix of 
quality studies were included: 14 of the included studies were of high quality, 24 were 
moderate and 12 were low quality.   
2.6.4 Results of Individual Studies 
The collected data items and results of individual studies are included in full in Appendix A, 
Table 1, and in summary in Table 2-2, below. 
Study results were heterogenous, thus meta-analysis was not attempted. While some studies 
described their outcome statistics as either proportions or actual numbers of doctors 
identifying certain barriers to compliance with guidelines, others asked participants to agree 
or disagree with a given statement concerning barriers to compliance, while still others used 
open ended questions. Some studies addressed doctors attitudes to guidelines in general, and 
some assessed barriers to specific guidelines, and/or specific cases. One study compared 
perceived barriers to compliance before and after the introduction of a new set of 
guidelines.(46)  
Ten studies did not specify particular guidelines, collecting reasons for non-compliance with 
guidelines in general. Other studies analysed different types of guidelines: twelve studies 
focussed on primary care guidelines and twenty-eight on secondary care guidelines. Seven 
studies looked at international guidelines, eighteen with national guidelines, three with 




specialty college guidelines and nine with local guidelines. These covered a variety of 
specialties. Four studies reported reasons for noncompliance with asthma guidelines; three 
with diabetes, colorectal cancer, hypertension, venous thromboembolism (VTE), other 
cancers and heart failure; and two with HIV, pneumonia, psychiatric conditions, sepsis, stroke 
and gynaecological conditions. 
Reasons for not following clinical practice guidelines were grouped into categories in 51% of 
the included studies. Half of these categorised the reasons into three separate categories; and 
of these, one third used the framework formulated by Cabana et al in their systematic review 
published in 1999 (the oldest study included in this review). They based their categories on a 
‘Knowledge, Attitude and Behaviour Framework’ because they proposed that behaviour 
change (compliance with guidelines) based on change in knowledge (training, education) and 
attitudes (confidence, readiness for routine change) is more sustainable than manipulation of 
behaviour alone (via incentives or punitive measures).(29) 
Table 2-2 - Literature review summary 
Locus of factor Factor Barrier No. of studies reported 
Doctor 
Attitude 
Disagreement with guideline 17 
Lack of self-efficacy 8 
Resistance to change 7 
Preference for clinical acumen 6 
Lack of attention 2 
Knowledge 
Unaware of guideline 13 
Lack of familiarity with subject 12 
Inadequate clinical skills 3 
Other 
Problem considered secondary 4 
Pharmacological concerns 4 
Communication limitations (doctor) 3 
Lack of documentation 3 
Preventative medicines inappropriate 2 
Forgetfulness 2 
Diagnostic uncertainty 1 
External Patient 






Patient knowledge deficit 6 
Patient preferences 6 
Communication limitations (patient) 5 
Psychosocial issues 3 
Side effects 2 
Adverse reactions 2 




Not applicable to all patients 6 
Inconsistent with other guidance 4 
Setting 
Lack of resources 25 
Prohibitive organisational structure 14 
Understaffing / underqualification 13 
Lack of continuity / communication 12 
Lack of peer support 8 
Lack of training 6 
Lack of systemic support 4 
Poor guideline dissemination 3 
Lack of monitoring/quality 
assurance 
3 
Lack of incentive 1 
 
2.6.5 Doctor Related Barriers to Compliance with Guidelines 
2.6.5.1 Attitude 
Seventeen studies mentioned disagreement with guidelines (either with specific 
recommendations or with the concept of guidelines in general) as a barrier to compliance (see 
Table 2-2, above).(47) In one systematic review, 43% of the included surveys disagreed with 
clinical guidelines in some way; guidelines were called ‘cookbook’, autonomy reducing, 
impractical, and biased. Concerns that they decrease the flexibility and self-respect of doctors; 
lack credible authors; make care impersonal; and do not always apply to the population they 




concerned about the involvement of the pharmaceutical industry in the development of 
guidelines.(45) In the same survey, 2% of the participants said there was a lack of clinical 
expert participation in Spanish guideline development.  
A preference for using clinical acumen rather than following guidelines was reported in 6 of 
the studies. An example of this is the 62% of doctors in one survey who used a subjective 
assessment of risk factors based on personal experience rather than using the recommended 
risk assessment tools.(48) Other studies reported similar findings, some doctors reporting that 
they personally did not need guidelines, preferred to rely on previous experience or had a 
predisposition not to use guidelines.(3, 45, 49) 
Lack of self-efficacy (loss of confidence in the ability to perform the tasks necessary to give 
guideline compliant care) amongst participants was reported in 8 studies. One systematic 
review found this mentioned in 25% of studies it included.(29) In another study, higher self-
efficacy was associated with initiating guideline compliant therapy.(50)  ‘Lack of outcome 
expectancy’ (the opinion that following guidelines will not change the outcome for the 
patient) was shown to be a barrier to guideline compliance in 6 studies.(29, 51) 
Resistance to change was cited by 7 of the studies as a reason for not following clinical 
guidelines. One systematic review included 18% of studies listing inertia of previous practice 
among reasons why guidelines were not followed.(29)  
Lack of attention when formulating a management plan was reported to lead to non-
compliance in 2 studies.(52, 53) One study found that doctors did not use guidelines due to 
the embarrassment of being seen to be looking things up.(3) 
2.6.5.2 Knowledge 
Thirteen studies reported that some participants were unaware of the guidelines in question. 
Between 13 – 60% of doctors cited lack of awareness as a reason for not following 
guidelines.(45, 54-57) In one survey, 39.3% of participants listed not being aware of 
guidelines as a reason for the non-compliance of others, but self-familiarity with guidelines 
was reported at 79%.(55) In 5 studies, doctors stated that they were aware of the guidelines 
but had not actually read them.(49, 58-61) One survey showed that although doctors might 
have read the guidelines, they may not understand them, and another reported that some 




Doctors were found to lack familiarity with the guideline subject matter in 12 studies. A 
survey exploring compliance with diabetic ketoacidosis and hyperosmolar hyperglycaemic 
state guidelines in the Emergency Department, for example, found that 13% of respondents 
cited inexperience with these presentations as a barrier to guideline compliance.(42) 
Similarly, in one systematic review, 11-43% of the included studies reported that doctors 
found inadequate knowledge of management, pharmacology, side effects, tolerance and 
contraindications made it difficult to comply.(29, 58) 
Inadequate clinical skill level was cited as a reason for non-compliance in 3 studies.(31, 62, 
63) One study looking at the Dutch College of General Practitioners urinary incontinence 
guidelines reported 29% of participants felt they lacked the skills necessary for compliance, 
even though the guidelines were produced specifically for primary care use.(62) Interviewees 
in one study stated that their lack of research skills mean they found it difficult to locate 
relevant guidelines.(49) 
2.6.5.3 Other Doctor Related Barriers 
Twelve percent of the studies in one systematic review examined the challenge of applying 
the correct set of guideline recommendations in the face of diagnostic uncertainty.(58) In an 
ideal world, doctors attend to the patient holistically, however, guidelines usually focus on 
just one condition or presentation. In 4 studies, doctors did not follow guidelines for co-
existing, secondary issues when they focussed on a different, primary problem. For example, 
treatments for chronic issues are overlooked when a more acute illness is present. In one 
survey on cholesterol guidelines, 21% of respondents agreed with the statement ‘cholesterol is 
the least of my patient’s problems’.(50) Preventative medication recommendations intended 
to reduce long term morbidity were referred to as being inappropriate for the very elderly or 
those with a short life expectancy in 2 studies.(44, 58)  
Pharmacological concerns were highlighted in 4 studies. One systematic review included 
20% of studies which mentioned worries concerning adverse effects, interactions, 
polypharmacy, contraindications and hesitancy to titrate drugs as advised by guideline 
recommendations for patients who are currently stable.(58) 
Communication limitations were found to be a barrier to compliance by 3 studies. In one 
systematic review of compliance with heart failure guidelines, 23% of the studies examined 
one or more communication issues, including language barriers, discomfort discussing certain 




Doctors reported problems treading the line between clarity and bluntness, and wanting to 
protect patients from the negative associations with the words ‘heart failure’. In a survey 
regarding guidelines for post stroke depression, respondents reported fears that using the 
recommended diagnostic tool might actually trigger depression.(64) 
Lack of documentation, either by themselves or others, was reported in 3 studies. In one 
study into CAP guidelines, 36% of emergency and medical doctors surveyed stated that 
calculating severity was a barrier to compliance.(55) One systematic review regarding 
guidelines for inpatient VTE prevention found doctors perceived that poor risk assessment 
performance made it difficult to follow these guidelines.(52)  
Forgetfulness was identified as a barrier to compliance in 2 studies. In one survey into 
induced abortion guideline compliance, 33% of the participants admitted that sometimes they 
did not follow guidelines due to accidental omission.(65)  
 
2.6.6 External Barriers to Compliance with Guidelines 
Even if doctors intend to follow guidelines in their practice, sometimes external 
circumstances mean they are unable to. These circumstances can be related to the patient, the 
guideline itself, or the setting in which they are working. One systematic review reported that 
doctors tended to focus on external barriers to compliance rather than being self-
reflective.(66) One of the larger surveys included in this review found that 91% of the 
participants felt they had little control over compliance, blaming organisational factors 
instead.(65) 
2.6.6.1 Patient 
Poor patient compliance was a barrier to the implementation of care that conforming to 
guideline recommendations in 17 studies. Twelve of these were focused on guidelines used 
for outpatient populations. A systematic review looking at heart failure guidelines, for 
instance, found that studies using data from nurse assessments found lower rates of 
compliance than those using patient self-reported data.(58) One survey reported that 96% of 
respondents ranked poor compliance with antihypertensive medications as a major barrier to 
following these guidelines; many reasons for this were discussed.(67) Finances were 
mentioned in 2 surveys: 30-93% of respondents attributed their patient’s compliance issues to 




Also, guidelines may not take cultural differences and diversity of living conditions into 
account. For example, one systematic review from the USA reported that African Americans 
were more likely to seek help than white patients.(58) Other reasons included physical 
limitations, low motivation, lack of support, negative experiences or beliefs, forgetfulness, 
resistance to change, and polypharmacy.(51, 58, 68, 69) 
 
Patient knowledge deficit was discussed in 6 studies. One systematic review found studies 
identified that patient’s lack of understanding regarding the seriousness of their diagnosis and 
the reasons why they had the disease were barriers to compliance.(58) Unsurprisingly, poor 
recognition of symptoms of exacerbation and inability to recall self-care instructions 
correlated with advanced age, short term memory loss and limited literacy. However, one 
study within the same review reported that 80% of patients with these knowledge deficits did 
not actually want any additional information, citing lack of interest, insufficient trust in their 
provider or avoidance of their condition.  
A treatment plan should generally take patient preferences into account and, as 6 of the 
studies showed, this might mean that their treatment is not guideline compliant. This could be 
due to a dislike of the tasks involved (for example finding a diet unpalatable, preferring not to 
take medications or avoiding healthcare settings) or differing goals between the guideline and 
the patient (for example a patient might focus on symptom relief rather than prognostic 
improvement). (66, 70, 71)  For instance, one study into rapid pharyngitis antigen testing 
reported that 63% of GPs cited patient preference as a barrier to compliance.(71) 
Six studies found that comorbidities can be barriers to guideline compliance: one survey 
reported that 19% of respondents were unable to follow guidelines fully due to their patient’s 
comorbidities.(72) Patient age was cited as a reason for non-compliance in 4 studies.(53, 69, 
73, 74) 
 
In 3 studies, patient communication issues were highlighted as limiting guideline compliance. 
Reasons for this included not wishing to question doctors, lack of trust in the doctor, 
disinterest, functional limitations (such as short term memory loss), and a reluctance to 
discuss certain topics.(47, 58) For example, the study into induced abortion guidelines 





Psychosocial issues were reported to influence compliance in 3 studies. A systematic review 
regarding cancer pain guidelines found patients reluctant to agree to try the recommended 
medication due to concern regarding addiction to pain medication, building a tolerance to the 
medication, the association of increased pain with disease progression, as well as fear of 
injections.(47) A systematic review into heart failure guidelines noted that 60% of patients 
with heart failure experienced depression, and patients who perceived themselves as having a 
poorer health state were more likely to seek help when they became symptomatic.(58) 
 
Two studies listed side effects as a barrier to compliance, and adverse reactions were also 
mentioned in 2 studies.(44, 47, 52, 67) For instance, a survey reported that 7% of participants 
reported that adverse effects affected their compliance with hypertension guidelines.(67) 
 
One study into oncology guidelines found that doctors documented poor prognostic status and 
the presence of metastatic disease as reasons why they chose to deviate from the 
guidelines.(74) Incidences of non-compliance in this study were often in cases where patients 
were more severely ill.  
 
2.6.6.2 Guideline 
Many studies reported that aspects of the guidelines themselves limited compliance. Doctors 
reported inconvenient guidelines were a barrier to compliance in 9 studies. Between 16 – 42% 
of participants in these studies thought that guidelines are often presented in a complex 
format.(45, 54)  A series of interviews with GPs in the UK regarding guidelines on managing 
depression highlighted issues with difficult to locate or inaccessible guidelines.(75) 
Predictably, perhaps, 8 studies reported that unclear guidelines are difficult to follow, and 
guidelines giving vague recommendations or overcomplicated guidelines were both cited as 
barriers to compliance.(49, 76)  
Guidelines not being applicable to particular patient populations was a reason why doctors 
did not comply in 6 studies: 21% of GPs and cardiologists answering a survey about 





In 4 studies, inconsistency with other guidelines on the same subject were highlighted: in a 
survey about pneumonia guidelines, 27% of respondents felt the guidelines they were asked 
about conflicted with other published recommendations.(55)  
Two studies showed that doctors felt some guidelines were not updated often enough, and 
contained out of date recommendations.(66, 77) More barriers to compliance were brought up 
by other studies: in reply to one survey, doctors stated they did not follow guidelines which 
gave controversial recommendations.(66) In another study, doctors stated that some 
guidelines fail to encompass all aspects of the index disease, while a survey into HIV 
screening reported that 65% of respondents did not comply with the recommendation to 
screen for HIV as it was not cost effective.(78), (79) 
2.6.6.3 Setting 
Some healthcare environments might not facilitate or could even prevent guideline 
compliance outright. Lack of resources was mentioned in 25 studies, making it the most 
frequently mentioned barrier to compliance overall.(58, 65, 77)  Time was the resource most 
commonly reported to be lacking, cited by 23-56% of participants, followed by lack of 
funding, cited by 20-50%.(45, 48, 72)  Other resources mentioned were space, beds, 
equipment, diagnostic tools and community services.(58, 61, 64, 80) 
Doctors reported that the structure of their organisation limited compliance in 14 studies. 
Indeed, in 13 studies, 26-43% of participants felt understaffing or lack of qualified staff 
presented a barrier to compliance, whereas a poor referral system was mentioned by 25% of 
the participants in another study .(42, 62), (65) Other examples of organisational structure 
which did not facilitate compliance was lack of integration, poor flexibility, no structured 
organisational strategy, bureaucracy around prescription of certain medications and a culture 
of adapting practice to that favoured by the head of the team.(47, 49, 53, 58, 81) 
Poor communication and lack of continuity of care within an organisation was highlighted in 
12 studies. One survey into the management of asplenic patients surveyed different 
specialties, and found that 50% of the responding internists, 46% of the surgeons and 55% of 
GPs all felt that there was a lack of overall responsibility taken for patient management and 
for following the guidelines.(82) The same study also found that doctors discharging patients 
from the hospital did not trust that GPs would follow their post discharge instructions, and 
GPs did not always trust that the instructions they received in discharge summaries were 




barrier to guideline compliance.(82) Similarly, one systematic review found 14% of the 
included studies cited lack of role clarity between doctors as a reason why guidelines were not 
followed.(58) Poor interdisciplinary communication was also identified as a factor affecting 
the multi-disciplinary team’s ability to successfully comply with guidelines.(59) 
Lack of support from peers was reported as a barrier to compliance in 8 studies. In one study, 
46% of participants felt the influence of senior doctors on junior doctors led to deviation from 
the guidelines, and 23% felt there was a general view that the hospital did not expect 
compliance.(55) Another study found that 42% of interviewees felt their patients were seen as 
low priority and this lack of support made guideline compliance more difficult.(65) Lack of 
training on guidelines was discussed in 6 studies. Between 18 - 56% of participants felt poor 
education around guidelines limited their ability to comply.(42, 54) 
A lack of systemic support was mentioned in 4 studies. One survey regarding cancer 
screening guidelines found that 84% of respondents were unable to schedule time for the 
screening procedure recommended in the guidelines.(70) Other studies noted a lack of 
investment in the guidelines from the organisations, lack of ability to request recommended 
diagnostic tests, and a general lack of systemic support leaving staff ‘exhausted’.(49, 59) 
Poor dissemination of guidelines was cited by up to 33% participants in 3 studies as a barrier 
to compliance.(43, 45, 61) Lack of monitoring and quality assurance measures were also 
reported by 3 studies- often it was not highlighted to doctors that they were failing to comply 
with guidelines.(49, 80, 83) One survey indicated that doctors felt that there was a lack of 
incentives for them to follow guidelines.(43) 
 Discussion 
This literature review shows there are many varied barriers to compliance, each with its own 
complex causes and background. 
2.7.1 Doctor Related Barriers to Compliance with Guidelines 
Most studies which divided reasons for non-compliance into categories used at least one 
category which related to the doctor. If they were included, reasons relating to the patient and 
the setting were variably categorised. Fewer studies used a category for the guideline itself. 
The target audience for the majority of these studies is healthcare professionals and so 
categories relating to the doctor and the setting were presented frequently because these are 




It is clear, from the high frequency with which it is mentioned in these studies, that 
disagreement with guidelines is widespread. Disagreement with specific guidelines is often 
due to views that either they are do not have a good evidence basis, or they have not been 
formulated rigorously.(84, 85) Disagreement with guidelines in general might stem from 
concern that junior doctors could grow to rely on written rules rather than being able to think 
through problems themselves. (86) Thus, creative innovation could be stifled, threatening the 
loss of new techniques. Some critics also worry that patients might come to harm if guidelines 
are followed without use of clinical judgement or situational awareness. 83  
Guideline developers who seek to improve have taken on this feedback, creating more 
flexible patient-centred recommendations, matched to patient response rather than time, for 
example, recommending doctors to consider discharge once the patient can breathe 
comfortably when mobilising, as opposed to considering discharge after 3 days.(22, 87) 
Elsewhere, guidelines are described as ‘shared baselines’ for doctors to adapt around their 
patients, with the doctors themselves adding their own expertise.(88) By summarising 
complex empirical evidence, guidelines allow clinicians to use this evidence to make 
individualised medical decisions, which often carry many more variables than a human mind 
is able to consider alone.(1) Humans are also poor at consistent decision making: our 
decisions on recent personal experience, current emotion and subjective observation, as well 
as our knowledge of the empirical evidence.(89) Given the same data set (or patient 
encounter), a clinical guideline always leads to the same decision, based purely on the best 
available evidence regarding relevant risk factors and likelihoods. In this way, the empirical 
nature of guidelines act as ‘guardrails’, helping doctors to reduce care inequalities by setting 
out what should be done at the very least and what can be done at the very most.(90)  
On the other hand, many doctors have difficulty changing personal routines despite 
agreement that the guideline recommendations represent an improvement.(66) Resistance to 
innovations threatening the status quo is due to inertia, resilience to change and a sense of 
tradition.(22) Additionally, personal experience is more emotionally charged than any clinical 
protocol, and doctors are more likely to recall the occasions when acting on a personal hunch 




2.7.2 External Barriers to Compliance with Guidelines 
Even though some causes of non-compliance are external, they are still amenable to change. 
Educating peers, involving managers or improving doctor-patient rapport were all put forward 
in these studies as ways to facilitate compliance.(82)  
2.7.2.1 Patient 
Having said this, patient demographics (such as comorbidities, concurrent acute illness, 
severity of disease, side effects and adverse effects) are barriers to compliance which are 
unlikely to change.(44, 92) One systematic review referred to conscious decisions to deviate 
from the guidelines to accommodate these as ‘intentional non-adherence’.(32) Unlike the term 
‘appropriate non-compliance’, used by another study and discussed in Chapter One, 
‘intentional non-adherence’ implies only the deliberate nature of the decision, and does not 
comment on whether the choice to deviate from the guideline enhances patient care.(3) It was 
noted, however, that most of the reasons found for ‘intentional non-adherence’ in the 
systematic review were thought to be ‘valid’ by the authors, as they represented the clinical 
judgement of a doctor who had considered the guideline in the context of the patient.(32) 
These studies, alongside others within this review reporting these characteristics as influences 
on non-compliance, acknowledge that in practice, guidelines are unlikely to capture the 
multifaceted mix of pathology and circumstance presented by each patient encounter.(44, 72)  
2.7.2.2 Guideline 
Guidelines are written by different bodies to serve different purposes, and serve multiple 
functions for multiple groups.(27) This can lead to guidelines giving conflicting 
recommendations, and thus decreasing trust in the use of guidelines and pathways.(24) 
Clearly written, easily accessible, guidelines, developed in a rigorous and transparent manner 
by the population who will be using them, which are well disseminated and provide clarity 
regarding their scope and limitations, achieve the highest rates of compliance.(93) On the one 
hand, those that are not flexible enough to respond to patient differences and do not 
accommodate relevant variation among patients are likely to be rejected by clinicians.(22, 24) 
On the other, vague guidelines are followed less than specific recommendations.(94)  
Expert consensus may be used within guidelines in cases where evidence to justify precision 
is lacking. However, experts who develop these guidelines might be under time constraints, or 
make errors, and so a transparent development process with appropriate citations is important, 




whether their patient is at all similar to the study population on which the evidence behind the 
recommendation was based.(24) Expert consensus differs from panel to panel: local 
consensus might be most important to consider, as this opinion is likely to be most relevant to 
the patient.(86)  
Guidelines should be piloted with real patients before full scale implementation to identify 
oversights or errors.(89) Training in use of the guideline and a feedback mechanism have also 
been found to increase compliance.(90, 93) This feedback should ideally be two way: doctors 
who have used the guidelines are best placed to suggest improvements. Doctors are also 
known to overestimate their compliance, however, and report that they value receiving data 
showing their actual rates of compliance. Compliance with key ‘quality indicators’, targeted 
with intense feedback systems and specific, achievable benchmarks, can be much higher than 
compliance with other evidence based recommendations not focussed on in this way. (22)  
2.7.2.3 Setting 
It is more difficult for doctors to change their behaviour and begin to comply with guidelines 
if following guidelines is not the subjective norm within their organisation, especially if 
senior doctors are not supportive of their junior colleagues following clinical guidelines.(55) 
Senior doctors are less likely to use guidelines than junior doctors; doctors with under ten 
years of professional experience have been shown to report fewer barriers to compliance, 
while doctors with over twenty-five are more likely to indicate that guidelines are too 
complex and limit them too much.(3), (77) This may reflect a differing vantage point between 
doctors who were surrounded by clinical guidelines whilst in training and those who were 
learning before published guidelines became more widespread; doctors who train while 
medical research progresses at its current velocity are used to relying on tools such as 
guidelines to ensure their practice is as up to date as possible.(95)  
The medical hierarchy also leads to deference to the decisions of seniors by junior doctors, 
even though these may not be compliant with the guidelines.(91) Senior doctors are powerful 
normative influencers, and if they do not comply with guidelines, it is less likely that other 
doctors will comply against social norms.(91, 96) 
 Limitations 
There were several limitations to the search process used to formulate this systematic review. 




not the primary outcome. Also, all study selection, data collection and quality assessment was 
carried out by one researcher, which may have led to influence of selection bias on results.  
There were multiple study designs of lower hierarchical rank included in the review. Due to 
the subjective and qualitative nature of the topic, there are limited studies of a high level of 
evidence: for example there were no randomised control trials found. Moreover, many of the 
studies were relatively low power, and varied in quality, with almost 25% rated as low in 
quality. Additionally, there was heterogeneity between the outcome statistics of the studies.  
Studies varied in setting, population, and design. This heterogeneity is the most likely reason 
for the large number of barriers to compliance identified, and the wide ranging frequency with 
which these were reported. 
Data concerning thought processes and reasons for behaviour can only be obtained via self-
reporting. In fact, comparisons between self-reported and observed compliance rates have 
found that self-reported compliance rates were on average 27% higher than observed 
compliance rates.(97)  
In addition, many studies included in this review asked their participants about barriers to 
compliance with guidelines generally, or with the entirety of a guideline.; general questions 
do not reflect how guidelines are used in reality, as each guideline contains a series of 
recommendations. Naturally enough, reasons for non-compliance will differ not only between 
individual doctors, but also between individual guidelines and individual 
recommendations.(66) 
 Conclusion 
Despite these limitations, this systematic review identified many reasons for non-compliance 
and helped inform the methodology of the research.  
As noted above, barriers to compliance are likely to differ between individual 
recommendations within a guideline. To keep this study focussed, compliance with specific 
key recommendations was explored. 
Some studies included in this review mentioned patient and situational variation as barriers to 
compliance.(44) Two studies named these specific deviations from the guidelines ‘intentional 
non-adherence’, and ‘appropriate non-compliance’, quantifying an ideal compliance rate 




quantified this rate (within the bounds of the study subject matter) and examined the reasons 
behind it. 
Some of the studies in this review included an audit of compliance as well as surveys or 
interviews regarding barriers to compliance, but only two studies linked specific cases in the 
audit to the reasons given for non-compliance. In both, these were reasons that had been 
documented by the doctor, providing limited information. By using a prospective 
methodology and interviewing doctors directly, this study linked observed data and self-
reported data for each case. 
 Chapter Summary 
The introduction to this chapter offers a broad-brush perspective of clinical guidelines in 
terms of medical advancement and explains the relevance of the literature review to the 
research reported below. The methodology and tools used to undertake the review are 
outlined. 
Both doctor related barriers to compliance and external barriers are reported in the results 
section. Disagreement with the guidelines, lack of self-efficacy or outcome expectancy, 
clinical inertia, inattention and embarrassment are doctor related attitudinal barriers to 
guideline compliance. Lack of knowledge on the part of doctors (of the guideline, the subject 
matter and the necessary clinical skills) can also prevent compliance. In addition, diagnostic 
uncertainty, difficult communication, pharmacological concerns, lack of documentation and 
forgetfulness can contribute to non-compliance. 
External barriers to compliance may involve the patient, such as poor compliance on the part 
of the patient, lack of understanding, patient preferences, comorbidities, side effects, disease 
severity and psychosocial influences. Meanwhile, the guideline itself can be inconvenient, 
inconsistent, controversial, or out of date, and it might not be applicable to certain 
populations. The setting in which compliance is expected can also prevent compliance, due to 
lack of resources, poor communication, lack of system and peer support, lack of feedback and 
unhelpful organisational structure.  
Doctor related barriers to compliance form most of the points in the discussion section. 
Reasons and solutions for disagreement with the guidelines, a commonly cited barrier, are put 
forward. Patient related barriers are noted to often be the source of appropriate non-




which facilitate compliance as described in the literature are presented. Issues with utilisation 
of expert consensus and the benefits of two-way feedback mechanisms are considered. The 
effects of social norms and different styles of training are discussed in the context of setting 
related barriers to compliance. 
The limitations of this systematic review in terms of the possible bias of a sole researcher, 
lower tier levels of evidence, and self-reported heterogenous results are acknowledged. To 
conclude, it is explained how the focussed, mixed methods prospective methodology of this 
study was born from the considerations of the literature review. 
3 Chapter 3 – Guideline access and reasons for not accessing 
guidelines 
 Chapter Overview 
This Chapter opens by discussing findings regarding access of Hospital HealthPathways from 
the previous CDHB study, and some effects of methodology employed. The methods this 
current study used to examine Hospital HealthPathway CAP guideline access are explained, 
and the modified SIRS criteria are introduced as an alternative severity score to CURB-65. 
The process of categorisation of the reasons why doctors did not access the clinical guideline 
is also presented. 
The results section reports the characteristics of the study sample, the rates of usage of the 
Hospital HealthPathways CAP guideline reported by doctors within the study population, and 
the reasons given for not accessing it. Findings of subgroup analysis of patient, doctor and 
setting demographic subgroups performed using single and multiple logistic regression are 
reported for both access of the guideline and reasons for not accessing the guideline. In the 
discussion, possible alternate sources for recommendations on the management of CAP and 
potential reasons for results of the subgroup analysis are put forward. Strengths and 
weaknesses of this part of the study are examined and the implication of the findings are 
discussed. 
 Introduction 
Access of Hospital HealthPathways increased steadily during the first 2 years after its launch 
in 2015.(3) In November 2015, prior to its expiration, the average number of Blue Book 
monthly unique page views was 10,194. Two years following the introduction of Hospital 




The percentage of cases where CAP guidelines were accessed within four hours of admission 
of a patient with CAP more than doubled following the switch from the Blue Book (27.7%) to 
Hospital HealthPathways (64.2%). The assumption is that this represents an increase in access 
of the CDHB CAP guidelines by clinicians assessing patients with CAP. However, without 
the ability to link website ‘hits’ to specific users, this remains only an assumption.  
The prospective methodology employed in this study allowed the researcher to ask doctors 
whether they had accessd the HealthPathways CAP guideline while managing a specific 
patient as soon as possible after the encounter. In addition, clinicians who had not accessed 
the guidelines were asked why not. Guideline use and guideline compliance are inextricably 
linked concepts, however, reasons for not accessing guidelines might be different from 
reasons for not complying with guidelines. This information furthers opportunities for 
guideline writers and developers to produce guidelines which are more helpful to the 
clinicians who use them. 
 Methods 
3.3.1 Selected time period 
Cases were collected non-consecutively over 100 days between February and June 2018. 
These are not the months in which pneumonia admissions tend to be highest; in 2017 the 
highest rates of admission of patients with pneumonia to ICUs in Australia and New Zealand 
was July – September and the peak rates of GP attendees with pneumonia was August - 
September.(98) This meant that that doctors are likely to be more available to approach for 
interview. This convenience sampling was employed out of necessity, as only one researcher 
collected the data. 
3.3.2 Case identification 
Manual search of hospital electronic whiteboard system ‘FloView’, online clinical 
information system Health Connect South, and an Emergency Department ‘discharge folder’ 
was undertaken, to identity patients with presenting complaints consistent with pneumonia 
assessed within the previous 24 hours. Presenting complaints containing the following terms 
triggered a review of the Admission Summary via Health Connect South and physical patient 
notes to identify cases meeting the inclusion criteria: pneumonia, chest infection, LRTI, 
cough, wheeze, asthma exacerbation, COPD exacerbation, shortness of breath, high 
respiratory rate, chesty, fever/febrile, high temperature, unwell, off legs, fall, collapse, 




3.3.2.1 Inclusion criteria 
Adult patients assessed in Christchurch hospital with a documented diagnosis of CAP were 
included. Pneumonia was defined as an acute illness with radiographic pulmonary shadowing 
which was at least segmental or present in one lobe, and was neither pre-existing nor of other 
known cause. (21)  CAP was defined as a pneumonia which was not contracted in a hospital 
or a long term care facility.  
3.3.2.2 Exclusion criteria 
Patients with known or suspected immunocompromise, bronchiectasis or tuberculosis, likely 
aspiration or nosocomial pneumonia were excluded, as were patients for whom the admission 
represented an expected terminal event. This was because management of pneumonia in these 
circumstances is expected to be different from the recommendations laid out in the Hospital 
HealthPathways guideline.(15) 
3.3.3 Data collection 
3.3.3.1 Independent variables 
For each case identified, data relating to the patient, the clinician and the setting was 
collected:  
• Patient data: National Health Indentifier (NHI), gender, age, ethnicity, co-morbidity 
(COPD, respiratory co-morbidity and total number of comorbidities) severity of 
illness (CURB-65 score – documented, as stated by the diagnosing doctor, or 
calculated by the researcher as detailed in the previous chapter; and modified SIRS 
score). 
• Clinician data: gender, seniority, specialty 
• Setting data: environment, day, shift 
The data collection form can be found in Appendix B. 
The modified SIRS score is a version of the widely used SIRS diagnostic criteria 
recommended to diagnose sepsis as part of the Hospital HealthPathways sepsis guideline.(99, 
100) Respiratory tract infections, including pneumonia, are the most common source of 
sepsis and have the highest mortality rate compared to sepsis arising from other sources.(101) 
The modified SIRS score was used here as a more sensitive severity score, including 




Table 3-1- Modified SIRS criteria components 
Modified SIRs criteria components 
Temperature <36 degrees or >38 
degrees 
Respiratory rate >20 breaths per minute 
Oxygen saturation <92% on room air 
Heart rate >90 beats per minute 
White blood cell count <4x109/L or >12x109/L 
Mental status Confusion 
 
3.3.3.2 Outcome variables 
The outcomes of interest were guideline access and reasons for not accessing the guideline. 
3.3.3.3 Data collection method 
Data was collected via online clinical information systems and the patient’s paper case notes. 
The patient’s demographic characteristics were found on each patient’s Health Connect 
South frontpage. 
In each case, the patient’s COPD status, total number of co-morbidities and the presence of 
respiratory comorbidities was determined from previous and current assessment 
documentation and clinical letters accessed through Health Connect South, or general 
practitioner notes accessed vis HealthOne. Conditions classified as respiratory comorbidities 
were asthma, COPD, obstructive sleep apnoea, obesity hypoventilation syndrome, 
bronchiectasis, inflammatory lung disease, current smoker, mesothelioma and previous 
pulmonary tuberculosis. Hypertension was included in the calculation of the total number of 
comorbidities. The total number of comorbidities was used rather than a comorbidity score as 
this study was not able to examine clinical outcomes or patient prognosis, focussing instead 
primarily on doctor decision making. The raw ‘past medical history’ lists found in previous 
documentation such as assessments, admissions and clinic letters constitute the information 
on which assessing doctors base their clinical decision making on, rather than a calculated 
score or index prognosticator. 
Clinician seniority and specialty were noted from the assessment documentation: on Health 
Connect South in the case of Emergency physicians, and in the paper case notes for doctors 




Environmental data was also obtained from the assessment documentation: patients with 
emergency physician documentation on Health Connect South were assumed to have been 
assessed in the Emergency Department, while nursing staff notes regarding patient transfers 
found in the patient’s paper case notes were used to identify the location of the assessment 
where patients were assessed elsewhere. The day of admission was obtained from the 
patient’s Health Connect South frontpage. The type of the shift the doctor assessing the 
patient was working on was found by using the time noted on assessment documentation (on 
Health Connect South or in paper case notes) and departmental rosters.  
Where the CURB-65 score was documented, this was recorded. If this had not been 
calculated, it was calculated by the researcher. ‘Confusion’ was defined as any acute 
disorientation to time, place or person documented by nursing or medical staff at the point of 
admission, or a diagnostic score in a delirium screening tool such as the Abbreviated Mental 
Test Score (AMTS) or a 4AT score.(102, 103) Urea results were obtained from admission 
blood tests. For patients assessed in the emergency department, the paper observation chart 
and the admission documentation on Health Connect South were used as sources to identify 
respiratory rate and blood pressure. In addition to these, where patients had been assessed on 
acute wards, online patient information software Patient Track and paper admission 
documentations were consulted. The presence of any modified SIRS criteria was also noted 
using these sources. The most severe recorded observation prior to the diagnosis of 
pneumonia was used to calculate the CURB-65 score and identify the presence of modified 
SIRS criteria, i.e. the highest respiratory rate or lowest blood pressure. In the instance that 
CURB-65 documented or calculated by the diagnosing doctor differed from that calculated by 
the researcher (either due to error on the part of the diagnosing doctor or calculation based on 
a set of observations which were not documented), the compliance category was allocated 
based on the diagnosing doctor’s calculation. 
Doctors were contacted and asked whether they had accessed Hospital HealthPathways CAP 
guidelines when formulating their management plan. The term ‘access’ was defined as 
reading the guidelines via the hospital intranet while assessing and treating that particular 
patient. Those who stated they had not accessed the guideline were then asked to give a 
reason why they had not. Interviews were attempted within 48 hours of the diagnosis of 
pneumonia being made to facilitate recall of the clinical decisions involved. A minority of 
interviews were carried out beyond this time as difficulties due to rostering and staff privacy 




interviews were identified via departmental rosters or by contacting doctors by the hospital 
paging system. However some interview opportunities became available by chance. Where 
shift patterns made meeting doctors difficult, telephone, text message and email interviews 
were necessary. The researcher carrying out the interview was a registrar working at 
Christchurch Hospital, known personally to some and professionally to most of the 
interviewees. The interview structure and wording of questions remained the same despite this 
circumstantial variation. 
Information was compiled on individual paper data collection forms (Appendix B) and 
subsequently transferred into an Excel spreadsheet. 
3.3.4 Ethics 
The concept of the project was presented at well-attended informal meetings, such as 
teaching sessions and handovers, and information sheets were available both then and when 
clinicians were approached to collect data. It was clearly stated at these times that clinicians 
were able to opt out of the study altogether or on a case-to-case basis and verbal consent was 
obtained prior to interviews. The clinicians involved remained confidential and were 
contacted in the first instance face to face or via their work email address, unless they had 
chosen to give personal contact details. 
Patient management was not altered by the researcher during the study and no identifiable 
patient information was used, therefore patients were not asked for consent. The Southern 
Health and Disability Ethics Committee was consulted regarding the need to apply for ethical 
approval who determined that formal approval from the committee was not required. 
3.3.5 Analysis 
Cases were categorised as ‘guideline accessed’ (where doctors stated they had looked at the 
Hospital HealthPathways CAP guideline while formulating a management plan for that 
patient), or ‘guideline not accessed’ (where doctors stated they had not looked at the Hospital 
HealthPathways CAP guideline while formulating management for that patient).  
The reasons given for not accessing the guideline were recorded and these were analysed for 
recurring ideas: for example ‘I used the Pink Book instead’ (referring to the hospital’s 
Preferred Medicine List) and ‘I referred to the Empirical Antibiotics poster’ (referring to a 
widely disseminated antibiotic recommendation poster displayed throughout the hospital) 




combined into five overarching categories set by two researchers with subject expertise (the 
thesis author and thesis supervisor), based on examination of the results and identification of 
repeating themes within it. The five categories thus decided were: I didn’t use the guideline 
because ‘I had another plan – for objective reasons’; ‘I had another plan – for subjective 
reasons’; ‘I disagree with the guidelines’; ‘I did not have time to access the guidelines’; and 
‘I know the guidelines’. These overarching categories were also chosen in order to work 
towards the quantification of a rate of ‘appropriate’ non-compliance 
Excel was used to produce comparison tables showing the study population demographics, 
guideline access and the frequency of reasons given for not accessing the guidelines. 
Statistical analysis software package R was then used to perform single and multiple logistic 
regression to identify trends among the demographic subgroups as well as access of 
guidelines and reasons for not accessing them. A P value of less than or equal to 0.05 was 
chosen at the outset as the level of significance for this study. This is the standard level of 
significance used to justify a claim of a statistically significant effect in scientific 
literature.(104) Multiple logistic regression models were built to account for confounding 
factors between variables found to be significant once single logistic regression had been 
used to separate ‘signal’ from ‘noise’.  
 Results 
3.4.1 Study Sample 
In the experimental group, 316 patients with a diagnosis of pneumonia were identified. 
Subsequently, 25 (8%) were excluded on review of their case notes: 9 were diagnosed with 
aspiration pneumonia and three were diagnosed with hospital acquired pneumonia, 12 were 
immunosuppressed, 2 were aged under 18 years and it was thought that the admission 
represented a likely terminal event for 2 patients. In addition, 14 (4%) were excluded at the 
interview stage: in 13 cases the doctor who had assessed the patient was not contactable, and 
in 1 case the doctor requested not to be involved. 
Between the remaining 274 patients, the genders of the patients in the study population were 
approximately equal (51.8% male and 48.2% female). Nearly half of the included patients 
were over 75, with the remainder split fairly equally between the 18-44, 45-64 and 65-74 
groups. The majority of the patients identified as NZ European in ethnicity, while the second 
largest ethnic group, labelled ‘Other’, was made up of 11 separate ethnic subgroups. These 




power. The second largest single ethnic subgroup was Maori. Of the patients in the study 
population, 23% had COPD, and 44.9% had a respiratory comorbidity. Half of them had 
between 4 and 8 comorbidities, and 10.2% had 9 or more. Approximately the same percentage 
of patients had moderate and severe pneumonias (28.1% and 28.8% respectively), but the 
majority (43.1%) had mild pneumonia. Of the included patients, 78.1% met the modified 
SIRS criteria for sepsis. 
The genders of the clinicians in the study population were approximately equal (49.0% male 
and 51.0% female). The majority of the doctors were registrars (66.8%) with slightly more 
Senior Medical Officers (SMOs) (18.2%) than House Officers (15%). One Trainee Intern (TI) 
was included, who was grouped into a ‘TI and House Officer’ subgroup to allow analysis. 
Half of the doctors were working in General Medicine, and 46.4% worked in Emergency 
Medicine. The remainder worked in respiratory medicine or another specialty. These doctors 
worked in other medical specialties, for example infectious diseases and gastroenterology, 
admitting patients to be seen by the General Medical or Respiratory teams. The percentages of 
patients assessed in the Emergency Department and on an acute ward were approximately 
equal (51.8% in the Emergency Department and 48.2% on an acute ward). Most cases (71%) 
were assessed on a weekday rather than a weekend or Public Holiday. The percentage of 
patients admitted on day shifts (defined as 0800 -1600) and night shifts (2230 – 0800) were 
similar (31.8% and 29.6%); 21.9% of patients were admitted by non-emergency doctors on a 
‘long day’ shift (0800 – 2230) and the remaining 16.8% were admitted by emergency doctors 
on ‘evening’ shifts (1500-0000). The Emergency Department is the only department in 
Christchurch hospital to roster ‘evening’ shifts and does not roster ‘long day’ shifts.  
3.4.2 Guideline Access 
Out of the 274 cases included in the study population, 105 of the doctors (38%) said that they 
accessed the Hospital HealthPathway CAP guidelines while assessing the patient and 
formulating their management plan. Thus guidelines were not accessed in 169 (62%) of the 
cases. These 169 doctors were then asked about their reasons for not accessing the guidelines. 
3.4.3 Reasons for not accessing guidelines 
Table 3-2 - Reasons for not accessing Hospital HealthPathways CAP guidelines 
35.5% 59 I already had another plan - for objective reasons 
 1 Particular organism isolated 
 2 Particular organism previously isolated 




 6 Risk factors meaning atypical cover is required (eg smoking, COPD, vasculitis, previous required ICU admission for pneumonia) 
 7 Worsening despite previous treatment as per CURB65 score 
 11 Initially treated as sepsis of unknown source prior to results 
 5 Sicker than CURB65 score reflects (due to fever, oxygen requirement, tachypnoea, CRP, type two respiratory failure, tachycardia or rigors) 
 2 Severe CXR findings (eg. Empyema, bilateral pneumonia, effusion, possible malignancy)  
 1 Concurrent illness putting patient at risk of becoming more unwell (HONK, muscular dystrophy, possible underlying airways disease, Parkinsons, COPD) 
 13 Used pink book/poster 
 1 Patient/family preference 
13.3% 22 I already had another plan - for subjective reasons 
 5 Appeared subjectively sicker than CURB65 score reflects 
 2 Looked more well than CURB65 score reflected 
 8 I continued antibiotics someone else started before the diagnosis was made as they would cover the infection 
 7 Previous course of antibiotics restarted 
29.5% 49 I disagree with guidelines 
 6 Management based on clinical judgement rather than guidelines 
 9 These guidelines inappropriate for Emergency Department patient /inpatient 
 22 I don't need to follow guidelines to treat pneumonia 
 8 I use the CURB score but not Hospital HealthPathways 
 1 Why use a narrower spectrum when you can use a broader spectrum 
 2 Personal preference/ habit 
 1 History of legionella exposure - put on azithromycin only 
3.6% 6 Didn't follow guidelines 
 6 There was not enough time to look at guidelines 
18.1% 30 I didn't look at the guidelines because I know them 
 30 I know guidelines without looking at them 
 
Of the 169 doctors who reported that they did not access the Hospital HealthPathways CAP 
guidelines when assessing and managing the index patient, 81 (48.8%) said that they did not 
use the guidelines because they already had a plan in mind for their patient. 35.5% were based 
on objective elements. These included advice or other guidelines from an expert source; 
current or previous microbiological or radiological results; the presence of tangible risk 
factors for atypical disease or deterioration; the presence of concerning or deteriorating vital 
signs. 13.3% were based on more subjective elements, such as: the clinical impression that the 
patient was unwell or well; the decision to continue or restart antibiotics prescribed 
previously.  
Of the 49 doctors who stated that they chose not to follow the guidelines because they 




assess and manage a patient with pneumonia, and 12.2% reported that personally they 
preferred to centre their management around their clinical judgement rather than written 
guidelines. Doctors managing 18.4% of these cases stated they felt the Hospital 
HealthPathways guidelines were not applicable to the case they were assessing. In 16.3% of 
the cases, the CURB-65 severity score was used and then the doctor subsequently made their 
own antibiotic choice. A smaller number of doctors who disagreed with the guidelines had 
their own preferences and habits which they preferred. 
In 18.1% of cases, doctors reported that they had not accessed the guidelines because they 
knew what the guidelines said and so did not need to physically look at the webpage in order 
to apply the recommendations. Similarly, in 3.6% cases doctors stated they had not had 
enough time during their assessment or management of the patient to access the guidelines. 
 Analysis 
3.5.1 Guideline access - subgroup analysis 
3.5.1.1 Single logistic regression  
After application of single logistic regression, two factors relating to the patient, two factors 
relating to the doctor, and one factor relating to the environment were found to significantly 
affect the likelihood of the doctor assessing the case having accessed the Hospital 
HealthPathways CAP guidelines. The full results of analysis using single logistic regression 
can be found in Appendix D. 
 The age of the patient and the severity of their pneumonia were both shown to have a 
statistically significant association with guideline access. Guidelines were less likely to be 
accessed for patients aged 45-64 compared to patients aged 18-44 (OR 0.32, 95% CI 0.13 – 
0.77, p = 0.01). The differences in guideline access for the other age groups (65-74 and 75 
and over) were not significant. 
Doctors were more likely to access the guidelines when treating patients with moderate 
pneumonia compared to mild pneumonia (OR 1.17, 95% CI 1.08 – 1.35, p= 0.03). The 
difference in guideline access for severe pneumonia compared to mild pneumonia was not 
significant. 
The seniority and the specialty of the doctor assessing and managing the case were both 
shown to have a statistically significant association with guideline access. TIs and House 




<0.001), but the difference in guideline access for Registrars compared to TIs and House 
Officers was not significant.  
Working in medical subspecialties, including respiratory, was associated with a lower 
likelihood of guideline access compared to working in Emergency Medicine (OR 8.06, 95% 
CI 1.45 – 150.81, p = 0.05).  The difference in guideline access between doctors working in 
General Medicine and Medical Subspecialties was not significant.  
The type of shift within which the encounter took place was shown to have a statistically 
significant association with guideline access. Guidelines were used more often when the 
doctors were working a ‘Long Day’ shift in comparison to when they were working a normal 
‘Day’ shift (OR 0.44, 95% CI 0.22-0.88,p = 0.02). The differences in guideline access 
between doctors working on other types of shift (i.e. Evening and Night shifts) were not 
significant.  
3.5.1.2 Multiple logistic regression 
When multiple logistic regression was applied to adjust for the other variables which were 
significant in single logistic regression, doctors treating patients aged 45-64 were still found 
to be significantly less likely to access the guidelines (p = 0.04). Additionally, doctors treating 
patients with moderate pneumonia continued to be more likely to access guidelines, as did 
TIs/House Officers (moderate pneumonia p = 0.03; TIs/House Officers p = <0.001). The full 
results of analysis using multiple logistic regression are included in Appendix D as ‘p 
adjusted’ values. 
3.5.2 Reasons for not accessing guidelines – subgroup analysis 
3.5.2.1 Single ordinal logistic regression 
Single ordinal logistic regression applied to the data showed that three factors relating to the 
doctor and one factor relating to the environment significantly affected what type of reason 
the doctor was likely to have given when interviewed about not having accessed Hospital 
HealthPathways CAP guidelines. The full results of this analysis are in Appendix E. 
Firstly, male doctors who did not access HealthPathways pneumonia guidelines were more 
likely to disagree with the guidelines than female doctors, and less likely to have other plans 
for their patients based on objective elements of their review (OR 0.32, 95% CI 0.18 – 0.57, p 




Secondly, SMOs who had not accessed the pneumonia guidelines were much more likely to 
say that they had done so because they disagreed with them than TIs and House Officers, and 
less likely to have made alternative plans for their patients based on objective features or say 
they knew the guidelines (OR 0.15, 95% CI 0.05 – 0.43, p value = <0.001). Strikingly, 48% 
of SMOs said they disagreed with the guidelines, but none of the TIs and House Officers 
disagreed. There was no significant association found when analysing responses given by 
Registrars. 
Thirdly, doctors working in General Medicine who reported not accessing the guidelines were 
less likely to state that they had made other plans for their patients based on objective 
features, but more likely to disagree with the guidelines, than those working in Emergency 
Medicine (OR 0.31, 95% CI 0.17 – 0.57, p = <0.001). There was no significant association 
found when comparing responses given by doctors working in the medical subspecialties. 
With regard to the setting of the encounter, and reflecting these results, doctors reviewing 
cases in the Emergency Department who had not accessed the guidelines were more likely to 
have made plans based on objective elements than those who reviewed cases on an acute 
ward. They were also less likely to disagree with guidelines (OR 2.42, 95% CI 1.37 – 4.27, p 
= 0.002).  
3.5.2.2 Multiple ordinal logistic regression 
When all factors shown to be significant via single ordinal regression were adjusted for by 
combination into a multiple ordinal regression model, doctor gender and specialty remained 
significant (doctor gender p = 0.004; specialty p = 0.01). The full results of analysis using 
multiple logistic regression are included in Appendix E. 
 Discussion 
Hospital HealthPathways CAP guidelines were accessed in 38% of the cases included in this 
study. ‘Access’ was defined as part or all of the guideline being read, specifically in order to 
apply it or decide whether to apply it to the assessment and management of the index case in 
question. This could go some way to explain the relatively low levels of access, as 
demonstrated when those doctors who did not use the guidelines were interviewed: i.e. 
doctors who often see cases of pneumonia are likely to become very familiar with the 
guidelines and are therefore capable of recalling the guideline recommendations without 
needing to reread them. Christchurch Hospital also has an alternative source of antibiotic 




same recommendations, and some doctors prefer to use these guidelines instead. As it is 
specifically a preferred medicines list, however, the Pink Book does not contain the 
recommendations regarding other aspects of assessment and management outside of antibiotic 
treatment which HealthPathways encompasses. 
Reasons for the associations found on logistic regression analysis can be considered, but not 
proved, and it should be remembered that correlation does not imply causation. For example, 
the 45-64 age group represent a ‘middle aged’ group of patients who might typically be seen 
as less vulnerable than very old or very young patients. This age group could also be thought 
of as more likely to have family support at home. These assumptions might lead doctors to 
feel confident in their assessment and management abilities and feel that they do not need to 
consult the guidelines. 
Patients with moderate pneumonia, who may not appear as clearly ‘well’ or ‘unwell’ as 
patients with mild or severe pneumonia, might present a diagnostic challenge. Doctors may be 
more likely to seek advice from guidelines as to how best to treat these patients. 
TIs and House Officers were shown to access the guidelines more than SMOs. During their 
longer medical careers, SMOs are likely to have looked at the these or similar guidelines 
many times, and therefore either recall the recommendations and/or have formed their own 
opinions regarding them. Due to greater experience, SMOs are likely to feel more comfortable 
relying on their clinical judgement to aid them in assessing and managing patients. This could 
also mean they have had more time to develop strong opinions regarding the guidelines, and 
thus why SMOs were more likely to say they did not access they guidelines because they 
disagreed with them.  
Doctors working in Emergency Medicine review patients presenting with a wider range or 
conditions than those who work within other medical specialties, and therefore assess patients 
with pneumonia less often, prompting the need to refresh their memory of the 
recommendations put forward in the guidelines. They might also feel they need to make their 
plans based more on objective findings than doctors working in General Medicine, who are 
likely to see patients with pneumonia comparably more often. However, doctors working in 
the respiratory subspecialty often assess patients with chest infections such as pneumonia, and 
therefore may feel that consultation of the guidelines is not required to formulate their 
management plan. A greater exposure to patients with pneumonia might mean more 




opinions regarding the guidelines based on personal experience that lead to disagreement with 
the guidelines. The association between setting and reasons given for not following the 
guideline is likely due to the fact that all the assessments carried out by Emergency Physicians 
are performed in the Emergency Department rather than an acute ward. 
An eight hour day shift takes place within normal working hours, meaning that more doctors 
(senior and junior) are present to review patients and give advice. A fifteen hour ‘long day’ 
shift, on the other hand, included time outside this when fewer doctors are present. 
Additionally, patients presenting on a normal day shift are more likely to be reviewed by a 
senior doctor than those presenting outside of the eight hour ‘in hours’ day shift window. 
Other doctors, meanwhile, might also be less likely to access guidelines on a normal day shift 
due to the confidence that being surrounded by more colleagues promotes.  
When multiple logistic regression was used to adjust for the other factors shown to have a 
significant association with guideline access using single logistic regression, the shift the case 
was assessed on, and the specialty the doctor assessing the case was working in were found to 
no longer be significant. However, the seniority of the assessing doctor remained significant. 
This supports the suggestion that a large part of the association between shift type and 
guideline access lies in the fact that most senior doctors do not assess patients on long day 
shifts. With regards to the association between specialty and guideline access, it is worth 
noting that doctors working in Emergency Medicine are not rostered for the ‘long day’ shifts, 
and, due to hierarchical structure, it would also be unusual for an SMO working in a 
subspecialty to assess a patient on a ‘long day’ shift. 
3.6.1 Strengths and limitations 
The prospective methodology employed in this study meant a wide range of reasons why 
doctors do not access clinical guidelines could be captured. Relating the interview questions 
to one specific case meant that statistical analysis was able to be carried to look for 
associations between features of different cases and guideline access. It is important, 
nevertheless, that any meanings attributed to these associations are discussed in the context of 
possibility, as examining reasons for effects found via post hoc analysis is inevitably inexact. 
The prospective nature of the study also meant that the study population size was limited by 
the time available. 
One researcher collected the data and conducted the interviews over a period of 100 days, 




This led to convenience sampling and the introduction of both sampling and systematic bias, 
limiting the confidence with which inferences about the entire population can be drawn from 
the results. 
Crucially, the interview methodology used in this study relies on honest self-reporting of 
behaviour by interviewees. Many of the participants knew the interviewer as a clinician 
themselves, which might, on one hand have encouraged openness on the assumption of 
insight into the clinical thought process. On the other hand, however, acquaintance could also 
have led to concern over the effect of their answer on future interactions with the interviewer 
in a personal or professional capacity. 
3.6.2 Implications 
The findings from this part of the study show that there are many reasons why guidelines are 
not being accessed. It should not be assumed that if doctors do not access guidelines they do 
not intend to follow them, as one of the most common reasons given by doctors for not 
looking at the guidelines was that they felt they could recall the recommendations without 
reading them. These results also reveal the extent to which there is controversy regarding both 
these particular guidelines and the use of guidelines as a whole: the presence of evidence-
based guidelines does not mean that all doctors agree that the recommendations represent the 
most effective treatment. These findings also underline the fact that clinical gestalt in many 
cases is employed prior to accessing (or not accessing) guidelines. In fact, many doctors 
claimed they did not look at the guidelines as they had already formulated a management plan 
based on their clinical judgement. This gives us some insight into the thought process 
involved in diagnosis and treatment. 
 Chapter Summary 
This chapter explains the method used in this study to examine usage of Hospital 
HealthPathways, which differs from that previously used. Access of the HealthPathways CAP 
guideline is reported to be low at 38% and the majority of reasons for not accessing the 
guideline are due to the doctor having already made a plan based on an objective element of 
the patient’s presentation. However, a large number were found to disagree with the 
guideline.  
Single logistic regression subgroup analysis findings are reported, and multiple logistic 
regression is used to adjust for the effect of other significant variables. These results indicated 




more likely to access them when treating patients with moderate pneumonia, while House 
Officers are shown to be more likely to access the guidelines than SMOs.  
With regards to reasons for not accessing guidelines, it is shown that male doctors are more 
likely to disagree with guidelines, and less likely to have deviated from the guidelines because 
they made other plans based on objective elements, than female doctors. Additionally, doctors 
working in General Medicine are less likely to have made plans based on objective elements, 
and more likely to disagree with the guidelines, than doctors working in Emergency 
Medicine. 
Possible reasons for these associations are considered in the discussion, and the fact that the 
validity of these findings depend on the honesty and accuracy of memory of the doctors 
interviewed was suggested as a limitation. Lastly, the assumption that guideline use directly 
equates to guideline compliance is challenged, and the point is raised that the presence of an 






4 Chapter 4 – Guideline compliance and reasons for non-compliance 
 Chapter Overview 
In the introduction to this chapter, the idea mentioned in Chapter Three, that guideline use 
does not imply guideline compliance, is revisited. The recommendations within the Hospital 
HealthPathways CAP guidelines are shown, and five key recommendations within the 
guideline are highlighted. 
The investigative methodology is laid out: specifically, this covers details of the collection of 
data relating to follow up chest x-rays (CXRs) and other additional data not previously 
included in the methodology explained in Chapter Three. The process of categorisation of the 
reasons why doctors did not follow the clinical guideline is again presented. Compliance with 
each individual key recommendation, as well as overall compliance, is shown in the results 
section. Reasons for non-compliance with antibiotic choice recommendations are listed and 
the relationship between guideline use and guideline compliance is discussed. Logistic 
regression is then used to find associations between characteristics of the patient, doctor and 
setting involved in each case. Potential reasons for subgroup associations are considered and, 
finally, a target compliance rate is put forward. 
 Introduction 
In the previous chapter, access of Hospital HealthPathways CAP guidelines by doctors 
working in Christchurch Hospital was examined. Use of guidelines is undeniably interlinked 
with the recommendations made within them, but the two are not synonymous. Over and 
above knowing whether their guidelines are being viewed, it is important for guideline 
publishers to know whether doctors are choosing to put the guidance into practice. 
The Hospital HealthPathways CAP guidelines (see Figure 4-1 below) are based around the 
internationally used CURB-65 severity score (explored in more detail in Chapter One) as well 
as local sensitivity data, patterns of antibiotic sensitivity and Preferred Medicine List 
guidelines. Thus, admission criteria laid out in the guidelines are based on the risk of 
morbidity and mortality published in the CURB-65 study. Antibiotic administration route 
recommendations and choice of antibiotic recommendations are made using the CURB-65 
risk stratification alongside local epidemiological data applied by local microbiology and 
infectious disease experts.(15) Recommendations regarding follow up chest x-rays are made 
















































Figure 4-4-2 - Hospital HealthPathways CAP Guidelines 
 
 Methods 
The prospective, patient specific methodology used in this study has previously been used to 
identify reasons for non-compliance with different clinical guidelines, but its use is not 
widespread.(32) With regard to pneumonia specifically, prospective studies have focussed on 
the application of Emergency Department admission criteria derived from the Pneumonia 
Severity Index (PSI - an alternative risk stratification score) to low risk patients.(105, 106) 
4.3.1 Data items collected 
4.3.1.1 Independent variables 
For each case identified, data relating to the patient, the clinician and the setting was 
collected: 
• Patient data: NHI, gender, age, ethnicity, co-morbidity (COPD, respiratory co-
morbidity, total number of comorbidities) severity of illness (CURB-65 score – 
documented, as stated by the diagnosing doctor, or calculated by the researcher as 
detailed in the previous chapter; and modified SIRS score). 
• Clinician data: gender, seniority, specialty 
• Setting data: environment, day, shift 
The data collection form can be found in Appendix B. 
4.3.1.2 Outcome variables 
Five key recommendations were identified from the Hospital HealthPathways CAP guideline 
(see figure 4-1, above) to build a full picture of compliance:  
• CURB-65 score calculation 
• Admission/discharge 
• Route of antibiotic administration 
• Antibiotic choice  
• Follow up CXR  
These were selected because compliance with these elements is straightforward to assess, and 




4.3.2 Data collection 
The study population used for this investigation was the same group used to investigate 
access of the Hospital HealthPathways CAP guideline in the previous chapter. The inclusion 
and exclusion criteria, case identification method, data collection method and applicable 
ethics are detailed in Chapter Three.  
Patients discharged from the Emergency Department were identified by manual search of the 
Emergency Department ‘discharge folder’, and paper case notes belonging to patients 
discharged from wards were found located separately from those remaining inpatients, 
therefore each patient’s admission and discharge status was clear. 
Data regarding the route of antibiotic administration and antibiotic choice was taken from 
paper drug charts included in the paper case notes where patients had been started on 
antibiotics by an emergency physician; and the MedChart e-prescribing system where a 
doctor from a different specialty had initiated treatment. If the paper drug chart was not 
found, the assessment documentation on Health Connect South was used. The antibiotic 
recorded was the one prescribed by the hospital doctor who made the diagnosis of CAP, 
whether they were initiating antibiotic treatment, switching the patient to a new antibiotic, 
continuing an antibiotic which had been started previously, or restarting a previous course of 
antibiotics. 
Data relating to follow up CXR was collected 30 days after the index encounter. Patients with 
a documented discharge diagnosis of a condition other than CAP were excluded from this part 
of data collection. Health Connect South was used to examine the patient’s discharge 
summary, plus radiology reports and radiology request listings ascertained whether a follow 
up CXR had been either advised or requested, and the reasons behind this. Risk factors for 
malignancy were found within the discharge summary and the comorbidities already recorded 
previously. Recommendations for repeat CXR by the radiologist or the SMO leading the 
patient’s care were found within the patient radiology reports and the discharge summary, as 
was evidence of ongoing symptoms.  
Doctors who had prescribed non-compliant antibiotics were approached and asked why they 
had not followed the guideline recommendation regarding antibiotic choice. Doctors who had 
not documented the CURB-65 score were asked whether they had calculated it. These 
questions were asked at the same interview as the question relating to guideline access, full 





Data regarding admission, antibiotic administration route, antibiotic choice and reason for 
non-compliance were transferred to the Excel spreadsheet entry for the index patient 
alongside the data detailed in Chapter Three. 
Cases were then categorised as ‘compliant’ (i.e. admission as per criteria laid out in 
HealthPathways CAP guidelines, and antibiotic administration route as recommended by 
CAP guidelines) or ‘non-compliant’ (admission not as per guideline criteria; and antibiotic 
administration route other than recommended in the guideline).  
Follow up CXR data was entered directly into the Excel spreadsheet alongside previously 
collected data relating to the index encounter. Cases were categorised as ‘compliant’ (follow 
up CXR either advised or planned only if patient meets criteria laid out in HealthPathways 
CAP guidelines, see figure 4-1, above), ‘non-compliant’ (follow up CXR neither advised nor 
planned in accordance with HealthPathways guideline criteria, ), or excluded (where the 
patient’s discharge diagnosis was not, in fact, pneumonia). 
The reasons given for not complying with recommendations regarding antibiotic choice were 
recorded and analysed for recurring ideas, for example: ‘The patient was unwell with a fever 
and rigors’ and ‘They were sick, with very low oxygen saturation’ were grouped together as 
‘Sicker than CURB-65 score reflects’. These thematic subgroups were then combined into 
four overarching categories, based on examination of the results and identification of 
repeating themes within it. The four categories were: ‘Objective reasons’, ‘Subjective 
reasons’, ‘Disagreement with guidelines’ and ‘Unintentional non-compliance’. 
Excel was used to produce comparison tables showing the study population demographics, 
compliance with the key guideline recommendations and the frequency of reasons given for 
not complying with guideline recommendations on choice of antibiotics. Statistical analysis 
software package R was then used to perform single and multiple logistic regression to 
identify trends among the demographic subgroups and the compliance with guidelines and 
reasons for this. A P value of less than or equal to 0.05 was chosen at the outset as the level 
of significance for this study and multiple logistic regression models were built to account for 







4.4.1 Study Sample 
The study sample used to investigate compliance with these key recommendations was the 
same population which was used to examine guideline access in Chapter Three, where details 
regarding the distribution of independent variables within the sample can be found.  
Patients with a documented discharge diagnosis of CAP, who were therefore investigated 
with regard to appropriate CXR follow up, amounted to 227. Of these, the percentage of male 
and female patients were approximately equal (50.7% male compared to 49.3% female). 
Easily the largest age group were those over the age of 75 (46.7%) while 21.1% were aged 
45-64, and the two smallest groups were 18-44 and 65-74 (17.2% and 15% respectively). The 
majority of the patients (72.2%) identified as NZ European in ethnicity, the second largest 
ethnic group was Other (14.6%), and the third was the Maori ethnic group (9.7%). The study 
population included 22% of patients with COPD, while a further 46.7% had a respiratory 
comorbidity. Almost half of the population had between 4 and 8 comorbidities, (49.3%) and a 
little under half (42.3%) had between 0 and 3 comorbidities. Mild pneumonia accounted for 
46.3% of cases, while 28.6% had moderate pneumonia, and 25.1% had severe pneumonia. 
Altogether, 76.5% of the 227 patients met the modified SIRS criteria for sepsis. 
4.4.2 Compliance with guideline 
 Table 4-1- Compliance with five key recommendations of the Hospital HealthPathways CAP guideline 
Overall, compliance with the four key admission recommendations was only 31% and 
compliance with the five recommendations (including follow up CXR) was 21%. CURB-65 
score calculation, admission criteria, antibiotic administration route and planned follow up 
CXR all had nearly 70% compliance, however there was less than 50% compliance with 







Calculating severity 189 (69.0) 85 (31.0) 
Admission 185 (67.5) 89 (32.5) 
Antibiotic route 187 (68.2) 87 (31.8) 
Antibiotic choice 130 (47.5) 144 (52.5) 
Overall compliance with admission 
recommendations 85 (31.0) 189 (69.0) 
Follow up CXR 166 (73.5) 60 (26.5) 




The majority of the non-compliance observed was overtreatment rather than undertreatment, 
ie. patients who received non-compliant treatment were mostly given treatment recommended 
by the guidelines for those with higher CURB-65 scores, rather than lower. For example, 85% 
of non-compliance with the antibiotic administration route involved prescription of IV 
antibiotics when the guideline advised oral. Of patients with mild pneumonia, 70% were 
admitted despite guideline recommendations for discharge. 61% of non-compliance with 
choice of antibiotics was due to prescription of antibiotics with broader spectrums than that 
advised by the guideline. 
4.4.3 Reasons for not complying with guideline antibiotic recommendations 
As antibiotic choice was the recommendation with the worst compliance level, reasons for 
this were investigated.  
Table 4-2 - Reasons given in interview for non-compliance with Hospital HealthPathways CAP antibiotic recommendations 
54.2% 77 Objective reasons 
  1 Particular organism isolated 
  3 Particular organism previously isolated 
  10 Advice (from Infectious Diseases specialist, senior, or accepting specialty) 
  4 
Needed to cover concurrent infection (eg. cellulitis, biliary colic, bacteraemia 
post prostate biopsy) 
  6 
Risk factors make me think they need atypical cover (eg smoking, COPD, 
vasculitis, previously required ICU for pneumonia) 
  15 Worsening despite previous treatment as per CURB65 score 
  17 Initially treated as sepsis of unknown source prior to results 
  12 
Sicker than CURB65 score reflects (due to fever, oxygen requirement, 
tachypnoea, CRP, type two respiratory failure, tachycardia or rigors) 
  4 
Severe CXR findings (eg. Empyema, bilateral pneumonia, effusion, potential 
malignancy)  
  3 
Concurrent illness putting patient at risk of becoming more unwell (HONK, 
muscular dystrophy, underlying airways disease, Parkinsons, COPD) 
  1 Recommended antibiotics not funded on discharge 
  1 Patient/family preference 
21.8% 31 Subjective reasons 




  1 Looked more well than CURB65 score reflected 
  12 
I continued antibiotics someone else started before the diagnosis was made as 
they would cover the infection 
  8 Previous antibiotics restarted/continued 
10.6% 15 Disagreement with guidelines 
  3 Management based on clinical judgement rather than guidelines 
  2 These guidelines inappropriate for Emergency Department patient 
  2 I don't need to follow guidelines 
  1 Why use a narrower spectrum when you can use a broader spectrum 
  1 No point in calculating CURB65 score as being admitted for other reason 
 3 History of legionella exposure - put on azithromycin only 
  3 Personal preference/ habit 
13.4% 19 Unintentional 
  1 There was not enough time to look at guidelines 
  10 Mistake / misread guidelines 
  6 Mistake because thought I knew guidelines but did not 
  2 Confused by the guidelines 
 
Objective reasons for not following the antibiotic choice recommendations in the Hospital 
HealthPathways CAP guidelines were most common, followed by Subjective reasons (see 
table 4-2, above).  
Doctors gave objective reasons for non-compliance in 54.2% of cases, and the most common 
objective reason, given in 22.1% of these cases, was that the patient had been treated with 
antibiotics for pyrexia of unknown origin prior to results confirming pneumonia being 
obtained. Other common objective reasons were that the patient had been prescribed the 
appropriate antibiotic but their condition had worsened despite this (19.5% of these cases) and 
that a specific objective sign (for example, oxygen saturations, temperature, heart rate) was 
concerning (15.6% of these cases). 
Subjective reasons were given in 21.8% of cases. This included the clinical impression that 
the patient was unwell or well (35.5% of cases where a subjective reason for deviation from 
the guidelines was given); and the decision to continue or restart antibiotics prescribed 




Cases featuring unintentional non-compliance came to 13.4%: due to mistakes (52.6% of 
these cases), confusion (10.5% of these cases) or lack of time (5.3% of cases). Some doctors 
were surprised that their management had not been compliant as they had thought that they 
had been treating according to the guidelines (31.6% of unintentionally non-compliant cases). 
Lastly, 10.6% were non-compliant because the doctors disagreed with the guidelines. Some 
did not think they needed to use guidelines to treat pneumonia (13.3% of cases where the 
doctor disagreed with the guidelines); others disagreed that the Hospital HealthPathways 
guidelines applied to their cohort of patients (another 13.3% of these cases); and some had 
used purely their clinical judgement as opposed to guidelines (20.0% of cases). There were 
also other habits and preferences, detailed further in table 4-2 above. 
4.4.4 How guideline use affects guideline compliance 
The categories of reasons given for non-compliance with antibiotic recommendations appear 
similar to those used to group reasons for not accessing the guidelines. It is likely that the 
reasons for each decision could be divided into such similar categories because the two 
decisions are interlinked, and the decision to use guidelines or to make a plan without using 
the guidelines has a subsequent effect on compliance with those guidelines.  
Interestingly, the percentage of doctors giving reasons within the similar categories varied 
considerably between the decision to access the guidelines and the decision to comply with 
the recommendations on antibiotic choice. An element of this variation could well be that the 
guidelines contain recommendations on many different steps of the assessment and treatment 
process, whereas, for reasons of time and resources, this study was only able to focus on 





Table 4-3- Guideline access and compliance with four key recommendations of Hospital HealthPathways CAP guideline 
Recommendation Compliance Guidelines accessed Guidelines not accessed 
No. of cases No. of cases 
Calculating 
severity 
Compliant 99 94.3% 90 53.3% 94.3%  53.6%  
Non-
compliant 
 6  7.1%  78  92.9% 
5.7%  46.4%  
Admission 
Compliant 80 76.2% 105 62.1% 76.2%  62.1%  
Non-
compliant 
 25  28.1%  64  71.9% 
23.8%  37.9%  
Antibiotic route 
Compliant 78 74.3% 109 64.5% 74.3%  64.5%  
Non-
compliant 
 27  31.0%  60  69.0% 
25.7%  35.5%  
Antibiotic 
choice 
Compliant 61 58.1% 69 40.8% 58.1%  40.8%  
Non-
compliant 
 44  30.6%  100  69.4% 
41.9%  59.2%  
Overall 
Compliant 
 45  60.8%  29  39.2% 
42.9%  17.2%  
Non-
compliant 
 60  30.0%  140  70.0% 
57.1%  82.8%  
 
Despite the majority of doctors who accessed the guideline complying with each individual 
recommendation, most doctors were non-compliant with the guideline overall. Nevertheless, 
the percentage of doctors who accessed the guideline and were still non-compliant with the 
guideline overall was noticeably lower than the percentage of doctors who did not access the 
guidelines and were non-compliant overall (25.7% lower, see table 4-3, above). The majority 
of doctors who did not access the guidelines were still compliant with the recommendations 
on CURB-65 calculation, admission and antibiotic route, but were non-compliant with the 
antibiotic choice recommendation and the guideline overall. While the majority of doctors 
who complied with the guidelines had accessed the guidelines, the majority of doctors who 
were non-compliant with the guidelines had not accessed the guidelines (both individual 





4.5.1 Compliance with guideline antibiotic recommendations - subgroup analysis 
4.5.1.1 Single logistic regression 
Single logistic regression was applied to each key recommendation in turn, then to the overall 
admission management, to examine any significant associations between the independent 
variables and the likelihood of the doctor assessing the case having complied with the 
Hospital HealthPathways CAP guidelines. The full results of analysis using single logistic 
regression can be found in Appendix F. 
4.5.1.1.1 CURB calculation 
The severity of the patient’s pneumonia, the seniority of the doctor treating them, the type of 
shift the doctor was working on and whether or not the doctor accessed the Hospital 
HealthPathwyas CAP guidelines were all shown to have a significant effect on the likelihood 
of the doctor calculating the CURB-65 score. 
Firstly, CURB-65 score was more likely to be calculated for patients with moderate 
pneumonia (OR 1.17, 95% CI 1.03 – 1.34, p = 0.02). The percentage of patients with severe 
pneumonia who had their CURB-65 score calculated was not significantly different to the 
percentage of patients with mild pneumonia. 
Secondly, SMOs were shown to be less likely than TIs and House Officers to calculate 
CURB-65 scores. (OR 0.78, 95% CI 0.64 – 0.94, p = <0.01). The percentage of registrars who 
calculated the CURB-65 score was not significantly different to the percentage of TIs and 
House Officers. 
Thirdly, those who accessed the Hospital HealthPathways CAP guidelines were more likely 
to calculate the CURB -65 score than those who did not (OR 1.50, 95% CI 1.35 – 1.66, p = 
<0.001). 
Lastly, working on ‘Long Day’ shifts was positively associated with CURB-65 score 
calculation in comparison to working on normal ‘Day’ shifts (OR 0.80, 95% CI 0.69 – 2.50, p 






The patient’s age, their number of comorbidities, whether they have COPD, whether they met 
modified SIRs criteria, the setting they were assessed in and whether the doctor accessed the 
guidelines were all significantly associated with compliance with the admission criteria. 
Firstly, doctors were more likely to apply the admission criteria set out in the guidelines 
when treating patients who were aged between 65-74 or 75 and over in comparison to patients 
aged 18-44 (OR 2.76, 95% CI 1.16 – 6.82, p = 0.02 for 65-74 year old patients, OR 6.22, 95% 
CI 2.96 – 13.43, p = <0.001 for those 75 and over). 
Secondly, patients with COPD were more likely to be admitted or discharged in accordance 
with the guidelines than those without (OR 1.93, 95% CI 1.02 – 3.84, p = 0.05). Similarly, 
patients with 4 – 8 comorbidities were more likely to be admitted or discharged in accordance 
with these criteria than those with 0-3 comorbidities (OR 1.83, 95% CI 1.08 – 3.14, p = 0.03). 
Thirdly, patients who met the Hospital HealthPathways modified SIRS were more likely to 
have the guideline admission criteria applied than those who did not (OR 1.93, 95% CI 1.07 – 
3.47, p = 0.03). 
Doctors who accessed the Hospital HealthPathways CAP guidelines were more likely to 
admit patients according to the guidelines (OR 1.95, 95% CI 1.14 – 3.41, p = 0.02). 
Lastly, cases reviewed in the Emergency Department were more likely to be admitted or 
discharged as per the guideline criteria than those reviewed on an acute ward (OR 2.38, 95% 
CI 1.42 – 4.03, p = 0.001). 
4.5.1.1.3 Route of antibiotics 
It was found that the age of the patient and the severity of the pneumonia had a significant 
effect on the likelihood of the doctor complying with recommendations regarding the route of 
antibiotic administration. 
Patients aged 75 and over were more likely to receive antibiotics via the compliant route than 
those aged between 18-44 (OR 4.04, 95% CI 1.94 – 8.51, p = <0.001). There was no 
significant association between use of compliant antibiotic route and patients in the other age 
groups. 
Treating moderate or severe pneumonias also made it more likely that doctors prescribed 




4.64 – 20.51, p = <0.001, and OR for severe pneumonia 29.35, 95% CI 11.23 – 101.06, p = 
<0.001).  
4.5.1.1.4 Choice of antibiotics 
Pneumonia severity and access of the guidelines were both significantly associated with 
compliance with the choice of antibiotics. 
As with the other key recommendations, patients suffering from severe pneumonia were 
more likely to receive antibiotics prescribed in compliance with guideline recommendations 
compared to those with mild pneumonia (OR 2.66, 95% CI 1.48 – 4.83, p = 0.001). 
Those doctors who accessed the Hospital HealthPathways CAP guidelines were more likely 
to comply with guideline antibiotic recommendations, and those who did not access the 
guidelines were less likely to (OR 2.01, 95% CI 1.23 – 3.31, p = 0.01). 
4.5.1.1.5 Overall management on admission 
Severity of pneumonia, gender and seniority of doctor, guideline uaccess and the setting of 
the encounter were shown to affect the likelihood of overall compliance with the four key 
admission recommendations.  
Treating moderate or severe pneumonias made it more likely that doctors complied with the 
admission recommendations overall (OR for moderate pneumonia 2.89, 95% CI 1.42 – 5.99, 
p = 0.003, and OR for severe pneumonia 4.82, 95% CI 2.45 – 9.81, p = <0.001).  
Male doctors were less likely to be compliant overall than female doctors (OR 0.305, 95% CI 
0.17 – 0.54, p = <0.001). 
SMOs and, to a lesser extent, registrars, were both associated with a lower compliance rate 
than TIs and House Officers. (SMO OR 0.17, 95% CI 0.06 – 0.45, p = <0.001 and registrar 
OR 0.36, 95% CI 0.18 – 0.73, p = 0.004). 
Doctors who had accessed the guidelines were more likely to be compliant overall than those 
who didn’t (OR 3.62, 95% CI 2.09 – 6.37, p = <0.001). 
Cases which had been reviewed in the Emergency Department were more likely to be 





4.5.1.1.6 Follow up chest x-ray 
The number of comorbidities the patient had an apparent significant effect on their likelihood 
of receiving appropriate radiological follow up, however, due to the small numbers in the 
group of patients with more than nine comorbidities, this subgroup analysis was 
underpowered and conclusions about this association should be drawn with caution. Patients 
with fewer than three comorbidities appeared to have guideline compliant radiological follow 
up more often than patients with more than nine comorbidities (OR 0.75, 95% CI 0.61 – 
0.93). 
4.5.1.2 Multiple logistic regression 
The association between certain independent variables and guideline compliance continued to 
be significant when multiple logistic regression was applied to adjust for the other variables 
which were significant in single logistic regression. The full results of analysis using multiple 
logistic regression are included as ‘p adjusted’ in Appendix F. 
Guideline access continued to be associated with likelihood of calculating CURB-65 score, 
compliance with antibiotic choice and compliance overall with all four admission 
recommendations (p = <0.001, <0.001 and 0.02 respectively, 95% CI). Doctors treating 
patients aged 75 and over, and doctors assessing patients in the setting of the Emergency 
Department were both still more likely to make admission decisions which were compliant 
with guideline recommendations (p = <0.001 and 0.002 respectively, 95% CI). Moderate 
cases and severe cases of pneumonia remained significantly associated with higher levels of 
compliance with both the recommendations regarding the route of antibiotic administration 
and the overall management on admission (p = <0.001 and <0.001 respectively for antibiotic 
route recommendation, and 0.009 and <0.001 for overall admission management, 95% CI). 
Male doctors and registrars also continued to be less likely than others to comply overall with 
admission management (p = 0.01 and 0.04, 95% CI). 
4.5.2 Reasons for not complying with guideline antibiotic recommendations – subgroup 
analysis 
4.5.2.1 Single logistic regression 
Single ordinal logistic regression applied to the data showed that two factors relating to the 
patient and one factor relating to the doctor significantly affected the likelihood of the doctor 
giving different types of reasons for not following Hospital HealthPathways CAP guidelines. 




Doctors treating patients with COPD were less likely to give objective reasons for not using 
the recommended antibiotic and more likely not to follow the guidelines unintentionally than 
those treating patients who did not have COPD (OR 2.84, 95% CI 1.32 – 6.09, p = 0.01).  
Doctors treating patients with severe pneumonia were less likely to give objective reasons or 
disagree with the guidelines, and more likely to give subjective reasons or not follow the 
guidelines unintentionally than those treating patients who had mild pneumonia. (OR 0.42, 
95% CI 0.18 – 0.98, p = 0.05). There were no significant differences in the reasons for 
deviation from the guidelines given by doctors treating patients with moderate pneumonia. 
SMOs were much less likely to give an objective reason for not using the recommended 
antibiotics, and much more likely either to give a subjective reason or not follow the guideline 
unintentionally than TIs and House Officers (OR 0.23, 95% CI 0.07 – 0.79, p = 0.02). 
Reasons given by registrars for deviation from the guidelines were not significantly different 
from those given by TIs and House Officers. 
4.5.2.2 Multiple logistic regression 
When all factors shown to be significant via single ordinal regression were adjusted for by 
combining them into a multiple ordinal regression model, only doctor seniority continued to 
be significant (p = 0.001). The full results of analysis using multiple logistic regression are 
included as ‘p adjusted’ in Appendix G. 
 Discussion 
As stated previously, reasons for the associations found on logistic regression analysis can be 
considered, but not proved. Doctors who accessed the HealthPathways CAP guidelines were 
significantly more likely to go on to calculate the CURB-65 score, select a compliant 
antibiotic and comply overall with admission recommendations. Thus the reasons for not 
accessing guidelines apparently illustrated that the thought process behind a clinical decision 
does not always follow a step-wise progression. Indeed, many doctors said they did not access 
the guidelines as they had already formulated a plan based on an objective or subjective 
element of the patient’s presentation. However, the other doctors who had not formulated 
plans in this way are possibly accessing the guidelines specifically for advice regarding 
antibiotic choice, resulting in increased compliance rates among this group. 
Patients with moderate and severe pneumonia were found to be more likely to receive 




treatment overall. As HealthPathways recommendations for both moderate and severe 
pneumonias is to prescribe intravenous (IV) antibiotics, this finding probably reflects a 
general tendency to use IV antibiotics in hospital. While patients with moderate or severe 
pneumonia constituted 57.3% of the sample, in fact 82.4% of patients received IV antibiotics, 
with 62.4% of patients with mild pneumonia also receiving IV antibiotics.  
Doctors who assessed patients in the Emergency Department were shown to be significantly 
more likely to admit or discharge patients in accordance with the admission criteria in the 
HealthPathways guidelines. However, the specialty the doctor assessing the patient was 
working for was not found to have a similar significant association. As it was, 96.5% of 
patients who were not admitted or discharged as recommended by HealthPathways had mild 
pneumonia, and 67.5% of these were assessed by doctors working in General Medicine or a 
medical specialty. Patients seen by these doctors are referred following an initial assessment 
either by a GP or by a doctor from the Emergency Department. Discharges from the hospital 
medical wards after only one assessment are uncommon. Where a medical doctor thinks a 
patient might be suitable for discharge, they are often assessed in the Emergency Department, 
prior to their official admission as an inpatient.  
Patients with fewer than three comorbidities appeared to have guideline compliant 
radiological follow up more often than patients with more than nine comorbidities, although 
this subgroup analysis was underpowered due to the small numbers in the group of patients. It 
is worth noting that for patients without significant smoking history, history of asbestos 
exposure, ongoing symptoms, suspicious radiological features for whom a public hospital 
physician or radiologist has not recommended follow up CXR, guideline compliant care 
constitutes no radiological follow up. It may be that patients with fewer than three 
comorbidities are more likely to fall into this category of patients for whom guideline 
compliant care does not require radiological follow up. In turn, compliance may be more 
likely in circumstances where compliance constitutes inaction, rather than organisation of 
radiological follow up. In fact, this was the only domain examined where the majority (56%) 
of non-compliance was due to undertreatment (follow-up CXR not organised for a patient 
meeting the guideline criteria for follow-up) rather than overtreatment (follow-up CXR 
organised for a patient who did not meet criteria). 
Fifteen percent of doctors who prescribed antibiotics other than those recommended by the 




reflected (whether that was subjectively or objectively). The modified SIRS score  (a more 
sensitive severity score including measures not used to calculate the CURB65 -see section 
3.3.3.1) was included as it could potentially be positive in patients with mild or moderate 
CURB65 scores. The analysis of results did not show any association between SIRS score and 
compliance. 
4.6.1 Strengths and limitations 
The data for this part of the study, looking at compliance with the hospital HealthPathways 
CAP guidelines, was collected alongside that used to analyse access of the guidelines. Thus 
the advantages and disadvantages of employing a prospective methodology to interview a 
convenience sample of doctors, discussed in Chapter Three, is also applicable to these 
findings. 
This study focussed on the encounter where pneumonia was diagnosed, and the antibiotic 
prescribed at this stage in the patient journey. Any alteration to this was not followed up. 
Patients receiving, for example, broad spectrum antibiotics for pyrexia of unknown origin on 
arrival from a doctor who then diagnosed pneumonia, were categorised as receiving non-
compliant treatment for an objective reason. The decisions made during subsequent reviews 
of the patient and any changes to their antibiotic, even though this may have continued on to 
be the main treatment component, were not recorded. 
In addition, it is important to acknowledge that the categorisation of reasons for non-
compliance is in itself a subjective decision. The fact that standards or judgements are often 
set via peer review in the medical field is testament to the view that the most correct solution 
is that supported by the opinion of a quorum of medical peers.(107) Likewise, in this study, 
the categorisation of reasons given for non-compliance was set by two researchers, both with 
clinical backgrounds and experience in managing the types of cases included in the study. 
However, it is acknowledged that two different researchers asked the same question might 
have produced differing results. 
4.6.2 Implications 
As noted in section 4.4.2 above, the majority of the non-compliance observed was 
overtreatment rather than undertreatment. Overtreatment in this way presents little risk for the 
patient in terms of CAP related morbidity, but may bring added risk from nosocomial 
infection, peripheral IV catheter associated infection, and C. difficile associated disease.(108) 




admission, and the use of broad spectrum antibiotics has the potential to add to the burden of 
multi-drug resistant anti-microbials.(18)   
After categorising the reasons given by doctors who participated in the study for not 
complying with the Hospital HealthPathways CAP guidelines, consideration was given as to 
how ‘appropriate’ each reason was. This was an attempt to quantify a realistic target 
compliance rate which acknowledged a certain percentage of cases of ‘appropriate non-
compliance’, i.e. scenarios which fall outside the remit of the guidelines. A requirement for 
guidelines written for day-to-day use by doctors is that they should be straightforward and not 
too complex for ease of reference in a clinical setting.(49) This means a certain amount of 
flexibility and caveats are sacrificed in order to strike this balance. Recognising that a certain 
amount of cases will fall outside the remit of any practical guideline is an important message 
which applied to any guideline auditing exercise. Nevertheless, it is equally important that 
guideline use is promoted and encouraged where possible, as it is by applying evidence-based 
investigations and treatments developed via research that medicine continues to modernise 
and improve. 
As with the categorisation of the reasons for non-compliance, the labelling of reasons for 
non-compliance as ‘appropriate’ or ‘inappropriate’ in itself is inevitably based on a certain 
amount of subjective opinion. In this study, an objective reason for non-compliance with 
antibiotic guideline recommendations was given in 28% of all cases. Therefore, if objective 
reasons for non-compliance with antibiotic guideline recommendations were termed 
‘appropriate’, appropriate non-compliance with this recommendation would be 28%. The 
target rate of compliance with these guideline recommendations could therefore be considered 
to be 72%.  A subjective reason for non-compliance with antibiotic guideline 
recommendations was given in in 11% of all cases. If we appreciate that a certain amount of 
subjective clinical gestalt has always been an unquantifiable, yet important, part of the 
practice of medicine, and termed both objective and also subjective reasons for non-
compliance as ‘appropriate’, the target rate of compliance based on the data from this study 
would instead be 61%. 
The previous Hospital HealthPathways study (introduced in Chapter One) also used data 
collected on compliance with CAP guidelines to quantify a target rate of compliance. 
Estimates were higher, with 87.8% reported as the target rate of compliance for antibiotic 




compliance rates between the studies is probably due the retrospective methodology of the 
previous study, which led to reliance on documentation. Reasons for non-compliance with 
antibiotic recommendations were only documented for 12.2% of patients. In this study, 
however, reasons were obtained via interview for every case of non-compliance with 
antibiotic recommendations, which pertained to 52.5% of patients. This study therefore noted 
more instances of ‘appropriate non-compliance’, and the target rate of compliant was 
estimated to be lower. The systematic reviews discussed in Chapter Two which coined the 
term ‘intentional non-adherence’ also quantified a target rate of compliance: a target rate of 
69-98% compliance for guidelines in general was estimated. This wide range was due to the 
wide range of examples of ‘intentional non-adherence’ reviewed in the paper.(32)   
 Chapter Summary 
In this chapter, the Hospital HealthPathways CAP guideline recommendations and the 
methods used for evaluating compliance with the guideline are explained. The results show 
that for most recommendations, there was approximately 70% compliance. However, for the 
choice of antibiotic, compliance was under 50%, and compliance with the guideline overall 
was approximately 30%. The majority of reasons reported for non-compliance with the 
recommendation regarding antibiotic choice are objective. 
In the analysis section, it is shown that after adjusting for other significant variables with 
multiple logistic regression, accessing the guideline was associated with compliance with 
severity calculation, antibiotic choice and overall compliance; doctors treating patients aged 
75 and over and doctors working in Emergency Medicine were associated with  compliance 
with the recommendation regarding admission criteria; male doctors and registrars are 
associated with non-compliance with the guideline overall; and doctors treating patients with 
moderate or severe pneumonias are associated with compliance with the antibiotic 
administration route recommendation and the guideline overall. It is explained that SMOs 
were less likely than TIs or House Officers either to give objective reasons for not following 
the recommendation regarding choice of antibiotic, or to not follow the guidelines 
unintentionally. 
The discussion section explores possible reasons for these findings, explores the finding that 
the majority of noncompliance is due to ‘overtreatment’, and notes that the categorisation of 




appropriate non-compliance with the antibiotic recommendation is estimated at 28-38%, 





5 Chapter 5 – The impact of ‘Practice Points’ 
 Chapter Overview 
This chapter addresses the impact of the addition of ‘Practice Points’ to the Hospital 
HealthPathways acute pancreatitis and CAP guidelines. Practice Points are bullet points 
making explicit a recommendation within the body of a clinical guideline. The concept of the 
Practice Points, their purpose, and the guidelines they were added to (acute pancreatitis and 
CAP) are introduced. It is explained that the control groups for this part of the study are 
formed of existing data obtained during the previous CDHB guideline research, introduced in 
Chapter One. The selection of both experimental groups and the data collection process are 
outlined. The data collection method is outlined in full in Chapter Three, above, with 
additional data specific to this part of the study detailed here. 
The composition of each study sample is reviewed in the results section, followed by the 
findings from each intervention. Strengths and limitations are discussed, and the chapter 
concludes after consideration of the implications of the results.  
 Introduction 
In many of the studies examined in the literature review in Chapter Two, it was reported that 
easy to read guidelines are more likely to be followed and that poorly accessible, complex, or 
vague guidelines are less likely to be followed.(33, 45, 109) The study carried out within 
CDHB in 2017, discussed in Chapter One, showed that a change in the platform of clinical 
guidance was associated with an increase in access and compliance and a reduction in 
variation in practice among clinicians.(3) In response to this, the Hospital HealthPathways 
team altered the presentation of certain guidelines, adding bullet points (known as ‘Practice 
Points’) to emphasise and clarify particular recommendations which already formed part of 
the guidelines.  
The Practice Points examined in this study were added to the acute pancreatitis and CAP 
pathways in May 2017. These were chosen for a sample of convenience, as compliance rates 
prior to addition of the Practice Point was available from the 2017 study. Examining these 
two guidelines provided information on conditions managed by different specialties: patients 
with CAP are assessed and managed by emergency, general and respiratory physicians, 
whereas those with acute pancreatitis are managed by emergency physicians and general 
surgeons. The two conditions also have different incidence rates, with approximately 600 




200 per year admitted with acute pancreatitis.(110) These differences therefore allow for more 
generalisation when discussing outcomes.  
5.2.1 Pancreatitis 
The acute pancreatitis guideline recommends that measurement of serum amylase should be 
used to make a diagnosis of pancreatitis, and measurements of serum complete blood count, 
electrolytes, urea, creatinine and CRP should be used to monitor patient progress thereafter 
(see Figure 5-1, below).  
Local expert opinion holds that further measurements of serum amylase did not change 
management and therefore testing should be limited to a single diagnostic measurement of 
serum amylase. As with any diagnostic test, reasons unnecessary measurements of serum 
amylase should be avoided are: patient centred (venepuncture can be associated with risks, for 
example, pain and site infection); financial (processing each sample costs $5.46); and clinical 
(more investigations increase the risk of encountering erroneous or false positive 
results).(111) The added Practice Point clarified these recommendations by specifying that 
‘amylase and lipase are useful for diagnosis only. Serial measurements are not useful to assess 










5.2.2 Community Acquired Pneumonia 
The CAP guideline recommends that Augmentin (known generically as co-amoxiclav) 
should only be used to treat patients with severe CAP (those with CURB-65 scores of 3-4), 
and that patients with mild CAP (those with CURB-65 scores of 0-1) should be treated with 
oral antibiotics.  
The study performed in 2017 highlighted that Augmentin was often being used to treat 
patients with mild and moderate CAP (those with CURB-65 scores of 0-2) too, instead of the 
recommended antibiotic, amoxicillin, and that patients with mild CAP were sometimes 
receiving IV antibiotics. The findings from the previous Chapter also showed poor 
compliance with antibiotic choice in comparison to the other four key guideline 
recommendations. The detailed observation of patterns of non-compliant antibiotic 
prescription and the examination of the impact of the Practice Point on compliance discussed 
within this Chapter, coupled with the reasons for non-compliance previously outlined, forms 
an in depth investigation into specific areas which can be improved and sheds light on how to 
improve them. 
Improvement in this area is important: C. difficile associated disease has been shown to occur 
more in patients taking clavalunate combinations, such as Augmentin. One study reported that 
37% of patients with C. difficile associated disease had been exposed to clavalunate 
combination antibiotics, while only 7.1% of patients who did not have C. difficile associated 
disease had been exposed to these antibiotics.(108) In line with the New Zealand Ministry of 
Health Antimicrobial Resistance Action Plan, Hospital HealthPathways recommendations for 
empirical antibiotic therapy are based on local sensitivity data, patterns of antibiotic 
sensitivity and Preferred Medicine List guidelines.(17, 21) Local epidemiological reports 
show that 97% of Strep. pneumoniae and 71% of H. influenzae isolates tested in Canterbury 
Health Laboratories are sensitive to amoxicillin.(20)  
Unfortunately, there is a paucity of published reports on the aetiology of CAP in adults in 
Canterbury and indeed in New Zealand within the last ten years. Streptococcus pneumoniae 
and Haemophilus influenzae (H. influenzae) were reported to be the two most common 
causative organisms almost twenty years ago, findings which aligned with global reports from 
the late nineties.(21, 113) However, due to improving diagnostic techniques as well as the 




Spain have recently reported an increase in viral pathogens, co-infection with more than one 
pathogen, and multi-drug resistant pathogens.(113, 114)  
IV antibiotics are more expensive than oral antibiotics, and less practical and comfortable to 
administer.(115) Additionally, IV lines present potential sites for further infection.(116) 
Evidence also shows that using oral antibiotics for non-life threatening lower respiratory 
infections leads to shorter hospital stays, with no difference in mortality compared to using IV 
antibiotics.(117) 
The added practice point (highlighted in Figure 5-2, below) now informs users that ‘Audits of 
Community Acquired Pneumonia at Christchurch Hospital have shown that amoxicillin + 
clavulanic acid and the IV route of administration are used too often. Management should be 
guided by the CURB-65 score’.(15) 
 
No other changes in the format of either guideline were made, and there was no change to the 
content of either of the guidelines. Although subject matter experts involved in writing the 
clinical guidelines were notified by email when the Practice Points went live, no Resident 








5.3.1.1 Selected time periods 
A data set of cases from a six month period between August 2016 and February 2017, 
collected for the previous CDHB study was used with the author’s permission as a control 
group. This time period ended 3 months prior to the change in format of the guidelines.(3) A 
new data set of cases from a 6 month period between August 2017 and February 2018, 
collected for this current study by the thesis author, formed the experimental group. This time 
period started 3 months after the change in guideline format. 
5.3.1.2 Inclusion Criteria 
The second, new cohort were included or excluded using the same criteria used for the 
control group. Adult patients discharged from Christchurch or Ashburton hospitals with a 
documented discharge diagnosis of acute pancreatitis, or a subgroup of acute pancreatitis, 
between the 1st of August 2017 and the 1st of February 2018 were included. Acute 
pancreatitis is defined as the fulfilment of two out of three diagnostic criteria: abdominal 
pain, serum amylase greater than 159 units/L or lipase greater than 210 units/L, and/or 
radiographic evidence of pancreatitis on imaging.(118) 
5.3.1.3 Exclusion Criteria 
Patients were excluded: if they had chronic pancreatitis or known pancreatic malignancy; if 
they were discharged with a different diagnosis; if their records were inaccessible; or if the 
diagnosis of pancreatitis was made using pancreatic lipase levels alone. 
5.3.1.4 Case identification 
The population of the new dataset was identified using the same method as that of the control 
group. Cases were identified by an information analyst from the CDHB’s Decision Support 
team using ICD-10-CM codes K85.0 to K85.9, which includes all diagnostic codes for acute 
and subacute pancreatitis.(119)  
5.3.1.5 Data items collected 
The patient’s NHI and the number of amylase results requested were the two data items 




5.3.1.6 Data collection and analysis 
The admission dates and discharge summaries of the included patients were examined and 
the corresponding laboratory results were subsequently accessed using the CDHB’s online 
clinical information systems, ‘Health Connect South’ and ‘Éclair’.  
Data was manually entered into a Microsoft Excel spreadsheet. The number of amylase 
measurements requested for each patient was assessed and, based on the number of amylase 
measurements performed, cases were categorised as either compliant (one amylase result 
only) or non-compliant (any more than one amylase result). The existing data from the control 
group was also available in Excel format and once combined, Excel was used to produce 
comparison tables. Statistical analysis software package R was used to calculate P values for 
the comparison using Pearson’s Chi squared test. 
5.3.1.7 Ethics 
Patient management was not altered by the researcher during the study and no identifiable 
patient information was used, therefore patients were not asked for consent. The Southern 
Health and Disability Ethics Committee was consulted regarding the need to apply for ethical 
approval who determined that formal approval from the committee was not required. 
5.3.2 Pneumonia 
5.3.2.1 Selected time periods 
A data set of cases from a 3 month period between September and December 2016, collected 
for the previous study, was used with the author’s permission as a control group. This time 
period ended 6 months prior to the change in format of the guidelines.(3)  
The experimental group was formed from the study population used in Chapters Three and 
four. This data set is from a period of just over 3 months (100 days) between February and 
June 2018, 8 months after the addition of the Practice Point.  
These cases were non-consecutive and collected over a slightly longer time period in 
comparison to those in the control group, as they were collected by just one researcher via a 
prospective methodology, whereas the cases in the control group were collected via a 
retrospective methodology.    
5.3.2.2 Data collection 
The inclusion and exclusion criteria, case identification method, data collection method and 




For each case identified, data relating to the patient, the clinician, the encounter and the 
clinical decisions was collected: 
• Patient data: NHI, gender, age, ethnicity, COPD, severity of illness, CURB-65 score 
• Clinician data: gender, seniority, specialty 
• Setting data: environment 
• Clinical decision data: antibiotic used 
The data collection form for the experimental group can be found in Appendix B. 
Information was compiled on individual paper data collection forms (Appendix B) and 
subsequently transferred into an Excel spreadsheet. 
5.3.2.3 Analysis 
Once collated within an Excel spreadsheet, cases were categorised as ‘compliant’ (antibiotic 
prescribed as recommended in HealthPathways CAP guidelines), ‘non-compliant 
Augmentin’ (Augmentin prescribed for a case where HealthPathways CAP guidelines 
recommends another antibiotic) or ‘non-compliant other antibiotic’ (an antibiotic other than 
Augmentin prescribed against HealthPathways CAP guidelines). 
The existing data from the control group was also available in Excel format and, once 
combined, Excel was used to produce comparison tables. Statistical analysis software package 
R was used to calculate P values for comparison of results and demographic data using 
Pearson’s Chi squared test. 
 Results 
5.4.1 Pancreatitis 
5.4.1.1 Study Sample 
All patients who received the diagnostic code for acute pancreatitis on discharge in the 
selected time periods were identified. There were 126 cases in the control group, taken from 
the 2017 study, after exclusion criteria were applied by that author. Prior to review of 
electronic clinical records of all of the identified encounters and application of inclusion and 
exclusion criteria, there were 203 cases in the experimental group. However, 11 cases were 
excluded as they had chronic pancreatitis or known pancreatic malignancy, 9 were excluded 
as acute pancreatitis was diagnosed on lipase measurement alone, and 1 case was excluded as 




The demographic characteristics of the 182 included cases are displayed in Appendix C.  
The proportions of male and female patients across the control and experimental groups were 
not statistically different (p= 0.23, 95% CI), with 59% males in the control group and 51% 
males in the experimental group. The mean age of the included patients was 53 years in the 
control group, with range of 20-96 years, and 55 years in the experimental group, ranging 
from 18- 94 years. The age category with the most patients in the control group was the 18-44 
category (35%) but in the experimental group the category with the most patients was 45-64 
(34%); however this difference was not statistically significant (p= 0.37 95% CI). In both 
groups the majority of patients in the sample self-identified as being of NZ European ethnicity 
(86% in the control group and 59% in the experimental group). There was a significantly 
greater percentage of patients categorised as ‘Other’ ethnicity in the experimental group (31% 
in comparison to 6% in the control group, P value <0.001, 95% CI). 
Half of the patients in both groups were admitted to General Surgery via the Emergency 
Department. Similar percentages were referred via their GP in both groups (38% and 35% in 
the control group and the experimental group respectively) and the remaining patients (12% 
and 15% of the patients in each group) were managed by a different specialty (rural medicine, 
gastroenterology, general medicine or healthcare of the elderly). These differences were not 
statistically significant (p= 0.62 95% CI). 
Due to the methodology, characteristics of the clinicians managing each case was unable to 
be examined. 
5.4.1.2 Results 
Table 5-1 - Compliance with guideline recommendations on amylase measurement before and after addition of a Practice Point 





1 (compliant) 82 65% 142 78% 0.01 
More than 1 (non-
compliant) 44 35% 40 22% 0.01 
Total 126  182   
 
Before the Practice Point was added to the guideline, 82 of 126 total cases (65%) had amylase 




After the addition of the Practice Point, 142 of 182 cases (78%) had one measurement of 
amylase, illustrating a 13% increase in compliance between the two time periods. This is a 
significant finding (P= 0.014, 95% CI) (see Table 5-1).  
Of the 44 non-compliant cases before the Practice Point was added, 30 cases (24%) had 2 
amylase measurements, 8 cases (6%) had 3 measurements, 3 cases (2%) had 4, 2 cases had 5, 
and 1 case had 8. After the addition of the ‘Practice Point’, 28 of the 40 non-compliant cases 
(15%) had 2 amylase measurements, 10 (6%) had 3 measurements, 1 had 4, and 1 had 5. 
Thus, of the non-compliant cases, the specific number of subsequent amylase measurements 
did not change significantly before and after the change in format (P= 0.095 – 0.403, 95% 
CI). 
5.4.2 Pneumonia 
5.4.2.1 Study Sample 
Patients assessed and diagnosed with pneumonia during the selected time period were 
identified. There were 388 patients in the control group (before the Practice Points were 
introduced) taken from the 2017 study, after exclusion criteria were applied by that author. 
After application of the exclusion criteria as detailed in Chapter Three, there were 274 
patients in the experimental group (after the Practice Points were introduced). The 
demographic characteristics of the study population are displayed in Appendix C.  
There was no statistically significant difference between the numbers of male and female 
patients in the control and experimental groups. The mean age of the included patients was 69 
years in the control group, with a range of 20-98 years, and 68 years in the experimental 
group, ranging from 18-101 years, which was not significantly different. The majority of 
patients in both groups were aged over 75 years. In both groups the majority of patients in the 
sample self-identified as being of NZ European ethnicity. There was a significantly greater 
percentage of patients categorised as ‘Other’ ethnicity in the experimental group (13.5% in 
comparison to 2.5% in the control group, P value <0.001 at 95% CI), and in both groups 
Maori was the largest ethnic minority group, followed by Pacific Islander. 
29.5% of patients included in the control group had been diagnosed with COPD, which was 
not statistically significantly different from the 23% of the patients with COPD in the 
experimental group. However, a significantly greater percentage of patients in the 
experimental group had severe pneumonia than in the control group (28.8% compared to 




and moderate pneumonias (43.1% and 28.1% respectively in the experimental group, and 50.6 
% and 46.3% in the control group, p = <0.001, 95% CI).  
There was no statistically significant difference between the numbers of male and female 
clinicians managing patients with CAP. The majority of patients in both groups were assessed 
by registrars, however significantly more patients in the experimental group were seen by 
SMOs (18.2% compared to 10.4%) and almost half as many patients were seen by TIs or 
House Officers in the experimental group (15% in comparison to 29.8%, p = <0.001, 95% 
CI). The majority of patients with CAP in both groups were assessed by clinicians working in 
the general medicine department, followed closely by clinicians working in emergency 
medicine. Significantly fewer patients were assessed by respiratory clinicians in the 
experimental group (1.8% versus 5.3%, p = 0.01, 95% CI).  
The majority of patients in both groups were managed in the emergency department and the 
remaining patients were diagnosed in an acute ward. There was a significantly higher 
percentage of patients assessed in the Emergency Department in the control group, despite the 
overall pattern remaining the same between the two groups (of the patients in the control 
group, 35.8% more were seen in the Emergency Department than the patients in the 
experimental group, p = <0.001). 
5.4.2.2 Results 









2016 165 (43%) 93 (24%) 130 (33%) 
2018 83 (30%) 65 (24%) 126 (46%) 
p value  
(95% ci)  <0.01  
 
 
Table 5-3 – Non-compliant antibiotics prescribed before and after addition of a Practice Point 
Non-compliant antibiotic 2016 N (%) 2018 N (%) 
Augmentin (co-amoxiclav) 165 (64) 83 (56.1) 
Cefuroxime 13 (5.1) 0 (0) 
Missed macrolide* 8 (3.1) 11 (7.4) 
Azithromycin alone 9 (3.5) 5 (3.3) 




Amoxicillin 7 (2.7) 4 (2.7) 
Ceftriaxone  7 (2.7) 4 (2.7) 
Amoxicillin and azithromycin  6 (2.3) 2 (1.4) 
Doxycycline 5 (1.9)  2 (1.4) 
Clarithromycin 5 (1.9) 0 (0) 
Tazocin (piperacillin/tazobactam) 0 (0) 8 (5.4) 
Benzyl penicillin  0 (0) 2 (1.4) 
Cephalexin  0 (0) 2 (1.4) 
Other eg. Vancomycin, cefuroxime, roxithromycin, 
gentamicin, meropenem 
26 (10.1) 20 (13.5) 
*Guideline recommendations for patients with moderate – severe pneumonias advise treatment with dual antibiotics – 
amoxicillin or Augmentin, dependant on pneumonia severity, and azithromycin. Azithromycin, a macrolide type 
antibiotic, treats the patient for pneumonia caused by the bacteria legionella. Legionella can cause serious pneumonia, but 
diagnosis relies on time consuming urinary antigen testing and confirmation with bacterial culture, therefore it is 
recommended to initiate treatment prior to these tests. 
 
Before the Practice Point was added to the guideline, 165 of 388 total cases (43%) received 
Augmentin when the Hospital HealthPathways CAP guideline recommended a different 
antibiotic. After the addition of the Practice Point, this reduced to 83 of 274 cases (30%), 
illustrating a 13% decrease in non-compliant Augmentin use between the two time periods. 
This is a significant finding (P= <0.01, 95% CI) (see Table 5-2). The rate of prescription of 
other non-compliant antibiotics remained the same before and after the addition of the 
Practice Point (24%), meaning that by reducing the percentage of inappropriate Augmentin 
use, the percentage of compliant antibiotics used rose by 13%, from 33% to 46%.   
The other antibiotics used against HealthPathways recommendations are listed in Table 5-3 
above. A wide variety of different antibiotics were prescribed, with the ‘Other’ antibiotic 
category (containing antibiotics and antibiotic combinations only prescribed in one case) 
being the largest category aside from Augmentin. Of the other antibiotic groups, cefuroxime 
was the next most commonly prescribed non-compliant antibiotic in the control group and 
missed macrolides for patients with moderate – severe pneumonia was the next most common 





These results show a significant increase in compliance with both guideline recommendation 
after the addition of Practice Points to the guideline. Interestingly, after Practice Points were 
added, compliance improved by 13% in both cases. As stated earlier, in each case, the 
recommendation already existed within the body of the guideline prior to the addition of the 
Practice Point, and the Practice Point served only to make the recommendations more explicit. 
This supports the findings of current literature that clinicians are more likely to comply with 
clearer guidelines.(45, 109) These results are also in line with the previous study examining 
compliance with Hospital HealthPathways in Christchurch Public Hospital, which noted that a 
change in how a clinical guideline is presented can lead to improved compliance with that 
guideline.(3) 
 Discussion 
The increased compliance seen following the addition of the Practice Points underline the 
point raised in the literature review that clarity facilitates guideline compliance.  
Movements such as ‘Choosing Wisely’ (an initiative of the American Board of Internal 
Medicine) are advancing dialogue around avoiding unnecessary medical tests and 
treatments.(120) According to these findings, if the average number of amylase measurements 
before adding the Practice Point had not changed, 54 more amylase measurements would 
have been taken over the six month period following its addition. Likewise, 35 more patients 
would have been put at risk of C. diff or other infections due to MDROs due to being 
prescribed Augmentin inappropriately.  
5.6.1 Strengths and limitations 
Due to the differing data collection methods employed to investigate the effect of the CAP 
Practice Point, these results must be interpreted with care. The data collection methods were 
chosen due to convenience: the control group data being readily available from the previous 
retrospective study, and the experimental group data forming part of data collected for the 
larger prospective study detailed earlier in this thesis. These differences in case identification 
could be why the population demographics differed so much regarding the severity of 
pneumonia, the setting it is treated in and which specialty and seniority of clinician it is 
treated by. On the other hand, these differences could represent a genuine shift in how patients 
with pneumonia present to hospital (perhaps more mild pneumonia is now being treated in the 




In the case of both the pancreatitis and the CAP Practice Points, it is difficult to know for 
certain that the Practice Point was the only influence on compliance that was altered in this 
time. Firstly, over the periods between the two data sets in each case, 6 months for 
pancreatitis and 8 months for CAP, many of the RMOs and some of the SMOs working in the 
departments managing these conditions will have rotated on to work elsewhere, as part of 
rostering or training. Secondly, informal teaching is carried out on a day-to-day basis, often 
by the subject matter experts involved in writing the guidelines. And thirdly, the online 
clinical information system did not record information pertaining to who requested the 
amylase measurement, and therefore characteristics of the healthcare professionals involved 
were unavailable for comparison. 
On the other hand, testing the effect of the Practice Point addition in this way lends the 
results ecological validity, as the study populations were not artificially isolated from other 
factors at work in the clinical environment of the hospital. 
Due to the methodology employed when collecting data relating to the pancreatitis Practice 
Point, characteristics of the clinicians managing each case were not able to be collected. 
Elsewhere in this thesis it has been reported that several clinician characteristics may 
significantly affect compliance. This lack of demographic information of the clinicians 
involved in the care of these patients should therefore be borne in mind when interpreting 
these findings.  
Due to the population size of this study, outcome measurement was not undertaken. Based on 
these results, it is possible to assert that over the 6 month period following addition of the 
Practice Point, an average of 35 fewer patients were put at risk of C. diff or other infections 
due to MDROs due to being prescribed Augmentin inappropriately. However, without 
outcome measurements such as morbidity and mortality, the clinical impact of using a narrow 
spectrum antibiotic instead of Augmentin on their pneumonia remains unknown. Other 
studies disagree with regards to the nature of the association between compliance with 










Findings from the first part of this study reflected a low rate of Hospital HealthPathways 
CAP guideline use, and poor compliance with the guideline antibiotic recommendation. By 
contrast, these findings in this chapter suggest that doctors are using the guideline, and that 
compliance with the antibiotic recommendation has improved. This may be due to the 
different methods of data collection (counting hits on the guideline webpage within 3 hours of 
admission in 2015 and 2016 may have led to more false positive results than asking doctors to 
self-report guideline access in 2018) or a real shift in how doctors are approaching Hospital 
HealthPathways (an extra year of exposure may have led to more doctors being able to recall 
the content of the guidelines without looking at them). 
The significant effect seen following this simple intervention has implications for guidelines 
developers seeking to maximise quality patient care. As the style and format of a clinical 
guideline is under the control of its author, changing these is an efficient way to affect levels 
of compliance with the guideline. Like Hospital HealthPathways, many clinical guidelines can 
now be accessed online, and therefore alterations can be made quickly and easily.(121)  
The findings from this interventional study imply that how recommendations are written and 
presented within clinical guidelines affects how they are used. If applied judiciously, 
financial, clinical and patient-centred improvements could potentially be achieved as a result 
of one simple addition to the guideline. 
 Chapter Summary 
In this chapter, the effect of Practice Points providing clarity regarding key recommendations 
within a clinical guideline is investigated by comparing compliance with acute pancreatitis 
and CAP clinical guidelines before and after their addition. The concept of Practice Points and 
the methodology behind the interventional study is explained. 
A 13% increase in compliance after the addition of the Practice Points is reported for both 
conditions and antibiotics contributing to ongoing non-compliance are analysed. In the 
discussion, the differing data collection methodologies between the CAP control and 
experimental groups, the effects of other variables and the ecological validity of the study are 




findings in terms of their implications for the use of and compliance with Hospital 





6 Chapter 6 – The influence of guideline purpose on compliance 
 Chapter Overview 
This chapter begins with the observation that the non-compliance reported in the previous 
three chapters, representing overtreatment rather than undertreatment, supports data already 
published in two key studies. The question is then asked whether this might be due to the 
importance that doctors place on the purpose behind the guideline. The Delphi technique, a 
systematic interactive forecasting method, is introduced. The design and dissemination of a 
survey employing a modified Delphi technique to investigate whether doctors are more likely 
to comply with recommendations which affect their patients in the short term than those made 
for other purposes is detailed.   
Median average responses and text responses from this survey are reviewed in the results 
section. Connections between these results and the findings of the previous chapters are 
described within the analysis and discussion and, in conclusion, strengths and limitations of 
the survey and the implications of the results are considered. 
 Introduction 
The main objective of this study was to explore, prospectively, the use of and compliance 
with guidelines, and the reasons for non-use and non-compliance. Using the CAP guideline 
and interviewing doctors who had managed patients with CAP, it was possible to quantify the 
concept of appropriate non-compliance. However, during interviews it was apparent that non-
compliance was sometimes because the doctors did not think the recommendation was very 
important. Indeed, some thought it would be better for their patient to offer more treatment 
than the guidelines recommended. Consequently, a novel concept emerged; that compliance 
will vary depending on the importance the doctors place on the recommendation in question. 
It was decided to add this additional piece of research to begin to explore this concept. 
 The majority of the non-compliance observed in Chapters Four and Five was overtreatment 
rather than undertreatment. Patients who received non-compliant treatment were mostly given 
treatment recommended by the guidelines for those with higher CURB-65 scores, rather than 
lower.  
Aujesky et al reported similar findings when they examined why Emergency Department 
providers do not rely on the PSI alone to determine the initial site of treatment for patients 




have been discharged safely according to their PSI. Only 3% were discharged who should 
have been admitted according to their PSI. Indeed, Halm et al introduced a new guideline 
recommending discharge for patients with low PSIs.(106) In their case, despite familiarity 
with and acceptance of the guideline, according to a post intervention survey and focus group, 
44% of low risk patients continued to be admitted. 
It could be that this skew of non-compliance towards overtreatment is due to the relative 
importance doctors allocate to the potential consequences of undertreatment and 
overtreatment. On the one hand, the potential consequences of undertreatment of pneumonia 
(for example discharge, oral antibiotics or narrow spectrum antibiotics) is clinical 
deterioration within the relative short term. This could occur while still under the doctor’s 
personal care. On the other hand, the potential consequences of overtreatment of pneumonia 
(for example admission, IV antibiotics or broad-spectrum antibiotics) include cost to the 
health service, long term IV site complications and colonisation with an MDRO. This may 
contribute to the acceleration of general antibiotic resistance within the wider population.(18) 
Recommendations included in clinical guidelines made for different reasons, and the reason 
behind a recommendation might influence the importance doctors tend to allocate to it, and 
thus, their likelihood of compliance.(27) The recommendation that patients with severe 
pneumonia should be admitted and treated empirically with Augmentin was made to prevent 
further short term clinical deterioration in unwell patients. The recommendation that patients 
with mild pneumonia should be discharged and treated empirically with amoxicillin was made 
to limit resource use and restrict contribution to antimicrobial resistance, while still treating 
common causes of pneumonia. This, and the outcomes of the studies above, suggest that 
doctors may be most likely to comply with recommendations which affect their patient in the 
short term, less likely to comply with recommendations which affect their patient in the long 
term, and least likely to comply with recommendations which affect the wider population. In 
order to explore this hypothesis, a survey was compiled from key recommendations of five 
different Hospital HealthPathways guidelines. 
 Methods 
The survey was carried out using a modified Delphi technique. 
6.3.1 The Delphi Technique 
The Delphi technique is a method of drawing together expert opinion, clarifying their 




feedback.(122) It was developed to address the need for decisiveness in subject areas where 
expert opinion is the highest level of evidence available, as it represents a quantitative 
approach to issues which may be controversial or uncertain.(123) Because of this, the Delphi 
technique is well used in the healthcare field.(124)  
Central to the Delphi methodology is the assumption that the consensus of a panel of experts 
is more likely to be accurate than that of a panel of non-experts.(125) Using a survey rather 
than a face to face focus group allows canvassing of multiple judges without the deficits 
associated with the social processes innate to group interaction, for example the domination of 
charismatic or ‘high status’ individuals, as the feedback given to participants is anonymous 
and allows individuals to consider the purely logic of the arguments.(122) 
6.3.2 Survey design 
The survey (included in Appendix H) comprised of five questions regarding compliance with 
recommendations taken from different Hospital HealthPathways guidelines, chosen to 
represent recommendations given for different reasons.  
Question one regarded the recommendation to exclude deep vein thromboses (DVT) in 
patients with low risk stratification scores (Wells score) with D-dimer alone, chosen to 
illustrate a recommendation made for cost and resource management purposes.(27) Question 
two involved the recommendation from the CAP guideline to use amoxicillin instead of 
Augmentin for patients with moderate pneumonia, a recommendation made to limit antibiotic 
resistance.(15) Question three, concerning exclusion of pulmonary emboli (PE) in patients 
with low risk stratification score (Revised Geneva score) with D-dimer alone, was similar to 
question two, with the additional impact of decreasing radiation exposure, which may affect 
the patient in the long term.(126)  The recommendation in question four, dealt with blood 
pressure management during stroke thrombolysis in order to prevent intracranial 
haemorrhage, and was chosen to illustrate guidelines which impact the patient in the short 
term.(127) Lastly, question five contained a recommendation to continue the first line 
antibiotic for worsening simple cellulitis for 48 hours. Like question two, this was included as 
a recommendation made for the purpose of antimicrobial stewardship.(15, 128) 
The survey was performed in three ‘rounds’, using a modified Delphi technique as described 
above. In rounds one and two, participants were asked to consider the full range of patients 
they see with each condition, and rate how often they thought the guideline should be 




asked to provide comments regarding their responses, for example the circumstances in which 
they would not follow the recommendation. These comments were then summarised and 
included alongside a graphical representation of responses in the round two survey. In round 
three, the guideline recommendations were removed from the questions, and participants were 
asked to rate the importance of recommendations made for each purpose (for example 
‘recommendations intended to decrease the rate of development of MDROs’, 
‘recommendations intended to limit cost and control use of resources’). The same scale was 
used, with 0 being ‘not at all important’, and 100 being ‘incredibly important’, and a graphical 
representation of the responses to round two were provided alongside each question. In round 
three, questions two and five were combined as they represented the same purpose, and the 
median ratings had been very close in round one, and the same in round two. The hypothesis 
and a summary of research findings were also included in the introduction to round three to 
clarify the reason for changing the wording of the questions to focus on the purpose of the 
guideline recommendations rather than the clinical detail. Figures 6-1, 6-2 and 6-3 
demonstrate the three iterations of the first survey question across the three rounds of the 
survey. The full survey can be found in Appendix H.  
The study was designed and validated by one researcher. The first round of the survey was 
designed in consultation with a post-doctoral clinician well versed in the use of the Delphi 
technique. It was initially disseminated to a test population of five participants, and small 
alterations in the wording of two questions was made prior to wider dissemination to the 113 
doctors who had been interviewed for the prospective CAP study discussed in Chapters 
Three, Four and Five. This population was selected because the survey was designed to test a 
hypothesis based on observations of this group. In addition, by virtue of their involvement 
with the first part of the project, they were known to be familiar with Hospital 
HealthPathways. It was also hoped that their previous participation would lead to investment 
and interest in the research, increasing retention over the three rounds. The wording of each 
recommendation was lifted directly from the Hospital HealthPathway guideline. The online 
survey building resource ‘Survey Monkey’ was used to construct an online survey. This 
method of delivery has been used previously in other studies and multiple similar online 
Delphi technique survey services are available and have previously been employed in 
healthcare research. REFERENCES Survey rounds were sent one month apart, with a 





















6.3.3 Data collection 
Survey responses were collected and reviewed using Survey Monkey’s ‘collect responses’ 
and ‘analyse responses’ features. Results were transferred to an Excel spreadsheet. The 
median response was reported as an aggregate of individual responses avoiding ‘pull’ by 
Round 3 




extreme responses, in keeping with literature on the Delphi Process.(125) Text responses to 
round one were summarised and grouped by theme. 
 Results 
6.4.1 Study Sample 
The number of respondents decreased with each subsequent survey from 30 who replied to 
the first survey, to 15 who replied to the last. 
The majority of respondents were registrars, with a smaller percentage of responses coming 
from House Officers and SMOs. There was no statistically significant difference over the 
three rounds (p = 0.946, 95% CI) 
The proportion of respondents working in General Medicine and Emergency Medicine were 
similar, but the respondents working in other specialties made up a slightly smaller 
proportion. This did not vary significantly over the three rounds (p = 0.919, 95% CI). 
Most of the respondents were male and the percentage of male and female respondents did not 
change significantly over the three rounds (p = 0.718, 95% CI). 
Details of these characteristics can be found in Appendix C. 
6.4.2 Responses 
In rounds one and two, participants were asked: “Considering the full range of patients you 
see with the conditions specified in each question, how often do you think you should follow 
each recommendation?” with the option of using a sliding bar to respond anywhere between 
“0% (Never)” and “100% (Always)”. 
In round three, participants were asked: “How important do you think it is to follow 
recommendations intended for this reason?” with the option of using a sliding bar to respond 








Table 6-1 - Survey results: round 1 
 Round 1 
 Most important      Least important 
Question 1 4 3 5 2 
Median response 95 95 92 85 84 
Range within questions 24 75 30 85 85 
Range among median responses 11 
 
Table 6-2 - Survey results: round 2 
 Round 2 
 Most important      Least important 
Question 3 1 4 5 2 
Median response 94 91 89 80 80 
Range within questions 30 25 60 60 54 
Range among median responses 14 
 
Table 6-3 - Survey results: round 3 
 Round 3 
 Most important     Least important 
Question 4 5 2 1 3 
Median response 95 85 85 75 71 
Range within questions 14 40 40 43 69 
Range among median responses 25 
 
The range of responses to most of the questions decreased over subsequent rounds but 
increased for two questions (questions one and three) (see Tables 6-1 to 6-3, above). This 
shows that respondents approached consensus for the majority of the questions.  
The range of responses between the questions increased over the three rounds. The difference 
between the median response to the question felt to be most important to comply with and the 
median response to the question felt to be least important to comply with increased from 11 in 
the first round, to 25 in the third. Initially the respondents considered each of the 




recommendations into a greater range of importance, supporting the hypothesis that doctors 
will vary their compliance based on how important they think the recommendation is. 
Question four, relating to short term adverse clinical events, had the highest median 
importance rating in the third round (95 out of 100). In both round one and round two, 
questions two and five, relating to prescribing narrow spectrum antibiotics, had the lowest 
median responses (84 and 85 respectively in the first round, and both had 80 in the second 
round).  
6.4.3 Text comments 
Analysis of text responses to the questions in the first round of the survey generated 
comments from respondents about circumstances in which each recommendation would and 
would not be followed. Summarised responses to each individual question can be found in 
Appendix I. 
Questions one and three, relating to the cost to the health service of using ultra sound 
sonography (USS) to diagnose DVT, and the long-term risks presented by radiation in the use 
of CT to diagnose PE, yielded similar comments to one another, likely due to the related 
nature of the pathologies. Most comments addressed scenarios where clinical suspicion might 
be aroused by features not included in the risk stratification scores recommended by the 
guidelines, and also the lack of specificity offered by the D dimer blood test (used to rule out 
VTE in low risk patients). In answer to question one, regarding the cost of USS DVT 
diagnosis, two respondents specifically mentioned that their decisions might vary based on 
the ease of each diagnostic test, for example the time of day might limit their access to 
radiology resources, and specific patient characteristics might make obtaining a serum sample 
difficult. One respondent stated that their patient’s level of anxiety would influence their 
decision. In answer to question three, regarding the long-term risks of CT diagnosis of PE, 
one respondent considered that a patient with undifferentiated symptoms might require a CT 
anyway to rule out alternative pathology.  
In response to question two, regarding the public health benefits of prescribing narrow 
spectrum antibiotics for moderate pneumonia, respondents gave many specific examples of 
circumstances in which they would consider deviating from the guideline recommendations, 
along the same lines as those included in the reasons given in Chapter Five for not complying 
with guideline recommendations regarding antibiotics. Many respondents said they might not 




atypical or resistant infection. Examples of this were many and varied. One respondent 
mentioned that the presence of high baseline urea would influence their thinking, and another 
mentioned that their decision would take into account high local rates of amoxicillin 
resistance. 
Question five concerned the public health benefits of prescribing oral narrow spectrum 
antibiotics for simple cellulitis in the first 48 hours. Some respondents gave similar answers to 
question two, stating that they would consider deviating from the guideline recommendation 
if their patient was elderly, comorbid, looked unwell/septic, or had features suggesting risk of 
atypical or resistant infection. One respondent said it would depend on the extent and location 
of the disease. Two respondents said they often did not follow this guideline, administering a 
bolus dose of IV antibiotics in the Emergency Department, or using a home IV service. 
Another raised doubts about the recommendation due to the poor oral bioavailability of 
flucloxacillin. Several respondents commented that patients themselves often request IV 
antibiotics or ‘stronger’ oral antibiotics within the first 48 hours, and still others added further 
actions they preferred to take in addition to following the guideline (for example, not marking 
boundaries on day one of the infection, reviewing the patient after another 24 hours). 
Many respondents felt unable to give a well-informed answer to question four, which dealt 
with the risk of short-term effects of stroke thrombolysis for a patient with high blood 
pressure, due to lack of experience and lack of clarity in the guideline recommendation. This 
was despite all respondents answering the question in all three rounds. However, those who 
did feel able to answer varied in their responses: some stated the guideline should always be 
followed, others stated they would not follow the guideline if they could lower the patient’s 
blood pressure medically or if the risk – benefit ratio favoured thrombolysis after discussion 
with the patient and a relevant SMO.  
 Analysis 
The idea that doctors place most importance on recommendations which affect their patient in 
the short term was illustrated in the survey results in the final round, when questions were 
posed in terms of the importance placed on recommendations made for each purpose. In this 
round, respondents placed the highest median average importance on the recommendation 
affecting their patient in the short term. However, in rounds one and two, when the questions 
were posed in terms of how often they would comply with the recommendations, this 




This could be due to the specific example used: many respondents felt unqualified to make 
decisions about thrombolysis while other respondents also felt the recommendation used as an 
example was unclear. These respondents may have felt more confident in their response when 
the thrombolysis guideline was removed from the question in the final round. 
Questions two and five were examples of antimicrobial stewardship recommendations 
affecting the patient in the long term and the wider population. Question two asked doctors 
how often they thought they should follow the recommendation to use IV amoxicillin and oral 
azithromycin rather than broad spectrum antibiotics for patients with moderate pneumonia. 
The median response was 84% of the time in the first round, and 80% of the time in the 
second round. In the final round, where respondents were asked how important antimicrobial 
stewardship recommendations were, they were rated second most important.  
The actual compliance rate for cases involving moderate pneumonia included in the results 
outlined in Chapter Six, was 60%. This is 20-24% lower than the median response to the 
survey questions relating to the same scenario. Reasons why these survey results do not 
reflect actual compliance rates could be either that the survey respondents represented only 7-
11% of the initial study population, or that the question asked how often should the 
recommendation be followed, not how often they are actually followed. It was shown in 
Chapter Five that 13.4% of non-compliance with this recommendation was unintentional. 
Despite the many text comments regarding circumstances where it might be appropriate to 
deviate from the guideline recommendations, most respondents indicated that they would 
follow each recommendation in the majority of cases. The overall lowest median response to 
the question ‘how often do you think you should follow each recommendation?’ in rounds 
one and two was 80% of the time. Although the respondents agreed these guidelines should 
be followed most of the time, the range and complexity of the text comments reflect the 
variety and intricacy of the exceptional circumstances. 
 Discussion 
Historically, doctors have been more willing to accept guidelines presented as guarantors of 
professional quality by clinical experts, rather than guidelines presented as tools of resource 
and cost control by administrators or managers.(27) This survey was constructed to test the 
hypothesis that doctors are most likely to comply with recommendations which affect their 




patient in the long term, and least likely to comply with recommendations which affect the 
wider population.  
The findings of the final round of the survey suggest that doctors do, indeed, place most 
importance on recommendations which affect their patient in the short term in comparison to 
recommendations made for other reasons. It must be borne in mind that the final round was 
also the round with the least respondents, and any conclusions should be drawn cautiously 
and with this in mind. In addition, it does not necessarily follow that doctors are more likely 
to comply with these recommendations. Judging from the many text comments discussed 
above, this could be due to variation between clinical scenarios which requires flexibility and 
reprioritisation to suit individual circumstances - for example patient frailty and 
comorbidities. There was no clear pattern to the importance placed on the other 
recommendations: they did not reflect the hypothesised order importance or likelihood of 
compliance at any stage in the survey. 
Responses to the survey reflected findings of the literature review. Doctors struggling to 
comply with guidelines due to inexperience with the relevant presentation could be seen 
within the survey: many respondents stated that they were not comfortable giving their 
opinions on how often the recommendation regarding hypertension in the setting of 
thrombolysis should be followed as they were not usually asked to assess the situation in 
practice. Lack of outcome expectancy was shown by the respondent who stated they would 
not follow the recommendation to use amoxicillin for moderate pneumonia due to high local 
rates of amoxicillin resistance. Many respondents to the same survey question stated they 
might not follow this guideline if their patient was comorbid, which was also a patient related 
barrier reported in the literature review.  
6.6.1 Strengths and limitations 
Strengths of using the Delphi technique are that social pitfalls, such as participants giving 
more weight to the opinions of louder or more senior members of the group, are avoided.(122) 
Consensus reached using this technique is specific to the experiences of the experts involved: 
the panel involved in this study provided a consensus on how doctors follow guidelines in 
Christchurch Hospital, which may not be generalisable to other settings.(124) 
On the other hand, the anonymity may lead to the feeling of a lack of accountability, and 
hasty decisions.(123) The validity of the decisions made could also be called into question, as 




exploration and acceptance of the alternative rationales discussed.(125) In this way the 
agreement reached might be viewed as the ‘watered down’ version of expert opinion. 
This study was additional to the main purpose of this thesis, in response to the emergence of 
the novel concept that the importance of the recommendation affects compliance. Given the 
time to prepare and recruit for the survey, both the numbers recruited and the nature of the 
survey questions were limitations. Participant uptake decreased and therefore the process was 
stopped after three rounds, despite ongoing differences in results from round to round. The 
persisting presence of a large range of responses to questions one and three indicates lack of 
consensus in these areas.  
The use of examples of recommendations served to make the survey questions ecologically 
relevant, however, the choice of examples likely influenced the participants’ responses based 
on their backgrounds and personal opinions. The inclusion of the hypothesis and summary of 
research findings from the rest of the study in the introduction of the third round of the survey 
was intended to explain the removal of the guideline recommendations from the questions, 
however their presence may have introduced bias to the results if some respondents had 
agreed with the hypothesis and responded accordingly, consciously or otherwise. 
6.6.2 Implications 
With the low response rate in the final round of the survey, interpretation of results is 
difficult. It could be cautiously said that the results of the final round of this survey support 
the hypothesis that doctors count recommendations which affect their patient in the short term 
as most important. No evidence was found to support the assertion that recommendations 
which affect the patient in the long term are more likely to be followed than recommendations 
which affect the wider population. When asked how often antibiotic recommendations for 
moderate pneumonia should be followed, respondents gave compliance rates higher than 
those reported in Chapter Five. This could illustrate either propensity for overestimation of 
compliance, especially around subjects of known interest, or acknowledgement that this 
recommendation should be followed more often. Respondents were active and insightful in 
discussing appropriate non-compliance with the recommendations. 
These findings imply that transparency around the reason for including a recommendation in 
a set of guidelines might impact subsequent rates of compliance and that a greater 
understanding on the part of the doctors using the guidelines could change their views 




of an explanation of the purpose of a recommendation to the guideline could be compared. 
This also may help us understand more about the psychology of clinical guideline application. 
 Chapter Summary 
In this chapter, the idea of the relative importance placed by clinicians on the purpose behind 
an individual recommendation as a novel factor influencing compliance is introduced and 
investigated using a modified Delphi technique. Results from the survey show a decreasing 
range of responses to each question over the course of the three rounds of surveys, and an 
increasing range of responses between questions are reported, and the presence of polarising 
consensus amongst participants is suggested. It is pointed out that the question relating to 
short term effects on patients was rated most important in the final round but no other pattern 
in responses was discernible. The text responses to the first round of the survey are then 
discussed. 
The analysis section of this chapter considers that when clinical context was removed, survey 
questions related to antimicrobial stewardship were rated of being higher importance than is 
represented by findings from Chapter Five and the text responses to the survey, and that 
respondents felt the recommendations in the survey should be followed a higher percentage of 
the time. The discussion unpacks the idea that situational variation causes reprioritisation, 
which might mean that clinical context alters the importance allocated to different 
recommendations on a case by case basis. The strengths and limitations are then outlined, 
namely: avoidance of social pitfalls; setting specific consensus; potential for normative effect; 
decrease in uptake from round to round; and the influence of clinical context on the results. 
Finally, further research into the benefits of transparency around the purpose behind guideline 




7 Chapter 7 – Discussion 
 Chapter overview 
The discussion that constitutes this concluding chapter covers a number of related areas, 
introduced by the implications of the approach to clinical guidelines from a legal perspective. 
The importance of more detailed examination of pathway variation is underlined by the 
exploration of pay-for-performance schemes, which are then related to how standards of care 
are used in New Zealand. 
Issues with the applicability of the evidence behind guidelines are then explored, with focus 
on the misapplication of clinical guidelines seen in this study. The pros and cons of the mixed 
methods approach and the prospective methodology are acknowledged. The thesis findings 
are summarised and compared with the findings of the previous CDHB study and to studies 
included in the literature review in Chapter Two. Areas for future research are suggested and 
lastly, it is indicated that although this study is specific to its setting, similarities between the 
results of other studies implies some generalisability. 
 Introduction 
When the CURB-65 score was published, the developers made it clear that they saw use of 
severity scores and evidence based recommendations playing a large part in guiding and 
informing practice, but that synonymous application of clinical judgement is crucial.(13) The 
literature search, interviews and survey undertaken over the course of this study suggest that it 
takes an adaptable human mind to treat a variable human body.(129)  
It must also be borne in mind that legally, if a question is raised concerning a doctor’s 
potential negligence, their practice is measured against that of their peers, rather than the 
advice within a clinical guideline.(107) However, as standards of care quality, clinical 
guidelines are used to defend actions which had adverse outcomes.(130) Non-compliance 
with a guideline recommendation does not legally imply negligence, thus acknowledging that 
guidelines are not appropriate for every scenario. 
Despite this, it is rare that these instances of appropriate non-compliance are quantified for 
more detailed examination, as this study has attempted. This is due to the inherent difficulty 
of adequately describing and assessing the scenarios which outlie the guidelines. If these were 
easy to summarise, they would be easy to include in the guidelines. Nevertheless, these 




care set out in clinical guidelines have become an intrinsic part of how healthcare is funded in 
some countries. 
A ‘pay-for-performance’ scheme called the Quality Outcomes Framework was introduced in 
the UK in 2004.(131) It funds GP practices for completing specific activities that represent 
good quality of care, or outcomes that are in line with best clinical evidence. Practices are 
able to record patients as ‘exceptions’, but only within the first year after each Quality 
Outcome is introduced.(132) Few other measures of performance used in the UK have these 
exception reporting facilities. The British Medical Association has voiced concern that if 
these indicators later have either direct or indirect payment linked to them, there is a risk of 
overmedicalisation and inappropriate treatment being provided to vulnerable patients and 
those with multi morbidity. Indeed many clinicians in the USA are already worried their 
traditional fee-for-service system has led to over-investigation and large charges: both public 
and private healthcare insurers in the USA recognise that pay-for-performance schemes value 
quality over quantity.(133) Due to the fragmented nature of US healthcare funding via many 
different insurers, rules regarding exception reporting vary. This has led to some primary care 
providers, unable to report individual patients as exceptions, forcing patients who refuse 
treatment or tests to disenroll from their practice and some secondary care providers avoiding 
offering treatments to patients they feel likely to reduce their performance on a quality 
measure.(133, 134) 
Here in New Zealand, the Ministry of Health develops performance measures to improve 
health outcomes, and these ‘health targets’ are reviewed annually.(135) Some targets quantify 
the target rate of compliance for example: in primary care, aiming for 90% of people in 
specified age and ethnicity cohorts to have had their cardiovascular risk assessed in the past 
five years; and in secondary care, aiming for 80% of stroke patients to be admitted to a stroke 
unit or an organised stroke service.(135, 136) Setting targets below 100% allows for 
reasonable clinical variation while, by reviewing the targets annually, these can be adjusted 
depending on feedback received during ongoing audit. However, these targets only exist for 
some clinical quality indicators. 
 Guideline scope and outcome 
In order for guidelines to be beneficial, they must be applied judiciously.  
One of the reasons doctors in this study gave, both for not accessing the HealthPathways CAP 




Hospital HealthPathways guidelines were not appropriate for their patients. The SIRS criteria 
were mentioned as a preferred alternative to CURB-65 score in some of the interviews 
conducted as part of this study. Another reason given for non-compliance with the CAP 
guidelines was starting antibiotic treatment before diagnosing CAP. Elsewhere, in the text 
comment responses to the survey, one respondent questioned the recommendation to use 
amoxicillin to treat moderate pneumonia, stating that there is a high local rate of amoxicillin 
resistance. 
These are examples of a common criticism of clinical guidelines: that evidence based 
recommendations are often based on evidence from research which did not include the types 
of patients to which the guidelines are applied in day to day practice.(137) This is because it is 
difficult to include patients with comorbidities or coexisting acute illnesses in randomised 
controlled trials as these conditions are likely to act as confounding factors, despite the fact 
that few real-life patients will be completely free of comorbidities.(138) However, in a 
situation in which a recommendation is not validated for use in the care of a specific 
subsection of the population, it is important to question whether either another diagnosis or a 
different set of guidelines should be considered. However, of the cases in this study where 
doctors did not use HealthPathways CAP guidelines because they had started antibiotics prior 
to the diagnosis of CAP, only 42% were prescribed the empirical antibiotics recommended by 
the Hospital HealthPathways ‘sepsis of unknown source’ guideline. 
Fifteen percent of the patients in the study population had been in a healthcare facility within 
the previous 90 days (this includes long term care facilities such as nursing homes and rest 
homes as well as patients who were being re-admitted after a recent hospital inpatient 
admission), which defines them as being at risk of having a nosocomial infection. These 
patients were, instead, diagnosed with CAP, and therefore included in the study population. 
The CURB-65 severity score is not validated for use with patients who are living in long term 
care facilities due to the likelihood of a differing bacterial ecosystem.(13) These patients were 
included in this study, as outcomes were not examined and therefore inclusion was based on 
the assessing doctor’s initial diagnosis and immediate management decisions. However, it is 
important to remember that the evidence basis of guidelines for the management of a certain 
condition has only been proven to be beneficial for that specific condition.(139)  
Another reason given for non-compliance with the HealthPathways CAP guideline was the 




classed comorbidities such as COPD or vasculitis as risk factors making patients more 
vulnerable to atypical infections and deviated from the guideline to accommodate these. Many 
patients, especially those who are older or socioeconomically deprived, suffer from multiple 
comorbidities.(140) Clinical guidelines for one condition may give recommendations which 
are contraindicated, either due to the presence of certain comorbidities, or the treatments 
required for comorbidities, or concurrent acute illnesses. It is often necessary to prioritise 
certain treatments over others; however as multimorbid patients are often excluded from 
research trials, there is little evidence on which to base this prioritisation.(141) 
Some clinical guidelines cross-reference recommendations for other common conditions. For 
example, Hospital HealthPathways CAP guidelines recommends targeted oxygen therapy, 
steroids and inhaled bronchodilators in patients with COPD, while Hospital HealthPathways 
COPD exacerbation guidelines recommend consideration of antibiotic treatment in the 
presence of signs of infection.(15) Another solution is presented by intention to treat analyses 
and pragmatic randomised controlled trials, which account for the realities of the complex 
medical environment by measuring outcomes for all cases allocated to each management arm, 
regardless of the clinical decisions made following this allocation.(142) Measurable effects 
found using these approaches imply the findings are ecologically valid within the existing 
health system.(143)  
Where recommendations are based on more traditional trials, doctors will continue to deviate 
from guidelines to individualise care for multimorbid patients.(137) Whether or not outcomes 
are improved by guideline adherence, pay-for-performance measures based on single disease 
guidelines lead to inaccurate reflections of practice. Thus multimorbid patients are put at risk 
of becoming medical ‘hot potatoes’ due to removal of incentive to care for them.(138) Despite 
this, many clinicians would agree that intentional noncompliance with guideline 
recommendations is beneficial for these patients. Indeed, in Chapter 5 (section 5.6.1), it was 
noted that there is lack of agreement in medical literature around whether guidelines 
positively affect clinical outcome measures.  
 Strengths and limitations 
This study used a mixed methods approach in order to quantify appropriate non-compliance 
and use qualitative data to examine the reasons why doctors chose not to access or not to 
comply with HealthPathways guidelines. The resulting analysis benefitted from the strengths 




naturally subject to the limitations of both types of data. The size of the study was necessary 
to enable statistical inferences and associations to be drawn confidently, however the study 
population was large for a qualitative study. Reasons for not acessing and not complying with 
the guidelines were categorised and analysed thematically, but more detailed explorations of 
individual responses could not be fully reported given the number of cases. In turn, 
categorisation of qualitative data collected via open questions by the researcher for use in 
statistical modelling risked misinterpretation of statements made at interview. 
A strength of the prospective methodology employed in this study is the ability to ascertain 
details which may not be routinely recorded in clinical records by interacting with the people 
involved in the clinical encounter (in the case of this study, the diagnosing doctor). As well as 
exploring the reasons behind the decisions whether to access and comply with guidelines, this 
allowed calculation of severity score in cases where it had not been documented. Sixty-three 
percent of the doctors in this study who calculated the CURB-65 score did not document it. 
The compliance of this majority would not have been acknowledged in a retrospective study.  
As discussed in Chapter Five, the utilisation of a prospective methodology led the 
investigative approach to differ too greatly in too many aspects to allow straightforward 
comparison with the previous study investigating compliance with CAP guidelines in 
Christchurch Hospital. The two studies agree that patients with moderate or severe pneumonia 
are significantly more likely to receive antibiotics via a compliant route of administration than 
those with mild pneumonia, even when other variable are adjusted for via multiple regression 
(p = <0.001 for both moderate and severe pneumonia in both studies, 95% CI). Interestingly, 
multiple regression analysis from the previous study showed that prior to the switch to 
Hospital HealthPathways from the Blue Book in 2015, male doctors were significantly less 
likely to comply with CAP guidelines overall than female doctors (p = 0.03, 95% CI). These 
associations were no longer significant after the switch to Hospital HealthPathways even prior 
to adjustment for other variables (p = 0.66, 95% CI), however multiple regression analysis 
from this new study again showed that male doctors are significantly less likely to comply 
with CAP guidelines overall (p = 0.01, 95% CI). As stated above, comparison between the 
findings of the two studies should be cautious given the differing methodologies employed.  
This study relied upon doctors to accurately self-report their thought processes and 
behaviour. Although the researcher was recognisable to many as a colleague and an emphasis 




could have been the case that doctors reported accessing the guidelines or calculating the 
severity score due to concern regarding judgement of their practice. Thus senior doctors may 
have felt more able to admit to not accessing or disagreeing with guidelines when being 
interviewed by a registrar. Conversely, House Officers might have felt less able to admit to 
not accessing or disagreeing with guidelines when being interviewed by a registrar. Far fewer 
SMOs than House Officers stated they access the guidelines, and nearly half of SMOs stated 
that they did not use the guidelines because they did not agree with them, while no House 
Officers gave this reason. Anonymity of clinicians in the study was promoted to minimise this 
effect as much as possible, however, this emphasis on lack of clinician identifiers resulted in a  
subsequent lack of ability to match patients who were assessed by the same clinician.  
In order to help organise interviews with participants, doctors working in relevant 
departments were informed of the project at meetings and handovers. This may have 
precipitated an observer effect, similar to the Hawthorne effect, whereby participants chose to 
access and/or comply with the guidelines due to their awareness that they may be asked 
questions around their decisions. 
 Future areas of research 
The size of the population included in this study was not large enough to be able to draw 
significant conclusions regarding the relationship between guideline compliance and any 
outcome measures, so this would be an important next step. Given that the most common 
deviations from the guidelines highlighted by this study were the overuse of broad spectrum 
antibiotics and IV antibiotics, the development of C. diff or colonisation with a multi-drug 
resistant organism would be a relevant outcome measure in these patients.(18) Examining 
morbidity and mortality alongside guideline compliance and reasons for noncompliance 
would further contribution to the ongoing discussion regarding the effect of guideline 
compliance on these outcomes in pneumonia patients. It may also be beneficial to evaluate 
any association between compliance and patient comorbidity scores and frailty indexes.  
This study focussed on the antibiotic prescribed by the doctor who made the diagnosis of 
CAP. A generally static approach to changing antibiotics was suggested by the fact that 8% of 
doctors who used an antibiotic other than that recommended in the guidelines did so because 
they were continuing antibiotics prescribed by someone else. As the average length of stay for 
patients included in this study was 3.5 days, on average, these patients received approximately 




not collected. Gathering his information would clarify whether non-compliant antibiotics 
prescribed at diagnosis for appropriate reasons are continued or changed once this reason no 
longer applies. 
The CURB-65 score is used within HHP guidelines due to its practical nature. With only five 
components, it is neither time consuming nor complicated to calculate. Eight percent of 
doctors who did not comply with HealthPathways antibiotic recommendations stated that 
their patient was showing objective signs of sickness which were not captured in the CURB-
65 score. Going further, a common criticism amongst the 30% of doctors who did not access 
the guidelines because they disagreed with them was that the CURB-65 score is a blunt tool 
which does not take many health indicators into account. Indeed, the creators of the CURB-65 
score themselves acknowledged at the point of publication that clinical judgement, social 
factors and the patient’s wishes should all influence management as well as the patient’s risk 
stratification.(13) However, 31% of doctors in the study did not actually calculate the CURB-
65 score, despite its simplicity. Therefore there is concern that this percentage would increase 
if a more complex severity score covering a wider range of health indicators was introduced 
into the guidelines. 
So whilst studies have shown that more complex severity scores, such as the extended 
CURB-65 score, give a more accurate risk stratification, there is clearly a trade-off with 
decrease in practicality of application.(14) However, a research opportunity which is 
becoming a reality lies in the role of technology in assisting doctors in the application of these 
risk stratification scores. Many of the details required by these scoring systems are already 
entered into the hospital patient information system during the admission process; a 
programme which automatically collates this data and calculates the severity score might both 
save time and increase compliance. 
 Conclusion 
This study has shown that evaluating the reasons for non-compliance with guidelines in 
specific clinical scenarios can provide more detailed and more reliable data than is obtained 
by investigating barriers to compliance either retrospectively or surveying more generally.  
It was found that, in the majority of initial encounters with patients with CAP, clinical 
guidelines are not accessed. Middle aged patients, moderate pneumonia severity and senior 
doctors were all associated with a low likelihood of accessing the guidelines. The most 




management plan based on an objective element of the patient’s presentation, or that they 
disagreed with the guidelines. Male doctors and doctors working in General Medicine were 
more likely to disagree with the guidelines but were less likely to have made other plans for 
their patients based on objective elements of their review.  
Despite this, addition of Practice Points to the CAP and pancreatitis guidelines increased 
compliance with the associated recommendation by 13%. This finding echoed the reason 
given by 18% of the doctors who did not access the guidelines: that many doctors who 
comply (or intend to comply) with the CAP guideline recommendations do not find it 
necessary to read the guideline every time they assess a patient with pneumonia. In spite of 
this, guideline access was associated with higher levels of overall compliance. 
While on the one hand, compliance with the majority of the key recommendations within the 
CAP guidelines was approximately 70%, on the other, overall compliance with these 
recommendations was low at 31%. This was due to a poor rate of compliance of 47% with the 
recommendations on antibiotic use. Both moderate and severe pneumonia severity were 
associated with higher levels of overall compliance, but male doctors, registrars and SMOs 
were less likely to comply overall. Reasons given for non-compliance with antibiotic 
recommendations were mainly based on objective observations, however, SMOs were much 
less likely to give an objective reason for noncompliance, and more likely to give a subjective 
reason or not follow the guideline unintentionally. 
For the most part, observed non-compliance involved overtreatment rather than 
undertreatment. The immediate risk to their patient and their responsibility for their safety 
were prioritised over the widely-recognised antimicrobial crisis contributed to by the use of 
broad spectrum antibiotics. This prioritisation puts the long term health of the wider 
community at risk but may increase the likelihood of a better clinical outcome for their 
individual patient in the short term. Clinicians such as those observed in this study are tasked 
with weighing up the potential clinical deterioration of their patient against contribution to 
long term antimicrobial resistance – two concepts so different in nature, comparison is nigh 
on impossible. It is clear from the lack of agreement in medical literature, regarding guideline 
compliance and its effect on clinical outcomes, coupled with studies such as this, showing 





It was suggested that low levels of compliance might be due to clinicians giving less weight to 
recommendations made with the intention of decreasing the rate of antimicrobial resistance as 
opposed to those made to decrease short term adverse clinical outcomes. This was supported 
by the results of a survey participated in by a sub-section of the doctors previously 
interviewed regarding their reasons for non-compliance. The survey results also suggested 
that the doctors became more confident on their opinions regarding guidelines when the 
purpose behind them was made clear. 
The reasons given at interview for either not accessing or not complying with Hospital 
HealthPathways CAP guidelines support some of the responses reported from the survey 
conducted into barriers to compliance as part of the 2017 Hospital HealthPathways study. The 
overwhelming finding from this survey was that doctors agreed that antibiotic 
recommendations do not apply to all patients. This was backed up by the doctors who stated 
that the guidelines were inappropriate for their patient (for example multimorbid patients, 
excluded from many clinical trials and thus the evidence on which some guidelines are 
based). Other respondents to the previous survey stated they felt they already knew what to do 
for patients with pneumonia, and also that a lack of time prevented them from consulting the 
guidelines. Thirteen percent of doctors who did not access the guidelines in this study stated 
they felt they did not need to use guidelines to treat pneumonia, while nearly 4% of doctors 
who did not access the guideline said they did not have time to do so. 
Many of the reasons given at interview for not accessing or not complying with CAP 
guidelines in Chapters Three and Four echo findings from the literature review in Chapter 
Two. Of the doctor related barriers to compliance reported in the studies included in the 
literature review, being unable to recall guideline content, disagreement with the guideline, 
reliance on personal experience rather than then guidelines, falling back on personal habits, 
diagnostic uncertainty, accidental omission and the need to calculate a severity score were all 
given as reasons in interview. Patient preference, comorbidities and disease severity were all 
patient related barriers reported by studies in the literature review which were also brought up 
in the interviews in this study. One guideline related barrier, the lack of applicability of the 
guideline to certain populations, and one setting related barrier, the influence of senior doctors 
on junior doctors, were also mentioned in these interviews.  
This study highlighted the day to day concerns of clinicians treating patients with pneumonia 




at the use of and compliance with guidelines for one clinical condition, it implies that there 
will be similar issues with other conditions where an empirical blanket approach is taken in 
guidelines. This study suggests that doctors see guidelines as an important and helpful part of 
their practice. They are viewed as guides rather than rules, and clinical expertise often trumps 
guideline compliance where a patient’s needs are perceived to outlie the guideline scope.  
The field of translational medicine is growing out of necessity as healthcare systems expand. 
The everyday adjustments clinicians make around clinical guidelines to shape them to the 
scenario at hand are a common tongue among the medical community, but a foreign language 
to non-clinicians. Findings from further exploration of this appropriate non-compliance can 




 Summary points 
• The barriers to guideline compliance mentioned most frequently in the literature 
review were: lack of resources, disagreement with the guideline, poor patient 
compliance and prohibitive organisational structure 
• In 38% of the cases of pneumonia included in the study, doctors reported accessing 
the Hospital HealthPathways Community Acquired Pneumonia guideline 
• Patient age, pneumonia severity and doctor seniority were shown to influence 
guideline usage 
• The reasons for not accessing the guideline given most frequently were: ‘I know the 
guidelines without looking at them’, ‘I don’t need to follow guidelines to treat 
pneumonia’, ‘Used Pink Book/poster’ and ‘Initially treated as sepsis of unknown 
source prior to results’ 
• Doctor gender and specialty were shown to influence the type of reason given for not 
accessing the guideline 
• Compliance with the recommendation regarding antibiotic choice recommendation 
was 48%, but compliance with the 4 other key recommendations were all nearly 70% 
• Guideline access, pneumonia severity, doctor seniority and doctor gender were shown 
to influence overall admission guideline compliance 
• The reasons for not complying with the antibiotic recommendation given most 
frequently were: ‘Initially treated as sepsis of unknown source prior to results’, 
‘Worsening despite previous treatment as per CURB65 score’, ‘I continued 
antibiotics someone else started before the diagnosis was made as they would cover 
the infection’ and ‘Sicker than CURB65 score reflects’ 
• Doctor seniority was shown to influence the type of reason given for not complying 
with the antibiotic recommendation 
• The target rate of compliance, taking into account the reasons for non-compliance 
with the antibiotic recommendation thought to be appropriate, was quantified at 61-
72%  
• Compliance with the relevant guideline recommendation increased by 13% following 






• Guidelines provide a platform for recommendations made for different purposes, 
which may influence the likelihood of compliance 
• There are many reasons why strict guideline adherence may not be ina patient’s best 
interest, and it should not be assumed that increased guideline compliance 
corresponds to improved clinical outcomes 
• Suggestions for future research based on the findings from this study include studying 
the relationship between guideline compliance and relevant outcome measures; 
antibiotic choices for inpatients with pneumonia throughout their hospital stay; and 
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Ab, E 2009 The Netherlands Interview 7 GPs Doctors 
Reasons why guidelines 
are not followed 
Compliance with 
national lipid lowering 
medications in diabetes 
guidelines 
Patient attributed barriers: patient doesn’t want 
to start (side effects or concern over side effects, 
preference for alternative medicine), patient doesn’t 
understand how to take properly or discontinues. 
Physician attributed barriers: wants to follow 
guideline but doesn’t (inadequate knowledge, 
doesn’t see it as their responsibility), wants to 
prescribe medication but doesn’t (contraindication, 
adds to prognosis not quality of life if short life 
expectancy, disagrees with guideline 
recommendation, doesn’t think patient will take it), 
doesn’t want to prescribe (concern over side 
effects, priority given to other co morbidities) 
Abudahish, A 2010 Saudi Arabia Survey 37 GPs Doctors 
Compliance with 
guidelines, awareness of 
guidelines, training in 
guidelines and barriers 
to compliance 
Compliance to national 
guidelines for asthma 
management 
Barriers: lack of essential medications (40%), 
patient non-compliance (32.4%), insufficient time 
(27%), lack of training on the protocol (21.6%) 





guidelines and barriers 
to compliance 
Compliance with 
national adolescent HIV 
screening guidelines  
Used Cabana’s groups to build survey. Barriers: 
Lack of self efficacy, lack of familiarity, 
environment of the ED 




Heitner, P compliance & perceived 
barriers to compliance 
speciality urinary 
incontinence guidelines 
lack of diagnostic tools (29%), lack of 
competence/skill (29%), patients not realising 
advantages of this care (28%) 












Barriers: External - influence of senior doctors on 
junior doctors (46.1%). Knowledge - lack of 
awareness (39.3%) (although reported self 
familiarity with guidelines was 78.6%). Attitude- 
having to calculate the severity (35.7%), existence 
of other, conflicting guidelines (26.6%), view that 
hospital did not expect compliance (23.2%) 
Arts, D 2016 The Netherlands 
Systematic 
Review 
16 studies Studies 






Reasons for conscious decisions not to follow 
guideline: contraindications, patient decision, 






Not documented Studies 
Provider related, 




Primary barriers: awareness, familiarity, 
agreement. Secondary barriers: perception of 
appropriate skills, inertia of previous practice. 
Tertiary barriers: differing 
patient/clinician/guideline goals. External 
barriers: equipment, space, educational materials, 
time, staff, finance, fragmented care. Guideline 
barriers: brevity, complexity, inaccessible, 
controversial, vague, out of date. Drs agree that 
guidelines are a good thing but have difficulty 
changing personal routines. Often Drs focus on 
external barriers. It is necessary to make the correct 
diagnosis to identify the correct guideline. Each 
guideline will have more than one recommendation 










with guidelines & 
provider reported 
barriers to compliance  
Compliance with 
national guidance on the 
use of hydroxyurea in 
children with sickle cell 
disease  
Barriers - patient compliance, required lab 
monitoring, female contraception required, poor 
access to care, patient’s concern regarding side 
effects, concern over toxicity, concern over age of 
patient. Education in these areas (there is evidence 
to refute these concerns) might help compliance 
Cabana, M 1999 US 
Systematic 
Review 
76 studies & 
surveys 
Studies 




Identified 7 types of barrier. Most surveys 
examined 1-2 types of barrier. Internal barriers - 
Lack of awareness (46 surveys) Lack of familiarity 
(31 surveys) Lack of agreement (33 surveys) 
(‘cookbook’, autonomy reducing, not practical, 
biased, decrease self respect, not applicable to their 
population, decrease flexibility, lacked credible 
authors, make care impersonal) Lack of self 
efficacy (19 surveys) Lack of outcome expectancy 
(8 surveys) Inertia of previous practice (14 surveys) 
External barriers (34 surveys) guideline related 
(not easy to use, not convenient, cumbersome, 
confusing), patient related, environmental (lack of 
time, insufficient staff/consultant support 
Callender, R 2017 NZ Survey 200 doctors Doctors 
Barriers to compliance 
with guidelines 
Compliance with local 
Community Acquired 
Pneumonia guidelines 
Attitudinal barriers (most common): reluctance to 
change, embarrassed to be seen to be looking thing 
sup, feeling like they personally do not need 
guidelines. Lack of outcome expectancy. 
Environmental barriers: lack of time. Guideline 





Caprini, J 2006 US 
Systematic 
Review 
Not documented Studies 
Physician related, 





Physician related barriers: Lack of awareness, 
Poor understanding, Disagreement, Resistance to 
change, Lack of outcome expectancy, Concern over 
bleeding risk, Asymptomatic nature of VTE , 
Routine surveillance is inefficient, Forgetfulness, 
Lack of peer support, Time pressure, Primary focus 
on underlying issue, Lack of confidence. Guideline 
related barriers: Evidence insufficient, difficult to 
understand/inconvenient/inconsistent guidelines. 
Environmental barriers: lack of 
resources/equipment, inappropriate skill level/staff 
mix, lack of reminder system/forcing strategies, 
low pay, increased costs, patient preference, low 
incidence of clinically apparent VTE 
Cardella, J 2008 Canada Survey 








attitudes towards the 
guidelines & barriars to 
compliance 
Compliance with local 
post-op colorectal 
cancer follow up 
guidelines 
Based on health beliefs model. Barriers: Patient 
identified: bowel prep. Provider identified: 
unclear guidelines, confusion re: responsibility 
Chapman, N 2011 Australia Interview 40 doctors Doctors 
Self-reported 





national VTE guidelines 
Fragmented system with lack of responsibility; 
medicine is considered an art & guidelines adapted 
to each patient; culture of adapting practice to the 
practice of the head of the team 




Awareness of, access to, 
attitude towards & 
barriers to complying 
with guidelines 
Compliance with local 
paediatric guidelines 
Main barriers: lack of access (17), lack of 









related & perception 
related barriers to 
compliance with 
guidelines 
Compliance with local 
psychiatry guidelines 
Organisational barriers: lack of time, lack of 
agreement between staff, exhaustion, influence of 
prior experiences, workload, information overload, 
lack of learning culture, lack of investment from 
the organisation, lack of structured organisational 
strategy/skills, lack of resources, lack of finance, 
lack of clear goals, lack of feedback, difficult 
guidelines format. Provider barriers: negative 
attitude to clinical guidelines, perceived limited 
validity of guidelines, fear of loss of autonomy, fear 
of standardisation of care, concerns about relevance 
of evidence to specific pts, lack of recall of 
guidelines, lack of research skills, lack of training. 
Perception barriers: overestimation of 
compliance, lack of familiarity with guidelines 









guidelines, barriers to 
compliance categorised 





abortion guidelines  
Barriers from interview: difficulty to coping with 
fluctuation in demand/supply (9). shortages of staff, 
space, facilities (6). These patients seen as low 
priority (5). Accidental omissions (4). Lack of 
trained staff (3) Poor referral system (3) Delay in 
obtaining pharmacy supplies (2). Barriers from 
survey: 91% related to low perceived behavioural 
control- ie. they blamed organisational factors 
Gagliardi, A 2008 Canada Interview 
26 surgeons & 
pathologists 
Doctors 
Awareness and attitudes 
toward new guidelines. 
Self-reported change in 
practice as a result of 
new guidelines. Barriers 
Compliance with local 
colorectal cancer 
staging guidelines 
Barriers: lack of awareness, lack of taking 
responsibility, lack of staff, lack of good quality 
equipment/facilities, lack of organisational support 
for interdisciplinary communication, lack of audit, 




to compliance with new 
guidelines 






related, attitude related 
& practice related 
barriers to compliance 
Compliance with 
national cystic fibrosis 
infection control 
guidelines 
Barriers: Lack of awareness (60%), disagreement 
with guidelines (27%), lack of time (24%), lack of 
support staff (27%), lack of self efficacy 
Gaston, S 2012 Australia 
Systematic 
Review 






practice guidelines  
Barriers: Lack of attention, lack of awareness, 
patient factors (concern over bleeding, adverse 
reaction, focus on acute illness), access to 
computer, ability with computers, disputing 
evidence, lack of documentation (risk assessment 
not carried out), lack of role clarity, lack of system 
support (no local guidelines), financial constraints, 
practice culture 









90.0% awareness of guidelines. 75.8% agree with 
guidelines. 45.5% reported insufficient time. 21.2% 
reported cholesterol is ‘the least of my patient’s 
problems’. Guidelines too complex for use during 
allotted time with patient 












Barriers: difficult to locate (46%), do not address 
different aspects of the disease (49%), high 
medication cost (30%), physician resources (eg 
time) (20%), limitation of physician flexibility, 
cookbook medicine (12.5%). 












48.9% of the treatment programmes contained 




cohort study treatment & patient 
preference related 
reasons for deviation  
treatment programme 
guidelines 
treatment programmes prescribed according to 
guidelines were not carried out in practice 
according to guidelines. Poorer prognostic status 
linked to higher deviation levels. Most of the 
deviations represented overtreatment. 67.3% of 
deviating treatment programmes had 1-4 reasons 
given, classified into 5 categories: cancer status, 
other clinical, current or prev. treatment related, 
patient preference related. 59% of all deviations 
were cancer related. 
Graham, I 2006 Europe Survey 
220 GPs & 
cardiologists 
Doctors 
Barriers & suggested 
practical means of 
overcoming these 
Implementation of 
national & international 
cardiovascular 
prevention guidelines 
Barriers: 36% lack of patient compliance, 23% 
time, 21% guidelines too theoretical, individualised 
treatment required, 20% financial aspects, 15% 
overcomplicated guidelines. When asked 
specifically, doctors agreed that lack of support 
from government (40%) & hospital (20%) policies 
were also barriers. 




Use & understanding of 








55.8% said education issues were the main barrier 
to compliance. Other barriers: staffing issues 
(25.6%), poor compliance with policy (24.8%), 
lack of time (24.8%), unfamiliarity with DKA/HHS 
(13.2%) & lack of access to medications (2.5%). 
Hart, S 2008 UK Survey 






guidelines, attitudes & 
beliefs about guidelines 
Compliance with 
national post stroke 
depression guidelines 
Barriers: limited time, discomfort with the subject, 
communication concerns (using the screening tool 
might trigger depression), lack of appropriate tool 
Jacobsen, R 2009 Denmark 
Systematic 
Review 
Not documented Surveys 
Patient, physician and 
institution related 
Management of cancer 
pain according to 
Patient related barriers: reluctance to report pain, 




barriers guidelines cognitive processes (fear of addiction, fear of 
tolerance, fear that increased pain means disease 
progression, fear of injections), side effects, fear of 
injections. These can all be overcome with good 
communication. Physician related barriers: 
inadequate assessment, inadequate understanding 
of tolerance, addiction, dosing. Institutional 
barriers: beaurocracy surrounding supply, 
prescription, administration of opioids, continuity 
of care. These differ between countries. 
Johnston, K 2012 Australia Interviews 




Compliance with key 
recommendations; 
patient reported and 




Patient reported barriers: difficult access to rehab 
(5), lack of awareness (3), difficulty managing co 
morbidities. Doctor reported barriers: Lack of 
awareness, lack of experience 
Kotzeva, A 2013 Spain Survey 2711 doctors Doctors 
Use of guidelines, ways 
of accessing guidelines, 
confidence in 





Barriers: Lack of time (56.4%), lack of brief, easy 
access format (42.2%), limitations in 
awareness/dissemination (32.7%) involvement of 
the pharmaceutical industry in their development 
(23.4%), lack of participation of clinical experts in 
guideline development (2.1%), lack of adaptation to 
clinical practice, inconsistencies between different 
guidelines, lack of habit, predisposition not to use 
guidelines 
Kuo, Y 2012 Taiwan Survey 135 doctors Doctors 
Objective compliance 
with guidelines & 





Barriers - Poor awareness of certain 
recommendations, lack of practical skills required, 
lack of time, lack of nursing staff 






attitude & external 
barriers to following 
guidelines, ways to 
improve compliance 
international 
management of asplenic 
patients guidelines 
clarity of responsibility (50% internists, 46% 
surgeons, 55% GPs), lack of mutual trust re: 
discharge letters/instructions (33-59%), lack of 
national guideline (>90%) 






Knowledge of & 






Nurse workload identified as most important 
barrier. 





Percieved barriers to 
implementation of 
guidelines 
Implementation of local 
enhanced recovery after 
surgery programmes 
Patient related barriers: elderly and comorbid 
patients, patient motivation/dependency, patient 
expectations Staff related barriers: tradition, 
practice inertia, lack of knowledge Practice 
related barriers: lack of flexibility, poor 
communication Health system resources: staff 
issues, resource availability 











perceived barriers to 
compliance 
Compliance with a 
variety of newly 
introduced local clinical 
guidelines 
Strongest barrier was time (with patient, and to 
receive lab tests, x rays & results) and strongest 
internal barrier was concern over professional 
autonomy. Intention to follow guidelines did not 
predict actual guideline compliance. 
McEntee, M 2009 US 
Systematic 
Review 
60 articles Studies 
Patient, provider and 
system level barriers 
Compliance with 
guidelines on diagnosis 
& management of heart 
Patient level barriers- knowledge, compliance, 
communication, functional limitations, 




failure Provider level barriers- knowledge, diagnostic 
challenge, pharmacological concerns, 
communication, personal factors. System level 
barriers- organisation structure, communication, 
lack of resources 




Knowledge of & 
compliance with 




national adolescent HIV 
screening guidelines 
Barriers: Privacy (67.4%), follow up (67%), 
perceived lack of cost effectiveness (65.4%) 





patients with AF 
Patients 
Objective rates of 
guideline compliance 




guidelines on warfarin 
in AF patients with 
ischaemic stroke 
Absolute and relative contraindications to warfarin 
recorded as per guidelines. Other reasons 
documented: falls, age, non bleeding peptic ulcer 
disease, polypharmacy, awaiting follow up, 
resolved pAF. 46% no documented reason. 
Pulcini, C 2012 France Survey 369 GPs Doctors 
Guideline compliance 




rapid antigen test 
guidelines 
Most common barriers- time (66.9%), patient 
preference (62.7%), reliance on clinical acumen 
(51.5%), disagreement with guidelines (32.8%) 
Radwan, M 2017 Palestine Survey 









Barriers: poor dissemination, poor awareness, lack 
of incentives, lack of resources, perceived lack of 
guideline trustworthiness, lack of time, lack of 
resources 
Shoukat, S 2011 Pakistan Survey 305 cardiologists Doctors 
Awareness of & 
attitidue to guidleines. 
Barriers to complying 
with guidelines & 




Barriers: patient compliance (59%), cost/health 
economics (50%), comorbid conditions of patients 
(19%). Suggestions: availability of compact 
summary (71%), delivery of latest update via 





Smith, L 2004 UK Interview 11 GPs Doctors 
Agreement with & 
opinion of guidelines. 
Barriers to following 
guidelines and 
suggested ways to 
promote compliance  
Compliance with a 
variety of primary care 
depression guidelines  
Barriers: large number of guidelines, time 
constraints, inaccessible guidelines, lack of 
resources. Suggested ways to promote compliance: 
audit & feedback 
Stoneking, L 2011 US 
Systematic 
Review 
Not documented Studies 
Barriers and potential 
solutions 
Compliance with 'sepsis 
bundle' clinical 
guidelines 
Barriers: Lack of time and staffing, Unfamiliarity 
with sepsis, Need for specialised equipment and 
training, Lack of agreement with guidelines, Lack 
of quality assurance measures, Lack of 
collaboration among medical specialties, 
Disagreement with guidelines 
Taba, P 2012 Estonia Survey 497 doctors Doctors 




Compliance with a 
variety of national 
clinical guidelines 
Barriers: time (42%), lack of medical resources 
(32%), lack of patient resources (eg. Expensive 
medications etc) 30%. Barriers in free text: 
concerns over malpractice liability, lack of 
motivation, concerns guidelines are out of date. 
Outpatient physicians more likely to come up 
against barriers. Doctors with <10yrs experience 
encountered fewer barriers. Doctors with >25yrs 
experience were more likely find guidelines too 
complex & limited them too much 
Van Den 
Boogaard, E 
2011 The Netherlands Interviews 




Patient and doctor 





Doctor reporting - Guideline barriers (23): time 
consuming, difficult to understand, vague, 
arbitrary, unclear to read, incomplete. Professional 
barriers (32): hard to resist insistent patients, lack 




confident in evidence base, fixed habits, difficult 
communication, other colleagues don’t comply, 
expensive, unfamiliarity. Patient barriers (19): 
patient compliance problems, insistence on 
investigation, differing goals, difficult history, 
difficulty in communicating guidelines. 
Organisation/setting barriers (22): expensive, 
request form prohibitive, seniors disagreeing with 
guidelines, prescribing prohibitive, time, taboo 
around the subject, discrepancies between 
guidelines. Patient reporting - Guidelines 
barriers (4): guidelines not individualised. 
Professional barriers (13): lack of knowledge, 
lack of motivation, overtreatment, lack of 
responsibility, poor communication. Patient 
barriers (13): difficulty in handling uncertainty, 
emotional reaction, resistance to discussion 
regarding certain topics, cultural differences. 
Organization/setting barriers (10): poor 
communication between specialists/MDT, long 
waiting times, social taboo of miscarriage 
Wahabi, H 2012 Saudi Arabia Interview 






Opinions on guideline 
related, provider related 
& organisational 
barriers to compliance 
Compliance with local 
paediatric asthma 
guidelines 
Guidelines related barriers- lack of clear 
development & dissemination plan, lack of 
implementation strategy, not suitable for some of 
the patients. Provider related barriers- language 
barrier between nurses & patients, lack of 
awareness, lack of familiarity, disagreement with 




shortage, bed shortage, poor referral system, cost of 
resources, availability of resources 




perceptions of barriers 





100% aware of guidelines, 51.8% used them. 20% 
did not agree with them. 21.4% routinely provided 
advice on dietary modification. 96.4% ranked poor 
patient compliance to antihypertensive drugs as 
major patient barrier to BP control, 92.6% of these 
attributed this to financial reasons & 7.4% 
attributed it to adverse effects. 
Wexler, R 2009 US Survey 28 GPs Doctors 
GP's self-reported 
compliance, agreement 
& familiarity with 
guidelines & perceived 




Patient non-compliance is perceived to be a 
significant barrier to BP control 
Wiener-
Ogilvie, S 
2007 UK Survey 





with, perceived barriers 
to compliance with & 






Barriers – preference of clinical acumen, patient 
physically unable to comply, lack of outcome 
expectancy, time, staffing, allocation of 
responsibility, poor patient motivation, continuity 
of care, lack of evidence provided to support 
guidelines, patients unwilling to change habits, 
poor patient compliance with polypharmacy, lack 
of training 
Wisnivesky, J 2008 US Survey 223 GPs Doctors 
Self-reported 
compliance with & 
awareness of guidelines. 





Barriers: lack of time, lack of awareness, lack of 
familiarity (general & specific), lack of agreement, 
lack of expected patient compliance, lack of 
outcome expectancy, lack of self efficacy 




perceived barriers to 
following guidelines 
national ulcer cruris 
venosum guidelines 
inconvenient to patients leading to non-compliance, 
some patients unable to comply given 
comorbidities, living conditions, funding, lack of 
patient understanding 
Zack, D 2001 US Survey 




Rate of screening test 





Compliance with local 
colorectal cancer 
screening guidelines 
84% said they had difficulty scheduling procedure. 
Other barriers: staffing difficulty, bowel prep 
difficulty, equipment difficulty, patient reluctance, 





















text dual analysed 
Quality 












Arts, D Yes Yes Yes Yes No Yes No Yes High 






No No No Low 
Jacobsen Yes No 
Not 
documented Not documented 
Not 
documented No No Yes Low 
Gaston Yes Yes Yes Yes Yes Yes No Yes High 
Stoneking Yes No Yes Yes 
Not 
documented No No No Moderate 
Cabana Yes Yes Yes Yes Yes No Yes Yes High 
Caprini Yes No 
Not 
documented Not documented 
Not 
documented No No No Low 
McEntee Yes Yes Yes Not documented 
Not 
documented Yes No No Moderate 























follow up at 

















































Partington Yes Yes Yes Yes Yes No Yes Yes No High 
































Ab Yes Yes Yes Very small Yes No No Yes Moderate 
Chapman Yes Yes Yes Small Yes Yes Yes No High 
Forsner Yes Yes Yes Not documented No No No Yes Moderate 
Foy Yes Yes 
Not 
documented Large Yes No No No Moderate 
Gagliardi No Yes Yes Small Yes No Yes No Moderate 
Johnston Yes Yes No Small No No No No Low 
Lyon Yes Yes Yes Small No No No No Low 
Smith Yes Yes Yes Small No No No Yes Moderate 
Van Den 
Boogaard No Yes Yes Small Yes No 
No 
No Low 
Wahabi Yes Yes Yes Small No No No No Low 










































Abudahish Yes Yes Yes Small No No No Yes Yes No Low 
Akhter Yes Yes 
Not 
documented 
Large Yes No No No Yes Yes Moderate 
Albers-
Heitner 
Yes Yes Yes Large Yes Yes yes Yes Yes Yes High 
Almatar Yes Yes Yes Medium Yes No No Yes Yes Yes Moderate 
Brandow Yes Yes Yes Large No No Yes Yes No No Moderate 
Callender Yes Yes Yes Large No No No No Yes Yes Moderate 
Cardella Yes Yes Yes Small Yes Yes No Yes N/A Yes Moderate 
Cohn Yes Yes Yes Medium No No No Yes Yes No Moderate 
Garber Yes Yes Yes Not documented No No No No No Yes Low 
Goebel Yes Yes Yes Small Yes 
Not 
documented No Yes Yes Yes Moderate 
Goldberg Yes Yes 
Not 
documented Medium Yes No Yes Yes Yes Yes Moderate 
Graham Yes Yes No Large Yes Yes Yes Yes Yes No High 
Hamelin Yes Yes Yes Large Yes Yes No Yes Yes Yes High 
Hart No No N/A Medium Yes Yes No Yes No Yes Low 
Kotzeva Yes Yes No Very large Yes Yes No Yes Yes Yes High 
Kuo Yes Yes Yes Medium No No No Yes Yes Yes Moderate 




Liu Yes Yes Yes Large No 
Not 
documented No No No No Low 
Mehta Yes Yes Yes Large No No No Yes Yes No Moderate 
Pulcini Yes Yes Yes Large Yes 
Not 
documented No Yes Yes Yes High 
Radwan No Yes Yes Large Yes No No Yes No Yes Moderate 
Shoukat Yes Yes Yes Large Yes N/A No Yes Yes No Moderate 
Taba Yes Yes Yes Large Yes No No Yes Yes Yes High 
Wang Yes Yes Yes Medium No No N/A Yes Yes No Moderate 
Weiner-
Ogilvie Yes Yes Yes Small Yes Yes Yes Yes Yes Yes High 
Wexler Yes Yes No Small No No No Yes Yes Yes Moderate 
Wisnivesky Yes Yes Yes Large Yes Yes No Yes Yes Yes High 





B. Appendix B – Data Collection Form 
Data Collection Form 
From electronic records/physical notes:  
Date of encounter  
Time of encounter  
Shift type  Day shift 0800-1600 Long day 0800-2300 Evening shift 1600-2300 Night shift 2300-0800 
Encounter setting ED AMAU Other: 
 
Clinician gender Male Female Other: 
Clinician seniority TI HO Reg SMO 
Clinician specialty ED Gen Med Respiratory ICU Other: 
 
Patient NHI  
Patient gender Male Female Other: 
Patient age  
Patient ethnicity NZ European Maori Pacific Islander Other: 
 
Temperature above 38 
degrees or below 36? 
RR > 20? O2 sats <92% on air? HR > 90 bpm? WBCs >12 or <4? Confusion? 
RR > 30? O2 sats <85% on air? SBP <90 or DBP <60? Urea >7? Age >65? 
Severity of illness (CURB score) Mild Moderate Severe Very severe 
Comorbidities COPD Other: 
Healthcare facility? Readmit Long term care facility resident 
 
CURB score documented? Yes No 
Admission/discharge as per HHP? Yes No: admitted instead of discharged No: discharged instead of admitted 
Antibiotic route as per HHP? Yes No: IV instead of PO  No: PO instead of IV No: other difference in route 
Antibiotic choice as per HP? Yes No: Augmentin used instead of other 
recommended antibiotic 

















Face to face interview:  
Did you access the HHP CAP page when formulating your management plan? Yes No 
If so, when did you 







When choosing abx/ route Other: 
If you did not access HHP, why not?  
If you did use HHP & chose to deviate from one of the 4 key recommendations, why was this?  
Reason for deviation written in notes? Yes No 
If CURB score not documented: CURB score not calculated CURB score calculated but not documented 
 
Follow up of inpatients:  
Length of inpatient stay (days)  
ICU transfer? (Unless initially admitted to ICU) Yes No 
Inpatient mortality Yes No 





C. Appendix C - Demographic Characteristics 
Table C-1 - Patient Demographic Characteristics of CAP Groups 
Demographic 
Characteristics 
2016 N (%) 2018 N (%) p value* 
Patient    
Gender    
Male 179 (50.3) 142 (51.8) 0.73 
Female 177 (49.7) 132 (48.2)  
Age (Years)    
18-44 35 (9.8) 42 (15.3) 0.15 
45-64 85 (23.9) 53 (19.3)  
65-74 67 (18.8) 43 (15.7)  
>75 169 (47.5) 136 (49.6)  
Ethnicity    
NZ European 315 (88.5) 220 (80.3) <0.001 
Maori 21 (5.9) 24 (8.8)  
Pacific Islander 11(3.1) 11 (4.0)  
Other 9 (2.5) 37 (13.5)  
Co-morbidity    
COPD 105 (29.5) 63 (23.0) 0.09 











0 to 3 comorbidities - 109 (39.8) - 
4 to 8 comorbidities - 137 (50.0)  





Severity of illness    
Mild 180 (50.6) 118 (43.1) <0.001 




Severe 11 (3.1) 79 (28.8)  
SIRS    
Met SIRS criteria - 214 (78.1) - 
Did not meet SIRS criteria - 61 (22.3)  
Doctor    
Gender    
Male 170 (47.8) 134 (49.0) 0.94 
Female 186 (52.2) 140 (51.0)  
Seniority    
TI/HO** 106 (29.8) 41 (15.0) <0.001 
Registrar 213 (59.8) 183 (66.8)  
SMO† 37 (10.4) 50 (18.2)  
Specialty    
Emergency Medicine 164 (46.1) 127 (46.4) 0.01 
General Medicine 171 (48.0) 137 (50.0)  
Respiratory 19 (5.3) 5 (1.8)  
Other 2 (0.6) 5 (1.8)  
Environment    
Setting    
ED 248 (69.7) 142 (51.8) <0.001 
Acute Ward 108 (30.3) 132 (48.2)  
Day    






Shift    
Day - 87 (31.8) - 
Evening - 46 (16.8)  
Night - 81 (29.6)  
Long Day - 60 (21.9)  







Table C-2 - Demographic Characteristics of patients with documented CAP discharge diagnosis 
Demographic Characteristics 2018 N (%) 
Gender  
Male 115 (50.7) 
Female 112 (49.3) 
Age (Years)  
18-44 39 (17.2) 
45-64 48 (21.1) 
65-74 36 (15.0) 
>75 106 (46.7) 
Ethnicity  
NZ European 164 (72.2) 
Maori 22 (9.7) 
Pacific Islander 8 (3.5) 
Other 33 (14.6) 
Co-morbidity  
COPD 50 (22.0) 
No COPD 178 (78.0) 
Respiratory comorbidity 106 (46.7) 
No respiratory comorbidity 121 (53.3) 
0 to 3 comorbidities 96 (42.3) 
4 to 8 comorbidities 112 (49.3) 
9 or more comorbidities 20 (8.4) 
Severity of illness  
Mild 105 (46.3) 
Moderate 65 (28.6) 
Severe 58 (25.1) 
SIRSs  
Met SIRs criteria 174 (76.5) 





Table C-3 - Demographic Characteristics of patients with acute pancreatitis included in the study 
Demographic 
Characteristics 
2016 – 2017 N 
(%) 
2017 - 2018 N 
(%) 
P value* 
Patient    
Gender    
Male 74 (58.7) 93 (51.1)  
Female 52 (41.3) 89 (48.9) 0.23 
Age (Years)    
18-44 44 (34.9) 55 (30.9)  
45-64 43 (34.1) 61 (34.3)  
65-74 17 (13.5) 37 (20.8)  
>75 22 (17.5) 25 (14.0) 0.37 
Ethnicity    
NZ European 108 (85.7) 108 (59.3)  
Maori 6 (4.8) 14 (7.7)  
Pacific Islander 4 (3.2) 3 (1.6)  
Other 8 (6.3) 57 (31.4) <0.001 
Route of referral    
ED  General surgery 64 (50.8) 91 (50.0)  
GP  General surgery 48 (38.1) 64 (35.2)  
Other 14 (11.1) 27 (14.8) 0.62 







Table C-4 - Demographic Characteristics of survey participants 
 Round 1 N 
(%) 
Round 2 N 
(%) 




Seniority     
SMO 5 (16.7) 3 (13.7) 2 (13.3)  
Registrar 18 (60.0) 14 (63.6) 11 (73.3)  
HO 7 (23.3) 5 (22.7) 2 (13.3) 0.946 
Specialty     
General Medicine 9 (30.0) 6 (27.3) 6 (40.0)  
Emergency Medicine 14 (46.7) 10 (45.4) 5 (33.3)  
Other medical 
subspecialty 
7 (23.3) 6 (27.3) 4 (26.7) 0.919 
Gender     
Male 18 (60.0) 15 (68.2) 12 (70.6)  
Female 12 (40.0) 7 (31.8) 5 (29.4) 0.718 




D. Appendix D – Subgroup Guideline Access and Logistic Regression 
 
Table D-1-Access of HealthPathways Guidelines: Number (percentage) of cases where Hospital HealthPathways was consulted and logistic regression analysis 
  Single Logistic Regression 
Multiple logistic 
regression 
 HHP looked at N (%) HHP not looked at N (%) *OR (95% CI) **p value ***p adjusted 
Patient      
Gender      
Male 59 (41.5) 83 (58.5) 1.33 (0.82 – 2.17) 0.25  
Female a 46 (34.8) 86 (65.2) - -  
Age (years)      
>75 58 (42.6) 78 (57.4) 0.82 (0.41 – 1.65) 0.57 0.38 
65-74 15 (34.9) 28 (65.1) 0.59 (0.24 – 1.40) 0.23 0.15 
45-64 12 (22.6) 41 (77.4) 0.32 (0.13 – 0.77) 0.01 0.04 
18-44 a 20 (47.6) 22 (52.4) - -  
Ethnicity      
NZ European 73 (36.5) 127 (63.5) 0.88 (0.44 – 1.83) 0.73  
Maori 13 (54.2) 11 (45.8) 1.81 (0.65 – 5.19) 0.26  
Pacific Islands 4 (36.4) 7 (63.6) 0.88 (0.20 – 3.44) 0.85  
Other a 15 (38.5) 24 (61.5) - -  
Co-morbidity      
COPD 22 (36) 39 (64) 1.02 (0.57 – 1.82) 0.94  
No COPD a 82 (38.7) 130 (61.3) - -  
Respiratory comorbidity 50 (39.7) 76 (60.3) 1.29 (0.79 – 2.11) 0.31  
No respiratory comorbidity a 55 (37.2) 93 (62.8) - -  
9 or more comorbidities 12 (42.9) 16 (57.1) 1.20 (0.51 – 2.77) 0.68  
4 to 8 comorbidities 51 (37.2) 86 (62.8) 0.95 (0.56 – 1.59) 0.83  
0 to 3 comorbidities a 42 (38.5) 67 (61.5) - -  




Severe  30 (38.0) 49 (62.0) 1.06 (0.92 – 1.22) 0.41 0.27 
Moderate  37 (48.1) 40 (51.9) 1.17 (1.08 – 1.35) 0.03 0.03 
Mild  a 38 (32.2) 80 (67.8) - - - 
SIRs      
Met SIRs criteria 79 (37.1) 134 (62.9) 0.79 (0.45 – 1.42) 0.43  
Did not meet SIRs criteria a 26 (42.6) 35 (57.4) - -  
Doctor      
Gender      
Male  37 (27.6) 97 (72.4) 0.40 (0.24 – 0.66) 0.74  
Female a 68 (48.6) 72 (51.4) - -  
Seniority      
SMO 4 (8.0) 46 (92) 0.07 (0.018 – 0.21) <0.001 <0.001 
Registrar 78 (42.6) 105 (57.4) 0.58 (0.29 – 1.15) 0.12 0.17 
TI/House Officer a 23 (56.0) 18 (44.0) - - - 
Specialty      
Emergency Medicine 60 (47.2) 67 (52.8) 8.06 (1.45 – 150.81) 0.05  
General Medicine 44 (32.1) 93 (67.9) 4.26 (0.76 – 79.74) 0.18  
Specialty (including respiratory) a 1 (10.0) 9 (90.0) - -  
Setting      
Environment      
Emergency Department 64 (45.4) 77 (54.6) 1.87 (1.14 – 3.08) 0.14  
Acute Ward a 41 (30.8) 92 (69.2) - -  
Day      
Weekday 73 (37.4) 122 (62.6) 0.88 (0.52 – 1.51) 0.64  
Weekend/Public Holiday a 32 (40.5) 47 (59.5) - -  
Shift      
Day 23 (26.4) 64 (73.6) 0.44 (0.22 – 0.88) 0.02 0.62 
Evening 27 (45.0) 33 (55.0) 0.86 (0.39 – 1.87) 0.70 0.56 
Nights 19 (41.3) 27 (58.7) 0.98 (0.50 – 1.92) 0.95 0.86 
Long day a 36 (44.4) 45 (55.6) - - - 
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p adjusted calculated using multiple regression model adjusting for 




E. Appendix E –Subgroup Reasons For Not Accessing Guidelines and Logistic Regression 
Table E-1 - Access of HealthPathways Guidelines: Number (percentage) of reasons for not accessing Hospital HealthPathways and logistic regression analysis 
 Number of cases (Percentage), Ordinal logistic regression 
 Objective N (%) Subjective N (%) Disagree N (%) Unintentional N (%) *OR (95% CI) **P value ***P adjusted 
Patient        
Gender        
Male 32 (36.0) 16 (18.0) 17 (19.1) 19 (21.3) 5 (5.6) 1.16 (0.67 – 2.01) 0.60 
Femalea 27 (35.1) 7 (9.1) 13 (16.9) 29 (37.6) 1 (1.3) - - 
Age (years)        
>75 21 (27.3) 13 (16.9) 11 (14.3) 26 (33.7) 6 (7.8) 0.50 (0.21 – 1.19) 0.12 
65-74 12 (42.9) 4 (14.3) 5 (17.8) 7 (25.0) 0 (0.0) 1.03 (0.37 – 2.87) 0.95 
45-64 17 (42.5) 4 (10.0) 9 (22.5) 10 (25.0) 0 (0.0) 0.98 (0.38 – 2.54) 0.97 
18-44a 9 (42.9) 2 (9.5) 5 (23.8) 5 (23.8) 0 (0.0) - - 
Ethnicity        
Other 7 (31.8) 2 (9.1) 2 (9.1) 8 (36.4) 3 (13.6) 0.52 (0.21 – 1.26) 0.15 
Pacific Islands 2 (28.6) 2 (28.6) 3 (42.8) 0 (0.0) 0 (0.0) 1.42 (0.42 – 4.83) 0.51 
Maori 6 (60.0) 0 (0.0) 0 (0.0) 4 (40.0) 0 (0.0) 1.70 (0.44 – 6.51) 0.44 
NZ Europeana 44 (34.9) 19 (15.1) 24 (19.0) 36 (28.6) 3 (2.4) - - 
Co-morbidity        




COPDa 10 (24.4) 5 (12.2) 9 (21.9) 15 (36.6) 2 (4.9) - - 
No respiratory comorbidity 38 (39.2) 16 (16.5) 16 (16.5) 24 (24.7) 3 (3.1) 1.63 (0.93 – 2.85) 0.09 
Respiratory comorbiditya 21 (30.4) 7 (10.1) 14 (20.3) 24 (34.8) 3 (4.4) - - 
9 or more comorbidities 5 (31.3) 2 (12.5) 3 (18.7) 6 (37.5) 0 (0.0) 0.75 (0.28 – 1.99) 0.57 
4 to 8 comorbidities 29 (34.1) 14 (16.5) 12 (14.1) 26 (30.6) 4 (4.7) 0.83 (0.46 – 1.48) 0.53 
0 to 3 comorbiditiesa 25 (38.5) 7 (10.8) 15 (23.0) 16 (24.6) 2 (3.1) - - 
Severity        
Severe 16 (33.3) 6 (12.5) 8 (16.7) 16 (33.3) 2 (4.2) 0.69 (0.36 – 1.33) 0.26 
Moderate 10 (25.6) 7 (17.9) 10 (25.6) 9 (23.1) 3 (7.8) 0.65 (0.33 – 1.28) 0.21 
Milda 33 (41.8) 10 (12.7) 12 (15.2) 23 (29.1) 1 (1.3) - - 
SIRs        
Did not meet SIRs criteria 12 (35.3) 4 (11.8) 8 (23.5) 10 (29.4) 0 (0.0) 1.07 (0.55 – 2.09) 0.84 
Met SIRs criteriaa 47 (35.6) 19 (14.4) 22 (16.7) 38 (28.8) 6 (4.5) - - 
Doctor        
Gender        
Male 25 (26.0) 10 (10.4) 18 (18.8) 41 (42.7) 2 (2.1) 0.32 (0.18 – 0.57) <0.001 
Femalea 34 (48.6) 13 (18.6) 12 (17.1) 7 (10.0) 4 (5.7) - - 
Seniority        
SMO 7 (15.9) 3 (6.8) 10 (22.7) 21 (47.7) 3 (6.9) 0.15 (0.05 – 0.43) <0.001 




TI/House Officera 10 (55.6) 1 (5.6) 6 (33.2) 0 (0.0) 1 (5.6) - - 
Specialty        
Other sub-specialty 3 (33.3) 1 (11.2) 2 (22.2) 3 (33.3) 0 (0.0) 0.46 (0.13 – 1.63) 0.23 
General Medicine 22 (23.9) 13 (14.1) 18 (19.6) 36 (39.1) 3 (3.3) 0.31 (0.17 – 0.57) <0.001 
Emergency Medicinea 34 (52.3) 9 (13.8) 10 (15.5) 9 (13.8) 3 (4.6) - - 
Setting        
Environment        
Emergency Department 36 (48.0) 10 (13.3) 12 (16.0) 14 (18.7) 3 (4.0) 2.42 (1.37 – 4.27) 0.002 
Acute Warda 23 (25.3) 13 (14.3) 18 (19.7) 34 (37.4) 3 (3.3) - - 
Day        
Weekend/Public Holiday 13 (27.7) 7 (14.9) 10 (21.3) 17 (36.2) 0 (0.0) 0.75 (0.41 – 1.36) 0.34 
Weekdaya 46 (38.7) 16 (13.4) 20 (16.8) 31 (26.1) 6 (5.0) - - 
Shift        
Long day 12 (36.4) 4 (12.1)  4 (12.1) 13 (39.4) 0 (0.0) 1.27 (0.59 – 2.74) 0.54 
Nights 18 (40.9) 10 (22.7) 5 (11.4) 9 (20.5) 2 (4.5) 1.91 (0.95 – 3.86) 0.07 
Evening 11 (40.7) 3 (11.1) 7 (25.9) 4 (14.8) 2 (7.4) 1.71 (0.75 – 3.87) 0.20 
Daya 18 (29.0) 6 (9.7) 14 (22.6) 22 (35.5) 2 (3.2) - - 
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p adjusted calculated using multiple regression model adjusting for variables 






F. Appendix F - Subgroup Compliance and Logistic Regression 
 
Table F-1 - Calculated CURB-65 Score: Number (percentage) of patients with guideline compliant care and logistic 
regression analysis 













Patient      
Gender      
Male 102 (71.8) 40 (28.2) 1.28 (0.76 – 2.14) 0.35  
Female a 88 (66.7) 44 (33.3) - -  
Age (years)      
>75 95 (69.9) 41 (30.1) 1.58 (0.76 – 3.22) 0.21  
65-74 29 (67.4) 14 (32.6) 1.41 (0.58 – 3.46) 0.43  
45-64 41 (77.4) 12 (22.6) 2.32 (0.96 – 5.78) 0.06  
18-44 a 25 (59.5) 17 (40.5) - -  
Ethnicity      
NZ European 139 (69.5) 61 (30.5) 1.04 (0.88 – 1.22) 0.65  
Maori 17 (70.8) 7 (29.2) 1.05 (0.83 – 1.33) 0.68  
Pacific Islands 9 (81.8) 2 (18.2) 1.17 (0.86 – 1.60) 0.31  
Other a 25 (65.8) 13 (34.2) - -  
Co-morbidity      
COPD 47 (74.6) 16 (25.4) 1.07 (0.94 – 1.22) 0.30  
No COPD a 143 (67.8) 68 (32.2) - -  
Respiratory 
comorbidity 92 (75.4) 30 (24.6) 1.66 (0.98 – 2.84) 0.06 
 
No respiratory 
comorbidity a 98 (64.9) 53 (35.1) - - 
 
9 or more 
comorbidities 17 (60.7) 11 (39.3) 0.94 (0.78 – 1.15) 0.59 
 
4 to 8 
comorbidities 101 (73.7) 36 (26.3) 1.08 (0.96 – 1.21) 0.20 
 
0 to 3 
comorbidities a 72 (66.1) 37 (33.9) - - 
 
Severity      
Severe  52 (65.8) 27 (34.2) 1.01 (0.89 – 1.16) 0.83 0.94 
Moderate  62 (80.5) 15 (19.5) 1.17 (1.03 – 1.34) 0.02 0.06 
Mild  a 76 (64.4) 42 (35.6) - - - 
SIRs      
Met SIRs criteria 148 (69.5) 65 (30.5) 1.03 (0.55 – 1.89) 0.92  
Did not meet SIRs 
criteria a 42 (68.9) 19 (31.1) - - 
 
Doctor      
Gender      
Male 90 (67.2) 44 (32.8) 0.82 (0.49 – 1.37) 0.44  
Female a 100 (71.4) 40 (28.6) - -  
Seniority      






Registrar 136 (74.3) 47 (25.7) 1.01 (0.87 – 1.18) 0.88 0.39 
TI/House Officer 
a 30 (73.2) 11 (26.8) - - 
- 
Specialty      
Emergency 
Medicine 88 (69.3) 39 (30.7) 1.20 (0.81 – 1.48) 0.54 
 
General Medicine 96 (70.1) 41 (29.9) 1.11 (0.82 – 1.49) 0.51  
Other Sub-
Specialty a 6 (60) 4 (40.0) - - 
 
HealthPathway 
Access     
 
Accessed 99 (94.3) 6 (5.7) 1.50 (1.35 – 1.66) <0.001 <0.001 
Not accessed a 91 (53.8) 78 (46.2) - - - 
Setting      
Environment      
Emergency 
Department 99 (70.2) 42 (29.8) 1.09 (0.91 – 1.14) 0.75 
 
Acute Ward a 91 (68.4) 42 (31.6) - -  
Day      
Weekday 134 (68.7) 61 (31.3) 0.98 (0.87 – 1.10) 0.72  
Weekend/Public 
Holiday a 56 (70.9) 23 (29.1) - - 
 
Shift      
Day 50 (57.5) 37 (42.5) 0.80 (0.69 – 2.50) <0.01 0.12 
Evening 48 (80.0) 12 (20.0) 0.88 (0.74 – 1.05) 0.16 0.16 
Nights 31 (67.4) 15 (32.6) 0.95 (0.82 – 1.11) 0.55 0.52 
Long day a 61 (75.3) 20 (24.7) - - - 
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p 
adjusted calculated using multiple regression model adjusting for variables shown to be significant on single regression 




Table F-2 - Admission as per Hospital HealthPathways recommendations: Number (percentage) of patients with guideline 
compliant care and logistic regression analysis 









OR (95% CI)* p value** p 
adjusted*** 
Patient      
Gender      
Male 97 (68.3) 45 (31.7) 1.08 (0.65 – 1.79) 0.77  
Female a 88 (66.7) 44 (33.3) - -  
Age (years)      
>75 112 (82.4) 24 (17.6) 6.22 (2.96 – 13.43) <0.001 <0.001 
65-74 29 (67.4) 14 (32.6) 2.76 (1.16 – 6.82) 0.02 0.07 
45-64 26 (49.1) 27 (50.9) 1.28 (0.57 – 2.92) 0.55 0.52 
18-44 a 18 (42.9) 24 (57.1) - - - 
Ethnicity      
NZ European 133 (66.5) 67 (33.5) 0.81 (1.25 – 5.16) 0.58  
Maori 17 (70.8) 7 (29.2) 0.99 (0.32 – 3.15) 0.99  
Pacific Islands 8 (66.7) 4 (33.3) 1.09 (0.26 – 5.65) 0.91  
Other a 27 (71.0) 11 (29.0) - -  
Co-morbidity      
COPD 49 (77.8) 14 (22.2) 1.93 (1.02 – 3.84) 0.05 0.60 
No COPD a 136 (64.5) 75 (35.5) - - - 
Respiratory 
comorbidity 100 (66.2) 51 (33.8) 1.13 (0.68 – 1.88) 0.65 
 
No respiratory 
comorbidity a 84 (68.9) 38 (31.1) - - 
 
9 or more 
comorbidities 22 (78.6) 6 (21.4) 2.58 (1.02 – 7.46) 0.06 
0.76 
4 to 8 
comorbidities 99 (72.3) 38 (27.7) 1.83 (1.08 – 3.14) 0.03 
0.94 
0 to 3 
comorbidities a 64 (58.7) 45 (41.3) - - 
- 
Severity      
Severe  79 (100.0) 0 (0.0)    
Moderate  71 (92.2) 6 (7.8)    
Mild  a 35 (29.7) 83 (70.3) - -  
SIRs      
Met SIRs criteria 151 (70.9) 62 (29.1) 1.93 (1.07 – 3.47) 0.03 0.27 
Did not meet 
SIRs criteria a 34 (55.7) 27 (44.3) - - 
- 
Doctor      
Gender      
Male 87 (64.9) 47 (35.1) 0.79 (0.48 – 1.32) 0.37  
Female a 98 (70.0) 42 (30.0) - -  
Seniority      
SMO 35 (70.0) 15 (30.0) 0.97 (0.39 – 2.38) 0.94  
Registrar 29 (70.7) 12 (29.3) 0.81 (0.37 – 1.66) 0.57  
TI/House Officer 








Specialty      
Emergency 
Medicine 97 (76.4) 30 (23.6) 1.39 (0.29 – 5.33) 0.65 
 
General Medicine 81 (59.1) 56 (40.9) 0.62 (0.13 – 2.33) 0.50  
Other sub-




Access     
 
Accessed 80 (76.2) 25 (23.8) 1.95 (1.14 – 3.41) 0.02 0.08 
Not accessed a 105 (62.1) 64 (37.9) - - - 
Setting      
Environment      
Emergency 
Department 108 (76.6) 33 (23.4) 2.38 (1.42 – 4.03) 0.001 
0.002 
Acute Ward a 77 (57.9) 56 (42.1) - - - 
Day      
Weekday 133 (68.2) 62 (31.8) 1.11 (0.63 – 1.93) 0.70  
Weekend/Public 
Holiday a 52 (65.8) 27 (34.2) - - 
 
Shift      
Day 63 (72.4) 24 (27.6) 1.75 (0.87 – 3.54) 0.12  
Evening 35 (76.1) 11 (23.9) 2.12 (0.92 – 5.11) 0.08  
Nights 51 (63.0) 30 (37.0) 1.13 (0.57 – 2.25) 0.72  
Long day a 36 (60.0) 24 (40.0) - -  
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p 
adjusted calculated using multiple regression model adjusting for variables shown to be significant on single regression 




Table F-3 - Correct route of antibiotics: Number (percentage) of patients with guideline compliant care and logistic 
regression analysis 













Patient      
Gender      
Male 96 (67.6) 46 (32.4) 0.94 (0.56 – 1.56) 0.81  
Female a 91 (68.9) 41 (31.1) - -  
Age (years)      
>75 109 (80.1) 27 (19.9) 4.04 (1.94 – 8.51) <0.001 0.11 
65-74 30 (69.8) 13 (30.2) 2.31 (0.96 – 5.72) 0.07 0.12 
45-64 27 (50.9) 26 (49.1) 1.04 (0.46 – 2.34) 0.93 0.47 
18-44 a 21 (50.0) 21 (50.0) - - - 
Ethnicity      
NZ European 137 (68.5) 63 (31.5) 1.00 (0.46 – 2.08) 0.99  
Maori 15 (62.5) 9 (37.5) 0.77 (0.262 – 2.28) 0.63  
Pacific Islands 9 (81.8) 2 (18.2) 2.08 (0.45 – 15.01) 0.39  
Other a 26 (66.7) 13 (33.3) - -  
Co-morbidity      
COPD 48 (78.7) 13 (21.3) 1.80 (0.95 – 3.59) 0.08  
No COPD a 139 (65.6) 73 (34.4) - -  
Respiratory comorbidity 88 (69.8) 38 (30.2) 1.31 (0.78 – 2.20) 0.31  
No respiratory 
comorbidity a 99 (66.9) 49 (33.1) - - 
 
9 or more comorbidities 22 (78.6) 6 (21.4) 2.04 (0.80 – 5.93) 0.15  
4 to 8 comorbidities 95 (69.3) 42 (30.7) 1.26 (0.74 – 2.15) 0.40  
0 to 3 comorbidities a 70 (64.2) 39 (35.8) - -  
Severity      
Severe  57 (72.2) 22 (27.8) 
29.35 (11.23 – 101. 
06) <0.001 
<0.001 
Moderate  56 (72.7) 21 (27.3) 9.39 (4.64 – 20.51) <0.001 <0.001 
Mild  a 74 (62.7) 44 (37.3) - - - 
SIRs      
Met SIRs criteria 149 (70.0) 64 (30.0) 1.41 (0.77 – 2.54) 0.26  
Did not meet SIRs 
criteria a 38 (62.3) 23 (37.7) - - 
 
Doctor      
Gender      
Male 88 (65.7) 46 (34.3) 0.79 (0.47 – 1.32) 0.37  
Female a 99 (70.7) 41 (29.3) - -  
Seniority      
SMO 36 (72.0) 14 (28.0) 1.19 (0.48 – 2.96) 0.70  
Registrar 123 (67.2) 60 (32.8) 0.95 (0.45 – 1.94) 0.89  
TI/House Officer a 28 (68.3) 13 (31.7) - -  
Specialty      







General Medicine 89 (65.0) 48 (35.0) 0.79 (0.17 – 3.00) 0.75  
Other Sub-Specialty a 7 (70.0) 3 (30.0) - -  
HealthPathway 
Accessed     
 
Accessed 78 (74.3) 27 (25.7) 1.59 (0.93 – 2.75) 0.09  
Not accessed a 109 (64.5) 60 (35.5) - -  
Setting      
Environment      
Emergency Department 102 (72.3) 39 (27.7) 1.48 (0.89 – 2.47) 0.13  
Acute Ward a 85 (63.9) 48 (36.1) - -  
Day      
Weekday 135 (69.2) 60 (30.8) 1.17 (0.67 – 2.03) 0.58  
Weekend/Public Holiday 
a 52 (65.8) 27 (34.2) - - 
 
Shift      
Day 62 (71.3) 25 (28.7) 1.15 (1.27 – 3.80) 0.70  
Evening 41 (68.3) 19 (31.7) 1.06 (0.46 – 2.46) 0.89  
Nights 32 (69.6) 14 (30.4) 0.83 (0.41 – 1.68) 0.61  
Long day a 52 (64.2) 29 (35.8) - -  
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p adjusted 





Table F-4 - Correct choice of antibiotics: Number (percentage) of patients with guideline compliant care and logistic 
regression analysis 













Patient      
Gender      
Male 64 (45.1) 78 (54.9) 0.82 (0.51 – 1.32) 0.41  
Female a 66 (50.0) 66 (50.0) - -  
Age (years)      
>75 70 (51.5) 66 (48.5) 1.06 (0.53 – 2.13) 0.87  
65-74 20 (46.5) 23 (53.5) 0.87 (0.37 – 2.04) 0.75  
45-64 19 (35.8) 34 (64.2) 0.56 (0.24 – 1.27) 0.17  
18-44 a 21 (50.0) 21 (50.0) - -  
Ethnicity      
NZ European 93 (46.5) 107 (53.5) 0.97 (0.48 – 1.95) 0.92  
Maori 13 (54.2) 11 (45.8) 1.31 (0.47 – 3.71) 0.60  
Pacific Islands 6 (54.5) 5 (45.5) 1.33 (0.34 – 5.35) 0.68  
Other a 18 (46.2) 21 (53.8) - -  
Co-morbidity      
COPD 30 (49.2) 31 (50.8) 1.14 (0.65 – 2.01) 0.65  
No COPD a 100 (47.2) 112 (52.8) - -  
Respiratory comorbidity 60 (47.6) 66 (52.4) 0.96 (0.60 – 1.55) 0.87  
No respiratory 
comorbidity a 70 (47.3) 78 (52.7) - - 
 
9 or more comorbidities 10 (35.7) 18 (64.3) 0.73 (0.30 – 1.71) 0.48  
4 to 8 comorbidities 73 (53.3) 64 (46.7) 1.50 (0.91 – 2.50) 0.11  
0 to 3 comorbidities a 47 (43.1) 62 (56.9) - -  
Severity      
Severe  39 (49.4) 40 (50.6) 2.66 (1.48 – 4.83) 0.001 0.86 
Moderate  37 (48.1) 40 (51.9) 0.98 (0.55 – 1.76) 0.95 0.09 
Mild  a 54 (45.8) 64 (54.2) - - - 
SIRs      
Met SIRs criteria 104 (48.8) 109 (51.2) 1.28 (0.73 – 2.30) 0.39  
Did not meet SIRs 
criteria a 26 (42.6) 35 (57.4) - - 
 
Doctor      
Gender      
Male 57 (42.3) 77 (57.5) 0.68 (0.42 – 1.09) 0.11  
Female a 73 (52.1) 67 (47.9) - -  
Seniority      
SMO 18 (36.0) 32 (64) 0.49 (0.21 – 1.12) 0.09  
Registrar 90 (49.2) 93 (50.8) 0.84 (0.42 – 1.65) 0.60  
TI/House Officer a 22 (53.7) 19 (46.3) - -  
Specialty      






General Medicine 61 (44.5) 76 (55.5) 0.80 (0.21 – 3.01) 0.74  
Other Sub-Specialty a 5 (50.0) 5 (50.0) - -  
HealthPathway Access      
Accessed 61 (58.1) 44 (41.9) 2.01 (1.23 – 3.31) 0.01 <0.001 
Not accessed a 69 (40.8) 100 (59.2) - - - 
Setting      
Environment      
Emergency Department 72 (51.1) 69 (48.9) 1.35 (0.84 – 2.18) 0.22  
Acute Ward a 58 (43.6) 75 (56.4) - -  
Day      
Weekday 98 (50.3) 97 (49.7) 1.48 (0.88 – 2.54) 0.14  
Weekend/Public Holiday 
a 32 (40.5) 47 (59.5) - - 
 
Shift      
Day 39 (44.8) 48 (55.2) 0.93 (0.48 – 1.80) 0.83  
Evening 28 (46.7) 32 (53.3) 1.49 (0.69 – 3.24) 0.32  
Nights 26 (56.5) 20 (43.5) 0.96 (0.49 – 1.88) 0.91  
Long day a 37 (45.7) 44 (54.3) - -  
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p adjusted 





Table F-5 - Correct overall management on admission: Number (percentage) of patients with guideline compliant care and 
logistic regression analysis 




  Compliant N (%) 
Non-Compliant 
N (%) 
OR (95% CI)* p value** p 
adjusted*** 
Patient        
Gender        
Male 41 (28.9) 101 (71.1) 1.22 (0.71 – 2.09) 0.47  
Female a 33 (25.0) 99 (75.0) - -  
Age (years)        
>75 43 (31.6) 93 (68.4) 1.70 (0.77 – 4.05) 0.21  
65-74 11 (25.6) 32 (74.4) 1.26 (0.46 – 3.52) 0.65  
45-64 11 (20.8) 42 (79.2) 0.96 (0.36 – 2.64) 0.94  
      
18-44 9 (21.4) 33 (78.6) - -  
Ethnicity        
NZ European 57 (28.5) 143 (71.5) 2.63 (1.06 – 7.98) 0.06  
Maori 8 (33.3) 16 (66.7) 3.30 (0.95 – 12.50) 0.06  
Pacific Islands 4 (33.3) 8 (66.7) 3.77 (0.77 – 18.23) 0.09  
Other a 5 (13.2) 33 (86.8) - -  
Co-morbidity        
COPD 20 (31.7) 43 (68.3) 1.35 (0.72 – 2.48) 0.34  
No COPD a 54 (25.6) 157 (74.4) - -  
Respiratory comorbidity 35 (28.7) 87 (71.3) 1.16 (0.67 – 1.97) 0.60  
No respiratory 
comorbidity a 39 (25.7) 113 (74.3) - - 
 
9 or more comorbidities 3 (10.7) 25 (89.3) 0.38 (0.09 – 1.21) 0.14  
4 to 8 comorbidities 45 (32.8) 92 (67.2) 1.56 (0.89 – 2.78) 0.12  
0 to 3 comorbidities a 26 (23.9) 83 (76.1) - -  
Severity        
Severe  34 (43.0) 45 (57.0) 4.82 (2.45 – 9.81) <0.001 <0.001 
Moderate  24 (31.2) 53 (68.8) 2.89 (1.42 – 5.99) 0.003 0.009 
Mild  a 16 (13.6) 102 (86.4) - - - 
SIRs        
Met SIRs criteria 58 (27.2) 155 (72.8) 1.05 (0.56 – 2.05) 0.88  
Did not meet SIRs 
criteria a 16 (26.2) 45 (73.8) - - 
 
Doctor        
Gender        
Male 21 (15.7) 113 (84.3) 0.305 (0.17 – 0.54) <0.001 0.01 
Female a 53 (37.9) 87 (62.1) -- -  
Seniority        
SMO 7 (14.0) 43 (86.0) 0.17 (0.06 – 0.45) <0.001 0.07 
Registrar 47 (25.7) 136 (74.3) 0.36 (0.18 – 0.73) 0.004 0.04 
TI/House Officer a 20 (48.8) 21 (51.2) - - - 
Specialty        
Emergency Medicine 43 (33.9) 84 (66.1) 4.61 (0.83 – 86.35) 0.15  






Other sub-specialtya 1 (10.0) 9 (90.0) - -  
HealthPathway Access        
Accessed 45 (42.9) 60 (57.1) 3.62 (2.09 – 6.37) <0.001 0.002 
Not accessed 20 (12.5) 140 (87.5) - - - 
Setting        
Environment        
Emergency Department 46 (32.6) 95 (67.4) 1.82 (1.06 – 3.16) 0.03 0.43 
Acute Ward a 28 (21.1) 105 (78.9) - - - 
Day        
Weekday  54 (27.7) 141 (72.3) 1.13 (0.63 – 2.08) 0.69  
Weekend/Public Holiday 
a   20 (25.3) 59 (74.7) - - 
 
Shift        
Day 21 (24.1) 66 (75.9) 0.88 (0.41 – 1.88) 0.73  
Evening 17 (37.0) 29 (63.0) 1.61 (0.70 – 3.72) 0.26  
Nights 20 (24.7) 61 (75.3) 0.90 (0.42 – 1.95) 0.79  
Long Day a   16 (26.7) 44 (73.3) - -  
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p adjusted 









  Single Logistic Regression 
 Complied N (%) Did not comply N (%) *OR (95% CI) **p value 
Patient     
Gender     
Male 88 (76.5) 27 (23.5) 1.42 (0.79 – 2.58) 0.24 
Female a 78 (69.6) 34 (30.4) - - 
Age (years)     
>75 76 (71.7) 30 (28.3) 1.17 (0.51 – 2.58) 0.33 
65-74 25 (69.4) 11 (30..6) 1.05 (0.39 – 2.84) 0.64 
45-64 39 (83.0) 8 (17.0) 2.25 (0.82 – 6.47) 0.59 
18-44 a 26 (68.4) 12 (31.6) - - 
Ethnicity     
NZ European 121 (74.2) 42 (25.8) 1.25 (0.53 – 2.79) 0.59 
Maori 14 (63.6) 8 (36.4) 0.76 (0.24 – 2.42) 0.64 
Pacific Islands 7 (87.5) 1 (12.5) 3.04 (0.45 – 60.82) 0.33 
Other a 23 (69.7) 10 (30.3) - - 
Co-morbidity     
COPD 33 (67.3) 16 (32.7) 0.70 (0.35 – 1.41) 0.30 
No COPD a 133 (74.7) 45 (25.3) - - 
Respiratory comorbidity 72 (68.6) 33 (31.4) 0.63 (0.34 – 1.13)  0.12 
No respiratory 
comorbidity a 94 (77.7) 27 (22.3) - - 
9 or more comorbidities 10 (50.0) 10 (50.0) 0.75 (0.61 – 0.93) 0.01 
4 to 8 comorbidities 81 (73.0) 30 (27.0) 0.95 (0.84 – 1.07) 0.40 
0 to 3 comorbidities a 75 (78.1) 21 (21.9) - - 
Severity     
Severe  31 (62.0) 19 (38.0) 0.71 (0.35 – 1.44) 0.34 
Moderate  49 (76.6) 15 (23.4) 1.13 (0.55 – 2.38) 0.74 
Mild  a 78 (74.3) 27 (25.7) - - 
SIRs     
Met SIRs criteria 130 (75.1) 43 (24.9) 1.51 (0.77 – 2.91) 0.22 
Did not meet SIRs 
criteria a 36 (66.7) 18 (33.3) - - 
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p 
adjusted calculated using multiple regression model adjusting for variables shown to be significant on single regression 




G. Appendix G – Reasons For Non-Compliance, Subgroup Reasons and Logistic Regression 
Table G-1 - Reasons for non-compliance with choice of antibiotics: Number (percentage) of reasons for non-compliance with choice of antibiotics and logistic regression analysis 
 Number of cases (Percentage), Ordinal logistic regression 
 Objective N (%) Subjective N (%) Disagree N (%) Unintentional N (%) *OR (95% CI) **P value ***P adjusted 
Patient        
Gender        
Male 45 (59.2) 12 (15.8) 7 (9.2) 12 (15.8) 1.31 (0.7 – 2.46) 0.4  
Female a 32 (48.5) 19 (28.8) 8 (12.1) 7 (10.6) - -  
Age (years)        
>75 32 (49.2) 17 (26.2) 6 (9.2) 10 (15.4) 0.53 (0.19 – 1.44) 0.21  
65-74 11 (47.8) 6 (26.1) 2 (8.7) 4 (17.4) 0.49 (0.15 – 1.59) 0.23  
45-64 20 (60.6) 5 (15.2) 5 (15.2) 3 (9.1) 0.77 (0.25 – 2.36) 0.65  
18-44 a 14 (66.7) 3 (14.3) 2 (9.5) 2 (9.5) - -  
Ethnicity        
Other 9 (47.4) 6 (31.6) 1 (5.3) 3 (15.8) 0.80 (0.32 – 1.97) 0.63  
Pacific Islands 2 (40.0) 3 (60.0) 0 (0.0) 0 (0.0) 0.95 (0.21 – 4.30) 0.94  
Maori 6 (54.5) 1 (9.1) 1 (9.1) 3 (27.3) 0.70 (0.20 - 2.43) 0.57  
NZ European a 60 (56.2) 21 (19.6) 13 (12.1) 13 (12.1) - -  
Co-morbidity        
No COPD 66 (58.9) 24 (21.4) 12 (10.7) 10 (8.9) 2.84 (1.32 – 6.09) 0.01 0.09 




No respiratory comorbidity 46 (59.0) 16 (20.5) 9 (11.5) 7 (9.0) 1.59 (0.85 – 3.00) 0.15  
Respiratory comorbidity a 31 (48.4) 15 (23.4) 6 (9.4) 12 (18.8) - -  
9 or more comorbidities 8 (47.1) 5 (29.4) 1 (5.9) 3 (17.6) 0.75 (0.75 – 2.04) 0.57  
4 to 8 comorbidities 33 (52.4) 17 (27.0) 5 (7.9) 8 (12.7) 0.92 (0.47 – 1.81) 0.82  
0 to 3 comorbidities a 36 (58.1) 9 (14.5) 9 (14.5) 8 (12.9) - -  
Severity        
Severe 11 (40.7) 7 (25.9) 2 (7.5) 7 (25.9) 0.42 (0.18 – 0.98) 0.05 0.93 
Moderate 23 (48.9) 15 (31.9) 2 (4.3) 7 (14.9) 0.72 (0.35 – 1.47) 0.36 0.30 
Mild a 43 (63.2) 9 (13.2) 11 (16.2) 5 (7.4) - - - 
SIRs        
Did not meet SIRs criteria 20 (60.6) 4 (12.1) 5 (15.2) 4 (12.1) 1.22 (0.57 – 2.64) 0.60  
Met SIRs criteria a 57 (52.3) 27 (24.8) 10 (9.2) 15 (13.8) - -  
Doctor        
Gender        
Male 38 (47.5) 19 (23.8) 13 (16.3) 10 (12.5) 0.73 (0.39 – 1.37) 0.33  
Female a 39 (62.9) 12 (19.4) 2 (3.2) 9 (14.5) - -  
Seniority        
SMO 11 (35.5) 7 (22.6) 6 (19.4) 7 (22.6) 0.23 (0.07 – 0.79) 0.02 0.001 
Registrar 53 (57.0) 22 (23.6) 9 (9.7) 9 (9.7) 0.59 (0.20 – 1.79) 0.35 0.29 
TI/House Officer a 13 (72.2) 2 (11.1) 0 (0.0) 3 (16.7) - - - 
Specialty        




General Medicine 39 (52.7) 20 (27.0) 7 (9.5) 8 (10.8) 1.10 (0.58 – 2.10) 0.76  
Emergency Medicine a 35 (55.6) 9 (14.3) 8 (12.7) 11 (17.5) - -  
HealthPathways Access        
Accessed 23 (53.5) 9 (20.9) 1 (2.3) 10 (23.3) 3.24 (0.59 – 17.82) 0.20  
Did not access a 54 (54.5) 22 (22.2) 14 (14.2) 9 (9.1) - -  
Setting        
Environment        
Emergency Department 38 (55.1) 18 (26.1) 5 (7.2) 8 (11.6) 1.21 (0.65 – 2.27) 0.55  
Acute Ward a 39 (53.4) 13 (17.8) 10 (13.7) 11 (15.1) - -  
Day        
Weekend/Public Holiday 22 (50.0) 11 (25.0) 5 (11.4) 6 (13.6) 0.83 (0.42 – 1.62) 0.58  
Weekday a 55 (56.1) 20 (20.4) 10 (10.2) 13 (13.3) - -  
Shift        
Long day 21 (65.6) 6 (18.8) 1 (3.1) 4 (12.5) 2.32 (0.95 – 5.67) 0.06  
Nights 22 (51.2) 13 (30.1) 2 (4.7) 6 (14.0) 1.43 (0.66 – 3.07) 0.36  
Evening 13 (65.0) 2 (10.0) 3 (15.0) 2 (10.0) 2.08 (0.73 – 5.92) 0.17  
Day a 21 (44.7) 10 (21.3) 9 (19.1) 7 (14.9) - -  
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression model ***p adjusted calculated using multiple regression model adjusting for variables 


















































































































I. Appendix I – Survey responses 
Table I-1 – Summarised text responses to survey round 1 
Question and topic I would follow this guideline 
when: 
I would not follow this 
guideline when:  
1 -Exclusion of 
DVT in patients 
with low risk 
stratification scores 
(Wells score) with 
D-dimer alone 
-I have low clinical suspicion of 
DVT and the patient has low 
Wells score 
-The patient is low risk for DVT 
and has a negative D dimer 
 
-I have high clinical suspicion 
despite low Wells’ score/d 
dimer 
-A raised d dimer will not be 
specific to DVT  
-I am unable to obtain serum 
sample to measure d-dimer 
-Point of care or easy to access 
USS is readily available 
-There is high patient anxiety 
-Missing a DVT would be 
dangerous 




-No responses -The patient has worsened despite amoxicillin in the 
community 
-The patient is clinically more unwell than the 
CURB score reflects 
-There is suggestion or risk of atypical or resistant 
infection (previous culture, smoker etc) 
-The patient is frail or comorbid 
-There is concurrent infection elsewhere 
-The patient has been treated for PUO prior to 
diagnosis of pneumonia 
-The patient is penicillin allergic 
-The patient has COPD 
-The team I am referring to advises me otherwise 
-The patient has already been placed on broader 
spectrum antibiotics by the Dr who saw them before 
me 




-Local data suggests high rates of amoxicillin 
resistance 
-My personal experience tells me that this regimen 
is ineffective 
3 -Exclusion of PE 
in patients with low 
risk stratification 
scores (revised 
Geneva score) with 
D-dimer alone 
-When I have low clinical 
suspicion for PE 
-In the majority of cases 
 
-I have high clinical suspicion 
despite low Geneva score/d 
dimer 
-The patient looks unwell or is 
too sore for discharge and no 
other diagnosis has been found 
-The patient would have a CT 
anyway for undifferentiated 
symptoms 
-A raised d dimer will not be 
specific to VTE 
-Missing a PE would be 
dangerous 






blood pressure from 
stroke thrombolysis 
-Always -The risk to benefit ratio 
favours thrombolysis, 
following discussion with the 
patient/next of kin and 
consultant on call 
-When marginal blood pressure 
can be maintained with 
labetalol infusion 
-I expect the blood pressure to 
drop 
I was unable to answer this 
question because: 
-The guideline is unclear 
-Thrombolysis for stroke is a 
consultant decision 
-I do not have enough experience 
in this area 
5 -The use of PO 
flucloxacillin to treat 
worsening 
uncomplicated 
cellulitis in the first 
48 hours 
-As worsening signs and 
symptoms lag behind bacterial 
killing and improving 
inflammatory markers 
-As I do not think there is a role 
for broad spectrum antibiotics for 
-If there were risk factors for 
complicated /atypical disease 
eg MRSA 
-If the patient had had previous 
atypical/resistant organisms 





-And review in another 24hrs 
-And avoid making the boundaries 
on day 1 
-Depending on the severity and 
location of the cellulitis 
 
cellulitis previously 
unresponsive to first line 
treatment 
-If the patient was 
septic/looked unwell 
-If the patient was 
elderly/comorbid 
-If there were compliance 
issues 
-If the patient is penicillin 
allergic 
-I normally switch to IV via 
Acute Demand 
-I often give IV antibiotics 
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